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ABSTRACT 
 
A successful transition into lactation determines optimum production, reproduction, and 
health. The peripartum period is characterized by an inflammatory state that, if not controlled, 
could be detrimental to the cow. The first experiment examined hepatic and adipose gene 
expression in response to injections of a non-steroidal anti-inflammatory compound (Carprofen) 
on 1, 3, and 5 d postpartum. Results indicated that after calving both tissues respond to 
inflammation signals, underscoring its role in the normal homeorhetic adaptations to lactation. 
The second experiment investigated the effect of prepartal nutrition and its interaction with BCS 
on hepatic and adipose tissue transcriptome, and the liver one-carbon metabolism and 
transulfuration pathway. Cows were randomly allocated to one of four groups in a 2 × 2 factorial 
arrangement: 4.0 or 5.0 BCS prepartum (10-point scale) and dietary energy at 75 or 125% of 
estimated requirements during the close-up. Tissue biopsies were harvested at -1, 1 and 4 wk 
relative to parturition. The greater number of hepatic differentially expressed genes in BCS4 
cows in response to increased prepartum feed allowance (1071 vs 310, over the entire transition 
period) indicated a greater responsiveness to prepartum nutrition than optimally-conditioned 
cows. Thus, overfeeding in late-pregnancy should be limited to underconditioned cows, while 
cows with optimal BCS should be maintained on an energy-restricted diet. Adipose tissue 
mRNA and microRNA expression further confirmed this hypothesis, and indicated a relationship 
between the immune and metabolic response of the adipose tissue underscoring the existence of 
a “self-regulatory” mechanism. The extensive analysis of the hepatic one-carbon metabolism and 
related pathways highlighted fundamental differences in the metabolic progression of grazing 
cows compared to their higher-yield counterpart in TMR-based systems. Results also indicated a 
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greater flux through these pathways in optimally conditioned cows feed restricted prepartum. 
The third experiment examined the effect of over-feeding in both close-up and far-off periods on 
the adipose tissue transcriptome. Far-off over-feeding is usually a standard practice in seasonal 
grazing systems as, compared with TMR-fed cows, cows are thinner at the end of lactation. 
Adipose expression data revealed how overfed cows in the far-off period had greater 
adipogenesis, consistent with their rapid gain in BCS following dry-off, but a lower body fat 
mobilization in early lactation. The results indicated that neither strategy negatively affected the 
adaptations to lactation. However, to ensure a favorable transition, cows should be subjected to a 
small feed restriction in the close-up period, irrespective of far-off nutrition. Overall, results 
indicated a beneficial involvement of the immune system in the adaptation to lactation, and the 
possibility to regulate this process through prepartal BCS and nutrition management. 
As a result of the three studies, New Zealand farmers, through DairyNZ (the industry 
organization that represents all New Zealand dairy producers), are now discouraged to apply 
prophylactic pharmacological intervention early postpartum, in favour of nutritional management 
during the dry period. Our recommendation is for cows to be properly managed in late lactation 
and early dry period to attain optimal condition (e.g, BCS 5) by close-up (3 wks from calving). 
Subsequently cows will benefit from a controlled feed restriction (75–90% of requirements). On 
the other hand, cows in less than optimal condition (e.g. BCS ≤ 4) should be fed to requirements 
or slightly overfed (110-120% of requirements) before calving. This is an easily implementable 
strategy based on pasture allocation capable of benefitting the farmer with a minimum cost.
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CHAPTER 1: INTRODUCTION 
 
The transition period, defined as last 3 wk prepartum through 3 wk postpartum, is one of 
the most important stages of lactation in dairy cattle, characterized by significant metabolic and 
immune challenges (Bell, 1995, Drackley, 1999). Because failure to adequately meet these 
challenges can compromise production, induce metabolic diseases, and increase rates of culling 
in early lactation (Curtis et al., 1985), the management of the transition cow remains a focal 
point for dairy producers. Traditional management provides dry cows with a high-fiber/low-
energy density ration, increasing the ration energy density and reducing the fiber content in the 
3-4 wk prior parturition. This practice originated from the recommendation of Boutflour (1928). 
However, studies from the last decades have demonstrated that prepartum overfeeding of energy 
often leads to a wrecked transition (Rukkwamsuk et al., 1999, Holtenius et al., 2003, Dann et al., 
2006, Soliman et al., 2007, Janovick et al., 2011, Graugnard et al., 2013, Ji et al., 2014, Khan et 
al., 2014, Shahzad et al., 2014). 
Even though cow adiposity (measured through body condition score, a qualitative 
measurement) plays an important role in the metabolic response of the animal to lactation and its 
level is regulated through nutrition, cows with different level of adiposity are generally managed 
similarly during the prepartum period. The connection of prepartal nutrition and BCS is further 
strengthened by the fact that similar negative responses to overnutrition have been also observed 
when cows reached parturition at extreme levels (e.g., too high or too low) of BCS (Waltner et 
al., 1993, Hayirli et al., 2002, Holtenius et al., 2003, Roche et al., 2005, Roche et al., 2009, Pires 
et al., 2013, Akbar et al., 2015, Randall et al., 2015). 
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During the transition period dairy cows experience an inflammatory status (e.g., increased 
plasma pro-inflammatory cytokines and acute-phase proteins) which magnitude and duration 
have been linked to increased disease risk and decrease performances (Ohtsuka et al., 2001, 
Ametaj et al., 2005, Bertoni et al., 2008, Huzzey et al., 2009, Dubuc et al., 2010, Qu et al., 2014). 
Both nutritional and adiposity management have been proven effective in counteracting the most 
negative effects of this transient inflammatory status (Drackley and Cardoso, 2014, Kay et al., 
2015). Scientist have however tried to use nonsteroidal anti-inflammatory drugs (NSAID) as a 
possible intervention to modulate the immunological status of the transitioning dairy cow. 
Successful results using aspirin derived compounds have been published (Bertoni et al., 2004, 
Trevisi et al., 2005, Trevisi and Bertoni, 2008, Farney et al., 2013a, Farney et al., 2013b), while 
other drugs have yielded variable outcomes (Newby et al., 2013, Priest et al., 2013, Shock et al., 
2018). 
The objectives of these studies were to evaluate the effect of (i) carprofen, a 
commercially available NSAID, or (ii) nutrional interventions (prepartal BCS, energy feeding, 
and their interaction) on transition cow physiology via molecular characterization of adipose and 
liver metabolism. These tissues were chosen as important players in the peripartal adaptation to 
lactation, and as immunoresponsive tissues involved in the network linking immunity and 
nutrient metabolism. We hypothesized that (i) early NSAID treatment postpartum (following 
published protocols; Bertoni et al., 2004) would improve lactation performance, reproductive 
parameters, and overall animal health via molecular mechanism in the adipose and hepatic tissue.  
Furthermore, we hypothesized that (ii) prepartal nutritional regimen has to be tailored to the cow 
adiposity level to obtain a favourable transition to lactation, such that the industry standard of 
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energy overfeeding is suitable for thinner cows, while optimally conditioned cows have to be 
feed restricted prepartum.  
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CHAPTER 2: LITERATURE REVIEW 
 
THE TRANSITION PERIOD 
Approaching parturition, dairy cows enter the most interesting stage of the lactation 
cycle, where they undergo tremendous changes during the transition from late gestation to early 
lactation. Although the length of time classified as the transition period, or periparturient period, 
has been defined differently by different authors, it is commonly referred to as the last 3 weeks 
before parturition to 3 weeks after parturition, following the definition by Grummer (1995). 
As stated by Goff and Horst (1997), “The transition from the pregnant, non-lactating state 
to the non-pregnant, lactating state is too often a disastrous experience for the cow. The well-
being and profitability of the cow could be greatly enhanced by understanding those factors that 
account for the high disease incidence in periparturient cows.” In this context, the term transition 
is to underscore the occurring physiological, metabolic, and nutritional changes. It constitutes a 
turning point in the productive cycle of the dairy cow from one lactation to the next. The manner 
in which these changes occur and how they are managed are of great importance as they closely 
relate to lactation performance, clinical and subclinical postpartum diseases, and reproductive 
performance that can significantly affect profitability. Many reports exist linking metabolic and 
health problems with a decreased productivity (Simianer et al., 1991, Jones et al., 1994, 
Emanuelson and Oltenacu, 1998) and with the economic losses associated with these (Drackley, 
1999). The occurrence of health problems during the transition period is clearly a major 
complicating factor for subsequent reproductive performance (Ferguson, 2005), resulting in 
additional economic losses. Poor transitions also result in milk income losses, with up to 900 to 
1800 kg of unrealized milk yield (Wallace et al., 1996). Translating this data to nowadays 
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production would result in even greater losses. It is, therefore, pertinent to elaborate nutritional 
strategies to facilitate the passage of the cow through this transition phase; while minimizing 
health problems and optimizing productivity/ profitability for the remainder of the ensuing 
lactation. 
 
Homeorhesis and Nutrient Partitioning 
The fundamental driver of the physiological changes is to ensure provision of adequate 
nutrients for the calf, both prenatally and postnatally. In mammals, during a general period, 
nutrients are utilized by tissues involved in maintenance and growth and for establishing body 
reserves including energy stores (lipids), glucose reserves (glycogen), and amino acid reserves 
(labile protein). However, during the transition period two additional tissues are utilizing a 
substantial portion of maternal nutrients: (i) the developing fetus, and (ii) the lactating mammary 
gland. One should not underestimate the importance of partitioning nutrients to support 
pregnancy and lactation, because these physiological states are the essence of survival of the 
species and, of course, the foundation of the dairy industry. These tissues differ from other body 
tissues in that they confer no special advantage to the animal. Instead, they make tremendous 
demands such that the total metabolism of the pregnant or lactating animal must be altered to 
accommodate these needs. The inability to adjust metabolism quickly enough to meet these 
needs frequently results in acute and subclinical metabolic disorders in farm animals. 
Nature has accorded a high priority to the functions of pregnancy and milk secretion, 
allowing them to proceed at the expense of other metabolic processes even to the point that a 
disease state is created. The partitioning of nutrients to various body tissues involves two types 
of regulation, homeostasis and homeorhesis. Homeostatic control involves maintenance of 
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physiological equilibrium or constant conditions in the internal environment. Homeorhesis 
instead, as defined by Bauman and Currie (1980), is “the orchestrated or coordinated changes in 
metabolism of body tissues necessary to support a physiological state”. Homeorhetic regulation 
involves a coordination of metabolism to insure a uniform flow of nutrients in support of a 
physiological state. One the most pronounced example of homeorhesis is the modern dairy cow, 
where initiation of lactation dramatically alters metabolism of many maternal organs in order to 
supply the mammary gland with the necessary nutrients for milk synthesis. All these 
physiological assessments happen also just before calving. The fundamental driver of the 
physiological changes is to ensure provision of adequate nutrients for the calf, both prenatally 
and postnatally. This can be read as an example of species homeorhesis: the many changes are 
supporting the continuity of the population, rather than the single animal. 
Pregnancy. Pregnancy imposes a substantial cost to the animal, because total 
requirements for nutrients at the end of pregnancy are about 75% greater than in a non-pregnant 
animal of the same weight (Bell, 1995). Striking maternal adaptations are required to meet these 
metabolic requirements and are achieved by regulatory influences arising in the conceptus. Thus, 
its needs are accorded high priority by the homeorhetic controls it transmits to the dam. The bulk 
of accumulation of fetal mass occurs late in pregnancy when cattle are in the dry period. The 
fetus acquires approximately 60% of its birth weight during these last 2 months of gestation, 
where, to compare the requirement of the dry period to those of the lactation, fetal demands for 
specific nutrients (glucose and amino acids) are equal to mammary use of nutrients equivalent to 
about 3 to 6 kg milk/day (Bell, 1995). 
Lactation. At the initiation of lactation, marked alterations in the general partitioning of 
nutrients and metabolism of the whole animal must occur to accommodate demands of the 
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mammary gland. The nutrient needs of the mammary gland are of such magnitude relative to 
total metabolism in a high producing dairy cow that the cow should be considered an appendage 
on the udder rather than the reverse (Brown, 1969). 
The table below (Table 2.1) is a partial listing of metabolic changes that occur with initiation of 
lactation. The listing is by no means complete, and many other important maternal functions also 
adapt to support lactation. Rather, the list is intended to underline that lactation is not just a 
function of the mammary gland. Commencement and maintenance of a successful lactation are 
dependent on alterations in many, perhaps even most, maternal tissues such that nutrients are 
partitioned to the mammary gland. Thus, regulation of nutrient partitioning by homeorhetic and 
homeostatic mechanisms is extremely important in insuring a high rate of milk production.  
Table 2.1 A partial list of the metabolic changes associated with lactogenesis in ruminants 
Physiological 
Function 
Metabolic Change Tissue involved 
Milk Synthesis Incremented use of nutrients Mammary 
Lipid Metabolism Increased lipolysis Adipose tissue 
Decreased lipogenesis 
Glucose metabolism Increased gluconeogenesis Liver 
Increased glycogenolysis 
Decreased use of glucose and 
Increased use of lipid as energy 
source 
Body tissues in general 
Protein Metabolism Mobilization of protein reserves Muscle and other body 
tissues 
Mineral Metabolism Increased absorption and 
mobilization of calcium 
Kidney, liver, gut and bone 
 
One of the major changes occurs in adipose tissue. Here uptake of nutrients for synthesis 
of storage lipids is decreased, and lipid reserves are mobilized instead (Drackley, 1999). Another 
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key nutrient is glucose, and the maximally secreting mammary gland may require up to 80% of 
the total glucose turnover (Bauman and Currie, 1980). A coordinated response meets this need; 
rates of gluconeogenesis in the liver are increased dramatically, and presumably glycogen is 
mobilized. A portion of the increase in liver gluconeogenic rates is from the increased intake 
when lactation commences (Lindsay, 1971), but total glucose synthesized per day increases even 
if a constant intake is maintained. The preference of other body tissues for nutrients to be 
oxidized for energy also is altered to allow partitioning of a greater percentage of glucose to the 
mammary gland (Bauman and Currie, 1980). At day 30 prepartum, 34% of the total glucose 
turnover is oxidized to CO2, whereas this decreases to only 8 to 9% by day 7 of lactation 
(Bennink et al., 1972). Nitrogen balance studies have demonstrated the importance of labile 
protein reserves in meeting amino acid needs for milk protein and glucose synthesis in early 
lactation. These reserves are substantial and may comprise 25 to 27% of total body protein in a 
dairy cow (Botts et al., 1979). Mineral metabolism is another area with extensive changes at 
onset of lactation, and its changes have been reviewed by Reinhardt et al. (1988) and Horst et al. 
(1994). 
 
The Dry Matter Intake (DMI) Around Parturition 
The most important aspect of transition period is the insufficient dry matter intake (DMI) 
compared to the energy requirements for lactation and maintenance (Drackley, 1999), resulting 
in a period of negative energy balance (NEB) (Drackley, 1999, Ingvartsen and Andersen, 2000, 
Trevisi et al., 2012). Some authors (Ingvartsen and Andersen, 2000, Hayirli et al., 2002) 
suggested a reduction of  DMI of about 30% in the last 3 weeks of gestation and almost 90% of 
13 
 
decrease occur during the 5 to 7 days before calving. Nevertheless, in some experiences this 
reduction does not occur in all the cows (Trevisi et al., 2002). 
The reasons behind the radical decrease in feed intake in dairy cows include a decrease in rumen 
volume and the hormonal actions that accompany the periparturient period (Bell, 1995, 
Grummer, 1995). Because of significant fetal growth during the last 60 days of gestation, 
ruminal capacity decreases by as much as 20%, then starts to increase again within 8 days after 
calving (Spain and Scheer, 2002). Decreased capacity of the rumen limits the amount of feed the 
cow can consume, however, it does not totally account for the magnitude of the decrease in dry 
matter intake that occurs around calving. Factors affecting and regulating feed intake of lactating 
cows are numerous and complex and span cellular to macroenvironmental levels (Forbes, 1996, 
Roseler et al., 1997, Allen, 2000). Factors affecting DMI in lactating dairy cows and other 
ruminants may influence DMI in prefresh transition cows as well. Some can be controlled by 
humans and include (i) animal factor (i.e., age, BCS, breed, physiological stage, milk yield 
level), (ii) dietary factors (i.e., ingredient and nutrient compositions of diets, and physical and 
agronomic characteristics of feeds), (iii) managerial factors (i.e., production, feeding and housing 
systems), and (iv) climatic factors: i.e., temperature, humidity and wind. Therefore, 
determination of factors affecting DMI and quantification of their effects are important for 
developing new feeding strategies during prefresh transition period. 
 
The Energy Metabolism And Energy Balance 
Due to the lagging DMI contrapose to the increasing milk production in the first third of 
the lactation cycle, cows undergo a negative energy balance (NEB), energetically equivalent to 
approximately 9kg/d milk, and must mobilize body reserves to compensate (Bauman and Currie, 
14 
 
1980). As parturition approaches and the dairy cow transitions into lactation, nutrient demand 
increases drastically. Requirements for glucose and metabolizable energy increase 2-3 fold from 
3 weeks before to 3 weeks after calving (Drackley et al., 2001). This physiological state puts the 
cow under a very high nutrient demand and forces her to alter her metabolism in order to meet 
these high energy needs; if the cow is unable to redirect nutrients to the fetus and mammary 
gland efficiently, she is susceptible to metabolic disorders. Nature has given pregnancy and milk 
production such high biological priorities that they will continue at the expense of other 
metabolic processes even if a state of disease is created (Bauman and Currie, 1980). 
In order to transition successfully, the cow must undergo several metabolic adaptations. She 
must increase hepatic gluconeogenesis (glucose generation from non- carbohydrate substances), 
decrease glucose usage by peripheral tissues, increase fatty acid production from adipose tissues 
and increase amino acid mobilization from muscle (Bell, 1995). These coordinated processes 
allow for increased nutrient usage by the mammary gland. Since after calving cows produce 
more milk than can be energetically produced from the amount of feed they are able to consume, 
they are forced to rely on body storages. At the onset of lactation, the adipose tissue begins to 
mobilize body reserves through lipolysis (Bauman and Currie, 1980). Triglycerides (TAG) are 
mobilized to non-esterified fatty acids (NEFA) though the action of the enzyme hormone 
sensitive lipase and increase the intracellular fatty acid pool; since there is no stimulus to re-
esterify them, they diffuse into the blood. Free fatty acids then bind to serum albumin and 
circulate to various body tissues (Drackley et al., 2001). They either enter the mammary gland, 
leading to an increase in milk fat, or are absorbed into the liver. Once in the liver, NEFA can 
either be (i) oxidized to provide energy in the liver, as the decrease in serum insulin and an 
increase in glucagon promotes oxidation of fatty acids (Vernon, 2005), (ii) converted back to 
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triglycerides, or (iii) partially oxidized to ketone bodies and released back into the blood stream 
to be used for energy by other body tissues (Drackley, 1999, Ingvartsen, 2006, Grummer, 2010). 
In non-ruminant animals, NEFA conversion to ketone bodies serves as a glucose sparing strategy 
in time of deficits and similar adaptive processes may occur in transition dairy cows. The heart, 
kidney, skeletal muscles, mammary glands and gastrointestinal tract can oxidize ketone bodies 
for energy (Heitmann et al., 1987); further, ketone bodies can be a substrate for fatty acid 
synthesis in the mammary gland suggesting ketogenesis is a strategy to compensate for 
insufficient glucose (Drackley, 1999) and a metabolic adaptation to hunger (Ingvartsen, 2006). 
Glucose metabolism. At calving, the demand for glucose sharply increases, leaving the 
cows with a deficit of around 500g/d (Overton et al., 1998). After parturition cows have 
decreased whole-body oxidation of glucose and increased glucose entry compared with 
measurements prepartum (Bennink et al., 1972). Glucose conservation is likely driven by the 
increased concentration of somatotropin (GH) that occurs around parturition (Simmons et al., 
1994). Reynolds et al. (2003) measured glucose output by the liver of transition cows and found 
out that it closely matches glucose demand calculated for the same cows, indicating that 
metabolic changes take places to support the animal during this period. The discrepancy of 
nearly 500 g/d between predicted glucose from digestible energy intake and estimated glucose 
demands must be made up by increased gluconeogenesis from intestinally absorbed amino acids 
and from endogenous substrates such as amino acids, lactate and glycerol. Esteems of 
contributions to gluconeogenesis indicates that propionate is responsible for 32 to 73 % of it, 
amino acids for 10 to 30%, lactate for 15% and glycerol only for small amounts (Seal and 
Reynolds, 1993). As a precursor, propionate produced during ruminal and hindgut fermentation 
is quantitatively the most important substrate for gluconeogenesis. Literature suggest that 
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metabolism of propionate by liver is modulated during the transition period (Overton et al., 1998, 
Reynolds et al., 2003), indicating that propionate supply and capacity of liver to utilize it for 
gluconeogenesis are linked closely during times of negative energy balance. Under most 
conditions, amino acids are not the primary gluconeogenic substrate, but they make a sizable 
contribution to ruminant gluconeogenesis. Alanine and glutamine are the two that typically make 
a net contribution to glucose synthesis, as together they account for 40-60% of all amino acids 
glucogenic potential (Bergman and Heitmann, 1978). During the early postpartal period amino 
acids may play a particularly significant role as glucogenesis increases. Compared to 21d 
prepartum, conversion of propionate to glucose increases 119 and 129% at 1 and 21d postpartum 
(Overton et al., 1998). However, conversion of alanine, increased 198 and 150% at same time 
point. In time of glucose shortage, the capacity to draw from the organism amino acids pool 
increases (Overton et al., 1999). The increased capacity in conversion to glucose of glucogenic 
amino acids might result in more instestinally-absorbed amino acids being converted, but even 
the skeletal muscle, skin and visceral tissue amino acids pool undergo adaptation to support 
gluconeogenesis during the periparturient period (Simmons et al., 1994, Bell et al., 2000). 
NEFA metabolism. A massive mobilization of NEFAs from adipose tissue during and 
after parturition in high-yielding dairy cows is the metabolic hallmark of the transition from 
pregnancy to lactation (Bell, 1995). Once up-taken by the liver, NEFA can be oxidized via β-
oxidation in the mitochondria to generate metabolites (acetyl CoA) that can be used to generate 
energy via the Krebs cycle, or alternatively, undergo β-oxidation in the peroxisomes, which are 
sub-cellular organelles present in most organs of the body. The main function of peroxisomal 
oxidation is the shortening of the NEFA chains, for example those larger than 22-24 carbon 
atoms, preparing them for beta-oxidation by the mitochondrial system (Drackley, 1999). The 
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ratio of peroxisomal oxidation to total oxidation is correlated positively to liver total lipid, liver 
TAG and plasma NEFA and negatively to DMI and energy balance (Drackley, 1999). Because 
peroxisomes do not contain a respiratory chain linked to ATP formation, peroxisomal oxidation 
is not regulated by energy demands of the cell, thus playing an important role as an “overflow” 
pathway to oxidize fatty acids during extensive NEFA mobilization. If not oxidized, the excess 
NEFA are repacked into TAG and exported as very low density lipoprotein (VLDL). However, 
the bovine liver has a limited capacity to metabolize NEFA into TAG. When the hepatic limit to 
handle NEFA is reached, the TAG accumulates in the liver, and acetyl CoA that is not utilized in 
the tricarboxylic acid cycle (TCA) is converted into ketone bodies, such as acetone, acetoacetate 
and beta-hydroxybutyrate (BHB) (Drackley, 1999). Excessive accumulation of TAG in the liver 
impairs its normal function, a scenario called fatty liver syndrome. While, when ketones are 
produced in excess of peripheral tissue's capacity to use them, they accumulate in the 
bloodstream, and in severe NEB can lead to the disease state known as ketosis. Clinically, dairy 
cows suffering from these two diseases exhibit reduced feed intake, reduced milk yield, loss of 
body weight, central nervous system involvement (staggering, lack of coordination, and 
appearance of staring or blindness) (Mulligan and Doherty, 2008).  
 
THE INFLAMMATORY STATUS OF PERIPARTURIENT COWS 
The transition period is doubtless the most important management issue of the whole 
dairy industry. Most of its many sides and mysteries have been unraveled so far and the 
comprehension of the metabolic adaptation is greater than 10 year ago, but perhaps one of the 
most challenging areas for both producers and scientist has been addressing the issues of herd 
health at the transition from dry to fresh cow (Ingvartsen and Moyes, 2015). 
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A successful transition is needed to set the stage for a successful lactation and optimum 
production, reproduction, health and culling. Metabolic disorders and health problems are 
common during this time and can easily erase the entire profit potential for dairy cows farms 
(Drackley, 1999). The well-being and profitability of the cow could greatly enhance by 
understanding those factors that account for high disease incidence in periparturient cows. 
Around parturition cows experience a period of generalize immunosuppression, from 
approximately 1 week prepartum to 1 week postpartum (Kehrli et al., 1989, Waller, 2000). This 
immune dysfunction is not limited to isolated immune variables; rather it is broad in scope and 
affects multiple functions of various immune cell types (Sordillo and Streicher, 2002). The 
combined results of immune and metabolic dysfunctions are that dairy cows may be 
hyposensitive and hyporesponsive to antigens, and therefore more susceptible to infectious 
disease such as mastitis during the peripaturient period (Mallard et al., 1998). 
Even if clear sign of immunosuppression and reduced immune functions in late 
pregnancy can be observed in late gestation and early lactation, transition cows were shown to 
display an overt inflammatory response related to pregnancy and lactation (Sordillo et al., 2009), 
even without signs of microbial infections and/or otherwise determined pathology (Bionaz et al., 
2007, Bertoni et al., 2008). This can be observed also in correlation with metabolic stress-related 
condition in early lactation.  
Many doubts remain according to the immunosuppression in the transition period and 
different studies have shown contradictory data about the function and response of the immune 
system (Ishikawa et al., 2004, Sander et al., 2011). 
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Hormonal Effect On Immunity 
The causes of the compromised immunological status during the transition period could 
lay in the nutritional and physiological status of the cow. The dry period, and the periparturient 
period in particular, is characterize by dramatic changes in the endocrine status (Hayirli et al., 
2002). Plasma insulin decreases, and growth hormone increases as the cow progresses from the 
late gestation to the early lactation, with visible surges of both hormones in plasma 
concentrations at parturition (Kunz et al., 1985). Plasma thyroxine (T4) gradually increases 
during late gestation, decreases about 50% at parturition, and then begins to increase again (Kunz 
et al., 1985). Progesterone concentrations during the dry period are elevated for the sake of 
pregnancy maintenance, but decline rapidly two days before calving, similarly to estrogen 
(primarily estrone of placental origin) that increases dramatically in plasma during late gestation, 
but decreases immediately at calving (Chew et al., 1979). Concentrations of glucocorticoid and 
prolactin increase on the day of calving and return to near prepartum concentrations the day after 
(Edgerton and Hafs, 1973). 
Estrogens and glucocorticoids are well known immunosuppressive agents (Goff and 
Horst, 1997). Estrogens have been found in some experiments to stimulate the humoral immune 
response, but most workers agree they have a strong suppressive effect on cell-mediated 
immunity (Wyle and Kent, 1977). Glucocorticoids have long been used as powerful 
immunosuppressive agents (Roth and Kaeberle, 1982). Plasma cortisol concentrations (primarily 
of maternal adrenal origin) increase from 4 to 8 ng/mL three days before calving to 15 to 30 
ng/mL at parturition and the day after calving. The cortisol secretion response is even more 
pronounced in those cows that develop milk fever (Goff, 2000). Thus, the immunosuppressive 
effects of the plasma estrogen and cortisol increases observed in the periparturient period would 
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be likely suspects as causative agents of the immunosuppression observed at calving. However, 
cortisol is elevated for only hours around calving and therefore its role in prolonged 
immunosuppression around parturition has been questioned. Although cortisol concentrations are 
only transiently elevated, changed in glucocorticoid receptor expression driven by changes in 
estrogen and progesterone at the time of parturition might contribute to immunosuppression for 
at least several days around calving (Preisler et al., 2000). 
 
Immune Functions And Pregnancy 
Apart from the endocrine status, there are significant interactions between the immune 
system and cells and tissues of the reproductive system that are critical for the maintenance of 
pregnancy, but are responsible for immune suppression that is associated with increased risk of 
disease. Sides of both the innate and acquired immune response are compromised, beginning 
about 1-2 weeks before calving and recovering between 2 and 4 weeks after calving 
(Kashiwazaki et al., 1985, Kehrli and Goff, 1989, Kehrli et al., 1989, Kehrli et al., 1990). 
Immunosuppression is manifested in a wide range of immunological dysfunctions, including 
impaired neutrophil and lymphocyte functions (Kehrli et al., 1989, Mehrzad et al., 2001). As part 
of the innate immune system, the neutrophil is an essential first responder to infection and is 
considered vital to effective clearance of bacteria from the mammary gland of the dairy cow 
(Smith, 2000, Paape et al., 2003, Zychlinsky et al., 2003). Neutrophils have various killing 
mechanisms to destroy pathogens (Smith, 2000, Segal, 2005). Beside the well-known oxidizing 
agents produced during the oxidative burst (e.g., ROS), they contain numerous antimicrobial 
proteins (such as cathelicidins, hydrolases, proteases, lactoferrin, and lysozyme) within granules, 
that are either released into phagosomes to destroy ingested pathogens, or out of the cell. These 
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neutrophil functions are suppressed at and around the time of parturition (Kehrli et al., 1989, 
Mehrzad et al., 2001). 
Human studies show significantly less respiratory burst activity in pregnant women 
(Crouch et al., 1995), maybe due to a different localization, in subcellular areas of pregnant 
women neutrophils, of two enzyme part of the reduced NAPDH production in the 
hexosemonophosphate shunt (Kindzelskii et al., 2004). Location of myeloperoxidase (MPO), an 
enzyme critical to oxidative burst, is also altered in non-pregnant women (cytosol) compared to 
pregnant women (external to the cell and associated with the cell membrane) (Kindzelskii et al., 
2006). Scientists have hypothesized that immune suppression may be an important mechanism in 
the maintenance of pregnancy and a breakdown of the suppression is a factor in spontaneous 
abortions (Vince et al., 2001). 
Other aspects underline the relationship between the immune and the reproduction 
system during pregnancy. During pregnancy, we observe and interaction between leukocytes and 
the corpus luteum: both macrophages and T-cells are found in it. During luteal regression, the 
number of lymphocytes and macrophages in the tissues increases by both recruitment of cells 
and proliferation of resident cells (Bauer et al., 2001). Cytokines thought to be expressed by 
luteal immune cells, but probably released by infiltrating cells, have the ability to inhibit 
progesterone synthesis by the bovine luteal cells and cause apoptosis of these cells, thus 
stimulating regression of the corpus luteum (Pate and Landis Keyes, 2001). 
 
Lactation And Immune Status 
Studies involving mastectomy of pregnant dairy cows, which removes the impact of milk 
production, while presumably maintaining endocrine and other changes associated with late 
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pregnancy and parturition, suggest that lactation plays a significant role in the recovery phase of 
periparturient immunosuppression, and that the absence of the mammary gland does no affect the 
manifestation of periparturient immunosuppression, but only affects the duration of the 
suppression after calving. Kimura et al. (1999) showed that lymphocyte function was 
significantly different in mastectomized animals compared to normal animals during transition. 
This demonstrated that the depression of lymphocyte function during the periparturient period 
could largely be attributed to the metabolic demands of milk production. In contrast to the 
lymphocytes, neutrophils showed a decrease in function starting about two weeks prior to 
calving and reaching the low point at the time of calving in both mastectomized and normal 
cows. However, mastectomized cows quickly recovered neutrophil function (7 days), whereas, 
normal animals had not recovered neutrophil function after 20 days. Moreover, in intact cows, all 
T cell subset populations decreased at the time of parturition, while the percentage of monocytes 
increased (Kimura et al., 2002). Scientist widely agree that the metabolic demands associated 
with the onset of lactation negatively impacts the composition of circulating peripheral blood 
mononuclear population of the immune system, associating two metabolic factors, greatly 
impacted by mastectomy: hypocalcemia and plasma NEFA concentration at parturition. 
 
Stress And The Immune System 
Dairy cows must adapt to numerous management challenges during the transition period. 
Following common practice, the transition from pregnancy to lactation is marked by several 
social regroupings and changes in diet: from far-off to close-up, then to single stalls for calving, 
after which cows are brought to the fresh lactating cows group, and finally (after the end of the 
the transition period) into the mid-late lactation one. Even if the regrouping is needed to ensure a 
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smother metabolic transition from dry to lactating cow and to closely monitor the cows as they 
approach parturition, there is evidence that it has negative consequences on both behavior and 
production. Phillips and Rind (2001) reported that regrouped animals had shorter feeding times, 
longer standing times, and decreased milk production relative to cows kept in a stable group. 
When new cows are introduced to a pen the group dynamics change, leading to increased levels 
of aggression among individuals as social relationships become established (von Keyserlingk et 
al., 2008). As parturition approaches, cows commonly are moved again to a maternity pen where 
they are usually isolated from the herd. Social isolation in unfamiliar surroundings has been 
shown to elicit stress responses in dairy cows in the form of increased heart rate, high cortisol 
concentrations and increased vocalizations (Rushen et al., 1999). After calving the calf is 
removed and the cow is moved again. 
Stress is not only related to regrouping, its causes are as varied as its manifestations. 
Other type of stress include heat, NEB, transportation, and pregnancy. Various immune cells, 
such as neutrophils, T-cells, and dendritic cells, are affected when an animal is stressed (Burton 
and Kehrli, 1995, Burton et al., 1995, Burton et al., 2005). One of the most well studied 
molecular effects of stress on the immune system is the effect of cortisol on the expression of the 
protein L-selectin, which is expressed on the surface of immune cells and is necessary for the 
transmigration of the cells from the vasculature into the site of infection. Cortisol causes the loss 
of this protein expression on neutrophils and, thus, the loss of the ability to migrate through the 
vascular epithelium. The activation of the hypothalamus, pituitary gland and the adrenal gland by 
a stress response, stimulates those to releases hormones, other than cortisol, such as epinephrine 
and norepinephrine, all known to have a dramatic effect on the immune system. Examples have 
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been found in swines, where stressed pigs have significantly fewer white blood cells compared to 
the dominant one (Sutherland et al., 2006). 
 
The Metabolic Adaptation Influence On The Immune System 
An emerging area within transition cow metabolism and management is the consideration 
of interrelationships with the immune system (Drackley, 1999, Drackley et al., 2001).  
Periparturient NEB has been implicated in contributing to immunosuppression. However, it 
alone had little effect on the expression of adhesion molecules on the surface of bovine 
leukocytes (Perkins et al., 2001). Furthermore, negative energy balance in mid-lactation cows did 
not affect the clinical symptoms associated with an intramammary endotoxin infusion (Perkins et 
al., 2002). These results are contrary to previously cited work in periparturient cows where the 
presence of a mammary gland (vs. mastectomized cows) and its attendant metabolic demands 
slowed recovery of neutrophil function, suggesting that the metabolic stress of lactation 
exacerbated periparturient immunosuppression (Kimura et al., 1999). Others have investigated 
individual metabolic components associated with negative energy balance and have concluded 
that although hypoglycemia alone is not likely to exacerbate periparturient immunosuppression 
(Nonnecke et al., 1992), hyperketonemia appears to have multiple negative effects on aspects of 
immune function (Suriyasathaporn et al., 2000). Ketosis may increase the risk of mastitis in 
periparturient immunosuppressed cattle because many immune cell types are negatively affected 
by metabolite levels typical of a ketotic environment (i.e., low concentrations of glucose, and 
high concentrations of ketone bodies and NEFA). Furthermore, experimental mastitis in 
ketonemic cows was more severe than mastitis in non-ketonemic cows (Kremer et al., 1993). As 
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reviewed by Suriyasathaporn et al. (2000), impairment of the udder defense mechanism in cows 
experiencing negative energy balance seems to be related to hyperketonemia.  
In addition to effects of metabolic dysfunction on immunological capacity, it is possible 
that perturbations of the immune system also may impact the normal adaptations of other aspects 
of metabolism during the transition period. Studies reported that lactating cows subjected to 
activation of the immune system via endotoxin administration responded with dramatic changes 
in circulating concentrations of cortisol, glucagon and insulin in order to maintain glucose 
homeostasis (Waldron et al., 2003a). Furthermore, immune system activation resulted in 
decreased concentrations of circulating Ca and P (Waldron et al., 2003b). It is then conceivable 
that a vigorous immune response during the periparturient period may also predispose cows to 
the development of secondary metabolic disorder. A significant amount of research focused on 
the cellular and molecular processes affected by calcium, and vitamins A and D (Mora et al., 
2008, Vig and Kinet, 2009).  Calcium, and vitamins A and D have a significant effect on the 
functionality of immune cells. Calcium plays an essential role in intracellular signaling. In 
immune cells, intracellular calcium regulates many cellular functions including cytokine 
production, cytokine receptor expression and cell proliferation. Stimulated peripheral 
mononuclear cells from hypocalcemic cows have a muted intracellular calcium response 
compared to cows with normal blood calcium levels (Kimura et al., 2006). Furthermore, when 
stimulated peripheral mononuclear cells from hypocalcemic cows were compared with the same 
cells obtained from the same cows after intravenous treatment with a calcium solution, a muted 
intracellular calcium response was demonstrated only when the animals were hypocalcemic 
(Kimura et al., 2006). A muted intracellular calcium response would have a significant effect on 
the functional capacity of the cells of the immune system. 
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The role of insulin in regulating glucose homeostasis and adipose tissue metabolism has 
received considerable attention relative to periparturient metabolism. In relation to the immune 
system, nsulin has been shown to be immune supportive in humans and other species. For 
example, a short term hyperinsulinemic euglycemic clamp resulted in increased concentrations 
of PMN in blood and increased phagocytic and chemotactic activity of these cells (Walrand et 
al., 2004, 2006). Nielsen et al. (2003) reported that bovine PMN possess insulin receptors, thus 
insulin could potentially increase the functional activity of leukocytes. To this end, preliminary 
data from Røntved et al. (2003) showed that insulin affects phagocytosis capacity of neutrophils 
during an a 96 h hyperinsulinemic-euglycemic clamp. Furthermore, high levels of insulin did not 
affect the number of bovine neutrophils in blood or the cells' performance of oxidative burst. It 
could be speculated that insulin might have a different effect depending on the physiological 
state of the cow (pregnancy or lactation) due to differences in circulating insulin concentration 
and insulin resistance in these different classes of animal. However, the same authors did not 
detect an effect of lactation stage (early vs mid) while testing the insulin effect on neutrophils 
functionality. In addition to the effect of insulin itself, PPAR-γ is involved in the immune 
function. In example, PMN are PPAR-γ responsive cells and binding of TZD to the transcription 
factor PPAR-γ results in direct effects on inflammatory and immune-function genes 
(Houseknecht et al., 2002). Neutrophils are known to have a preference to engulf refined 
carbohydrate (glucose, fructose, sucrose, etc.) over bacteria (Sanchez et al., 1973). The 
neutrophil phagocytic capacity to engulf bacteria is affected when simple sugars are digested and 
fasting strengthens the neutrophils phagocytic capacity to engulf bacteria. However, the 
digestion of normal starches has no effect. With these data authors conclude that the function, 
and not the number of phagocytes, in engulfing bacteria was altered by the ingestion of sugars 
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(Sanchez et al., 1973). Being insulin involved in the homeostasis of blood glucose, hypothesis 
could be made about its role in influencing the immune system activity. Data from Revelo and 
Waldron (2010) support this hypothesis, as in vitro incubation with insulin did not modify 
neutrophils functionality, contrary to the in vivo data (Røntved et al., 2003). In the same 
experiment instead, TZD shown anti-inflammatory potential. 
 
PREPARTAL MANAGEMENT OF THE DAIRY COW 
At the end of lactation, approximately two months before parturition, dairy cows enter 
the dry period, a part of their production cycle in which lactation is stopped (hence the name, 
“dry”). The dry period is a very important moment for the dairy cow. It provides the cow with an 
opportunity to “rest” from the metabolic demand of milk production, and dedicate its resources 
for the growing calf, which just started its exponential growth phase (e.g. ~60% of its total 
growth in mass). Furthermore, it allows the mammary gland to recover from the previous 
lactation, a process involving the involution of the parenchymal tissue and the regeneration of 
the mammary epithelial tissue. In fact, without the dry period, milk production per day would be 
reduced, while transition problem will not disappear (Schukken et al., 2011). Dairy cows with a 
short dry period (10- to 40-days) produced significantly less milk in the following lactation than 
cows with a 40- to 60-day dry period (Watters et al., 2008). The dry period offers as well the 
opportunity to the farmer to closely monitor the status of each animal and ensure a proper 
transition to the next lactation cycle. Nutritional strategies, feeding management, and control of 
cows adiposity during this period can impact high-producing dairy cows holistically: health, 
productivity and fertility. 
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Nutritional Management 
One of the greatest influences and easily controllable factors by the farmer, on metabolic 
functions and status of the periparturient dairy cow is nutrition, with an emphasis on pre-calving 
nutrition management. At the beginning of the 20th century Robert Boutflour (1928) 
recommended producers to “steam up” dairy cows before calving, increasing their energy intake 
and DMI in the weeks prior parturition. This recommendation still stood decades later, supported 
by positive correlation between pre-partum NEFA concentration (e.g., the increased energy 
intake decreased tissue mobilization) and incidence of post-partum metabolic diseases Dyk et al. 
(1995). To further support Boutflour century-old strategy, a negative association between pre-
partum energy intake and peripartum liver TAG accumulation was observed (Bertics et al., 
1992). Throughout the years the assumed benefits of Boutflour strategy were believed to result 
from (i) a stimulation of ruminal papillae development, (ii) an adaptation of the rumen 
microflora to the higher concentrate offered in the post-partum diet, (iii) a provision of more 
readily available precursor for gluconeogenesis and thus glucose to the conceptus preventing 
maternal loss of energy reserves, and (iv) a stimulatory effect on insulin production, suppressing 
lipolysis and reducing influx of NEFA into the liver, reducing ketosis and steatosis. However, 
these benefits were disproven in recent years, as reviewed by Roche et al. (2013), Drackley and 
Cardoso (2014) and Kay et al. (2015). 
Years prior to the support of Dyk et al. (1995) and Bertics et al. (1992) findings, Kunz et 
al. (1985) already started casting doubts on the steaming-up strategy (modernly called close-up 
diet), reporting that limiting nutrient intakes to requirements of the cows was preferable to 
overconsumption of energy. This led to a long series of studies showing that controlling energy 
intake prepartum to near calculated requirements favors a successful transition (Grum et al., 
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1996, Dann et al., 2005, Dann et al., 2006, Douglas et al., 2006, Janovick et al., 2011, Graugnard 
et al., 2012, Ji et al., 2012, Graugnard et al., 2013). Cows even slightly overfed with moderate-
energy diets (1.50 to 1.60 Mcal NEL/kg DM) can consume from 40%, up to 80% more net 
energy for lactation (NEL) than required during both far-off and close-up periods (Dann et al., 
2005, Dann et al., 2006, Douglas et al., 2006, Janovick and Drackley, 2010), with no evidence of 
benefits on their periparturient performances. On the other hand, these studies indicated that the 
prolonged over-consumption of energy led to a decreased post-calving DMI, negative responses 
of metabolic indicators (e.g., NEFA, BHBA, liver TAG), and decreased lipogenesis, increased 
lipolysis and decreased ability of insulin to inhibit lipolysis (Drackley and Cardoso, 2014). 
Furthermore, the steaming-up strategy led to decrease immune-competence postpartum 
(Graugnard et al., 2012), supporting field observation that the opposite strategy (a controlled 
energy dry cow program), decreases health problems throughout transition (Beever, 2006). 
This line of research has then unequivocally disputed the “benefits” of the Boutflour (1928) 
strategy, recommending instead a controlled limit-feeding of moderate energy diets, or ad 
libitum feeding of high-bulk, low-energy rations. (Drackley and Cardoso, 2014). Interestingly, at 
the time of its recommendations, the steaming up-strategy attacked the already prevailing 
wisdom that underfeeding cows in the weeks preceding calving was the way to avoid milk fever. 
 
Body Condition Score 
The term body condition was first defined by Murray (1919) as the ratio of body fat to 
non-fat components. During the transition period the dairy cow mobilizes its adipose storages to 
meet lactation needs, at a time where DMI lags behind the milk production performances. Thus, 
great importance has been on the quantification of the animal body reserves. Despite popular 
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misconception, body weight per se is not a great indicator of body reserves, as it relationships 
with adiposity is affected by multiple factors, including parity, lactation stage, frame size, 
gestation stage, and breed (Roche et al., 2009). Furthermore, tissue mobilization early 
postpartum is concomitant to the gradual increase of feed intake, so that actual decreases in 
adiposity could be masked by the enhanced gastrointestinal fill, nullifying the relationship 
between body weight and changes in adipose and lean tissue weight (NRC, 2001). Therefore, 
independent systems to asses dairy cow body condition are required. Multiple subjective systems 
were introduced in the 1970s and 1980s. Scores were assigned to reflect the apparent degree of 
animal adiposity, giving them the name of body condition scores (BCS). The first scored 
introduced (4-point) to the dairy industry was adapted by Lowman et al. (1973) from a beef 
cattle oriented scoring system. Subsequently, independent systems were developed around the 
world, based on different scales: a 5-point system in the United States, a 6-point scale in the UK, 
and 8-point scale in Australia, and a 10-point scale in New Zealand (Roche et al., 2009). A 
comparison of the systems, with conversion equations, was conducted by Roche et al. (2004). 
Irrespectively of the scale used, low values reflect thin, emaciated cows, while high values 
equate to obesity scenarios. 
Effectiveness of the scaling system was tested, with strong positive correlation between 
BCS and the proportion of fat physically dissected from Holsteins cows (r = 0.75 or 0.93), or 
observed body fat (r = 0.83) (Wright and Russel, 1984, Otto et al., 1991). However, since BCS 
assesses the level of subcutaneous fat (r2 = 0.89), it poorly predicts inter- and intramuscular fat 
(r2 = 0.43) (Wright and Russel, 1984). As the latter account for up to 45% of the body fat, BCS 
may be less accurate in establishing the adiposity level of thin cows that have little subcutaneous 
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fat (Ferguson et al., 1994). A further factor affecting BCS accuracy is whether the score was 
assessed via tactile or visual appraisal of the animal (Roche et al., 2004). 
One could think that, since lipomobilization after calving supplies the organism with 
additional energy to meet the lactation requirement, increased levels of reserves at calving (e.g., 
greater BCS) will results in greater milk yields. This relationship is true on the lower end of the 
BCS scale, with peak milk production registered at 3.5 (US 5-point scale), and marginal 
increments past 3.0 (Waltner et al., 1993, Roche et al., 2007). Additionally, reports show a 
curvilinear association between BCS and milk production, with impaired lactation performances 
at the right end of the scale (e.g., decreased milk yield with high calving BCS) (Roche et al., 
2009). This reduction can be explained by the negative association between BCS at calving and 
DMI (Roche et al., 2008), as fatter cows tend to eat less postpartum, compared to thinner 
animals, thus limiting the animal energy supply. This creates a domino effect: a lower DMI 
increased the animal NEB, which increases tissue mobilization, which increases liver NEFA 
overload, leading to metabolic disfunctions such as ketosis and steatosis (Cameron et al., 1998, 
Buckley et al., 2003, Drackley and Cardoso, 2014). Furthermore, cows that calve at a higher 
BCS display postpartal impairment of the immune function, increased blood inflammatory 
markers, and may be more subjected to oxidative stress (Contreras and Sordillo, 2011). 
These reports ultimately suggest that excessive adiposity contributes to transition problems, with 
impaired subsequent production, health, and reproduction. However, what constitutes excessive 
BCS changes from author to author. Optimal BCS at calving has trended downwards over the 
last decades, and nowadays consensus advices BCS of 3.0-3.5 in US 5-point scale, or 5.0 in the 
New Zealand 10-point scale for grazing cows (Roche et al., 2009, Drackley and Cardoso, 2014). 
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NSAID For Inflammation Control 
The transition period represents the highest-risk period in the production cycle of dairy 
cows, with more than 50% of cows estimated to suffer from at last one subclinical disorder. The 
complexity of the adaptation to lactation have made it difficult for researchers to determine 
which process are physiological (e.g., homeorhetic), and which are pathological. The subacute 
inflammatory state typical of this period has been subject of great interest in the past decade, 
clearly showing that essentially all dairy cows experience some degree of systemic inflammation 
for a variable number of days after calving (Bradford et al., 2015). As the magnitude and 
duration of this inflammatory state have been linked to increased disease risk and decrease 
performances (Ohtsuka et al., 2001, Ametaj et al., 2005, Bertoni et al., 2008, Huzzey et al., 2009, 
Dubuc et al., 2010, Qu et al., 2014), it is clear why extensive research has been dedicated to its 
control. 
Even thou the interrelated management of prepartal nutrition and BCS at calving have 
been shown to be effective ways to control and contain the inflammatory response throughout 
transition, a branch of transition cow research focused on pharmacological intervention as a way 
to counteract the spike in acute and subacute inflammation postpartum. Nonsteroidal anti-
inflammatory drugs (NSAID) have been the preferred choice for their ability to inhibit enzyme 
cyclo-oxygenase (COX) 1 and/or 2 production of pro-inflammatory mediators (Cashman, 1996). 
Aspirin, as a broad inhibitor of both COX1 and COX2 was among the first tested. Trevisi et al. 
(2005) tested in a pilot trial (n = 5 cows/group) the effect of 25g/d of sodium acetylsalicylate for 
the first 5 days after calving. Treated cows had greater milk yield, a lower BCS loss postpartum, 
but no significant changes in inflammatory markers. The same authors (Bertoni et al., 2004) then 
tested the efficacy of an intra muscular injection of lysine acetyl-salicylate in the first five days 
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of lactation (15 g/d d 1-3, 7.5 g/d d 4-5). They reported better health status (i.e. more favorable 
indices of inflammation) and a higher feed intake in treated cows, which according to the authors 
allowed the animals to promptly recovery of common metabolic conditions (e.g., lower NEFA 
BHBO). Their data also showed better liver activity, a rise in milk yield, and an improvement in 
fertility. Authors repeated the experiment two more time and concluded that the suggested 
treatment with intra muscular injection of lysine acetyl-salicylate during the first 5 days of 
lactation accelerates the recovery from the inflammatory consequences of the transition period, 
while improving milk yield, fertility, and health conditions (Trevisi and Bertoni, 2008). Overall, 
even if milk must be dump due to NSAID presence during the treatment (short half-life in the 
organism of the used NSAID guarantees milk cleanliness when injections are terminated) authors 
indicates a favorable benefit/cost ratio. 
Looking at the success of these results, other have tried to replicate the effects of NSAID 
administration. Farney et al. (2013b) administered via water 1.95 g/l of sodium salicylate to 
Holstein cows in the first 7 days post calving. Despite increase in milk fat yield by the third week 
postpartum, they did not detect overall treatment effects on milk yield, nor intake. They however 
detected an interaction of treatment and parity on 305-d milk yield, with NSAID decreasing 
whole lactation performance of primiparous cows, while increasing that of pluriparous (3 or 
greater) animals. Authors noted as well that salicylate treatment prevented postpartum insulin 
resistance, likely causing excessive glucose utilization in peripheral tissues and hypoglycemia 
(Farney et al., 2013a). These results represent, according to the authors, the first evidence that 
inflammation-associated pathways are involved in homeorhetic adaptations to lactation. To 
support the need for a certain level of inflammation around parturition, others have also reported 
increased incidence of retained placenta in cows treated with NSAID (Bradford et al., 2015).  
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Other NSAID, such as carprofen and meloxicam have been tested in transition dairy cows for 
control of pain, metritis, or mastitic events. In two separate controlled experiment, either 
carprofen or meloxicam were unable to stimulate and increased milk production in treated 
animals (Newby et al., 2013, Priest et al., 2013). However, in a large field trials in Canadians 
herds, meloxicam increased milk production by ~ 0.65 kg/d. (Shock et al., 2018).
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CHAPTER 3: ADIPOSE AND LIVER GENE EXPRESSION PROFILES IN RESPONSE 
TO TREATMENT WITH A NONSTEROIDAL ANTIINFLAMMATORY DRUG AFTER 
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ABSTRACT 
The peripartal or transition period in dairy cattle is often characterized by an 
inflammatory state that, if not controlled, could be detrimental to production, health, and fertility. 
Approaches to control the postpartal degree of inflammation include treatments with 
nonsteroidal antiinflammatory drugs (NSAID) postcalving, which have improved cow 
production and health. To date, most of the research on NSAIDs has been conducted in 
confinement cows that reach milk production levels substantially greater than those on pasture. 
Furthermore, there are little data available on the effect of NSAIDs on the mRNA expression of 
inflammation and metabolism-related genes. Transcription regulation is an important mechanism 
of inflammation and metabolic control. The present study was conducted to examine hepatic and 
adipose tissue gene expression in response to injections of a NSAID, carprofen, on 1, 3, and 5 d 
after calving. Grazing Holstein-Friesian cows from a control group and one treated with 
carprofen during the first 5 d post-calving were used. Liver and subcutaneous adipose tissue 
biopsies were harvested at -1, 1, and 2 wk relative to parturition. More than 30 genes associated 
with fatty acid oxidation, growth hormone/IGF-1 axis, hepatokines, lipoprotein metabolism, 
gluconeogenesis, and inflammation were analyzed. After calving, data suggest that both tissues 
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respond to inflammation signals at the onset of lactation. Administration of NSAID led to greater 
hepatic expression of pyruvate dehydrogenase kinase, isozyme 4 (PDK4), which helps regulate 
gluconeogenesis, and microsomal triglyceride transfer protein (MTTP), important for the 
assembly and secretion of very low density lipoproteins. In adipose tissue, NSAID 
administration resulted in greater expression of the inflammation-related genes interleukin-1, 
beta (IL1B), interleukin-6 receptor (IL6R), toll-like receptor 4 (TLR4) and chemokine (C-C 
motif) ligand 5 (CCL5). The data support the role of inflammation as a normal component of the 
homeorhetic adaptations to lactation and reveal a possible mechanism of the administration of 
NSAID in transition dairy cows, but do not reflect an effect of carprofen on the extent of the 
peripartum inflammation.
 
INTRODUCTION 
The transition period, defined as last 3 wk prepartum until 3 wk postpartum, is one of the 
most important issues in dairy cattle management. A successful transition into lactation is a 
primary determinant of optimum production, reproduction, and health. Metabolic disorders and 
health problems are common during this time and can easily erase a farm’s profit potential 
(Drackley, 1999). Postpartal cows are reported to display an overt inflammatory response related 
to the cessation of pregnancy and the beginning of lactation (Sordillo et al., 2009), even without 
signs of microbial infections or otherwise determined pathology (Bionaz et al., 2007; Bertoni et 
al., 2008).  
A typical signature of an inflammatory state is the release of pro-inflammatory cytokines, 
which can cause a myriad of metabolic changes, including anorexia, lipomobilization, reduced 
insulin sensitivity, and reduced milk yield (Kushibiki et al., 2001; Kushibiki et al., 2003; Bertoni 
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et al., 2004). Given the detrimental effects of pro-inflammatory cytokines, it has been 
hypothesized that a reduction in postpartal inflammation might improve the transition into 
lactation, partly by reducing the accumulation of liver triacylglycerol (TAG), promoting 
gluconeogenesis, and reducing the incidence of disorders. To this end, treatment of early 
postpartal cows with a nonsteroidal antiinflammatory drug (NSAID) has been proposed to 
facilitate a successful transition through calving; results, however, have been inconsistent 
(Bertoni et al., 2004; Farney et al., 2013a; Priest et al., 2013).  
Bertoni et al. (2004), the first published study utilizing an NSAID (acetyl-salicylate), reported a 
positive effect of treatment during the first 5 d postpartum on milk production and, also, more 
favorable indices of inflammatory status (e.g. greater Zn, lower haptoglobin and ceruloplasmin) 
during the first 4 wk postpartum. In a more recent study with a higher dose of acetyl-salicylate 
there was no change in milk production; however, data from the study suggested a possible 
homeorhetic role of inflammatory signals during the peripartal period as components of 
metabolic adaptations to lactation (Farney et al., 2013a). The roles of molecular mechanisms in 
coordinating such responses in key metabolic organs, such as adipose and liver, have not, to our 
knowledge, been studied in dairy cattle. 
The objective of the present study was to use adipose and liver tissue from grazing dairy 
cows receiving an early postpartal administration of an NSAID to control inflammation (Meier et 
al., 2014) to profile mRNA expression of key metabolic genes associated with inflammation, 
oxidative stress, adipokines, fatty acid oxidation, ketogenesis, and lipoprotein export.  
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MATERIALS AND METHODS 
Animals, Management, and Sampling 
All details of animal management have been reported (Meier et al., 2014). Briefly, cows 
enrolled in the experiment were part of two seasonal calving dairy herds managed on a single 
commercial farm (Whareroa Dairy Farm, Hawera, New Zealand). Animals were allocated to one 
of three groups as they calved within a randomized block design (control: n = 221, earlyNSAID: 
n = 214, and lateNSAID: n = 204). Only control and earlyNSAID treatment groups were used for 
gene expression profiling. Cows allocated to earlyNSAID received three subcutaneous injections 
of 1.4 mg/kg BW of the NSAID carprofen (Carprive LA; Norbrook Ltd., Auckland, New 
Zealand) on d 1, 3, and 5 postcalving. Adipose and liver tissues were sampled on wk -1, 1, and 2 
relative to parturition from 20 cows in each of the two selected groups. 
 Liver Biopsies.  Liver samples were collected by biopsy during the wk before calving 
(wk -1), and subsequently on wk 1 and 2 post-calving. Briefly, the skin was shaved and 
disinfected and the area through the skin and body wall were anesthetized with 7 mL of 2% 
lignocaine (Lopaine 2%, lignocaine hydrochloride 20 mg/mL, Ethical Agents, South Auckland, 
New Zealand). A stab incision was made through the skin in the right 11th intercostal space at 
the level of the greater trochanter, through which a 12G  20 cm biopsy needle was inserted into 
the liver and approximately 1 g (wet weight) of liver tissue was collected. Liver samples were 
snap-frozen in liquid nitrogen and stored at -80°C. 
 Adipose Biopsies. Tissue was harvested during wk -1, 1 and 2 relative to calving as 
described previously (Grala et al., 2013; 2014). Briefly, subcutaneous adipose tissue was 
collected posterior to the shoulder blade, and approximately 10 cm down the withers. The site 
was clipped and cleansed with iodine before administering a local anesthetic (2% lignocaine). A 
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3 cm incision was made through the skin and 30 to 80 mg of adipose tissue removed by blunt 
dissection. Biopsies were immediately placed in screw-capped, microcentrifuge tubes, 
snapfrozen in liquid nitrogen, and stored at −80 °C until RNA extraction. 
RNA Extraction, Target Genes, and Real-Time Quantitative PCR (qPCR)  
 Complete details of these procedures are included in the supplemental material 
(Appendix A). Briefly, RNA samples were extracted from frozen liver tissue and used for cDNA 
synthesis, using established protocols in our laboratory (Khan et al., 2014). qPCR performed 
were SYBR Green-based, using a 7 point standard curve. 
Data Processing and Statistical Analysis 
After normalization with the geometric mean of the internal control genes, the qPCR data were 
log-2 transformed prior to statistical analysis to obtain a normal distribution. Statistical analysis 
was performed with SAS. Normalized, log-2 transformed data were subjected to ANOVA and 
analyzed using repeated measures ANOVA with PROC MIXED. The statistical model included 
time (1 and 2 wk postpartum), treatment (TRT; control and NSAID), and the time*TRT 
interaction as fixed effects. Cow, nested within treatment, was the random effect. Data on -1 wk 
were used as covariate in the model. The SP(POW) was used as the covariate structure. 
Denominator degrees of freedom were computed by SAS dividing the residual degrees of 
freedom into between-subject and within subject portions using the DDFM statement. Data were 
considered significant at a P ≤ 0.05 using the PDIFF statement in SAS. For ease of 
interpretation, the data reported in Table 1 and 2 are the log-2 back transformed means that 
resulted from the statistical analysis. 
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RESULTS AND DISCUSSION 
Hepatic metabolic adaptations. There were no TRT, time (wk), or interaction (TRT*wk) 
effects (P > 0.05) for genes associated with fatty acid oxidation, ketogenesis and the GH/IGF1 
axis (Table 3.1). However, PDK4 transcript abundance was affected by treatment (P < 0.05), 
with a greater expression in NSAID cows. Expression of PC decreased gradually over time (P < 
0.05) regardless of treatment. Expression of APOB also was not affected by TRT (P > 0.05) and 
there was no interaction; however, there was an overall TRT effect for MTTP, with a greater 
expression (P < 0.05) in cows on NSAID. There was no interaction or TRT effect (P > 0.05) for 
ANGPTL4 and FGF21. Over time the expression of ANGPTL4 was not affected (P > 0.05), 
while there was a trend (P = 0.08) for a time effect for FGF21 with greater expression at wk 1 
than 2.  
The lack of change in FGF21 and ANGPTL4 expression after calving suggests that cows in the 
current study underwent a period of “mild” negative energy balance (NEB) around parturition, 
i.e., the more pronounced the NEB the greater the expression of these genes in liver tissue 
(Schoenberg et al., 2011; Koltes and Spurlock, 2012; Khan et al., 2014). From a mechanistic 
standpoint, the modest change in these two genes reinforces the idea that the degree of NEB in 
the present study did not reach a threshold at which PPARα-regulated transcription was 
activated, i.e. both genes are PPARα targets (Bionaz et al., 2013). 
The absence of treatment effect on NEFA level (Meier et al., 2014) could explain the lack 
of effect of NSAID administration on PC expression because there are data indicating that NEFA 
may stimulate hepatic PC gene expression by activating the PC promoter I (White et al., 2011). 
The numerical decrease (P = 0.09) in PC expression between wk 1 and 2 agrees with previous 
work with confinement (Greenfield et al., 2000; Loor et al., 2006) and grazing (White et al., 
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2012) cows. The NSAID effect on expression of PDK4 suggests a positive effect on 
gluconeogenic capacity of liver in NSAID cows despite lack of statistically significance effects 
between groups in terms of milk production (Meier et al., 2014). The NSAID cows also appeared 
to be better adapted to the increase in hepatic influx of NEFA typical of the post calving period, 
e.g. the greater expression of MTTP could have increased the rate of lipoprotein synthesis, thus, 
preventing the accumulation of triglycerides in hepatocytes. 
Inflammation mediators in hepatocytes.  There was no interaction or treatment effect (P 
> 0.05) for any of the inflammation-related genes. A time effect was detected for the expression 
of HP (P = 0.0001), SAA2 (P < 0.0001), SAA3 (P = 0.02) and the expression of the stress-related 
transcription factor XBP1 tended to be affected (P = 0.09) due to a general decrease in their 
transcript abundance from wk 1 to 2. 
The peripartal period in dairy cows is often characterized by inflammatory conditions that 
can result in the impairment of optimal milk yield (Bionaz et al., 2007; Bertoni et al., 2008). The 
inflammatory state is characterized by the induction of positive acute-phase protein (+APP) 
synthesis, mostly detected in blood plasma (e.g., haptoglobin and ceruloplasmin) and the 
impairment of hepatic synthesis of negative acute-phase proteins (−APP), such as albumin and 
retinol binding protein (Bionaz et al., 2007; Bertoni et al., 2008). As expected, signs of an overt 
inflammatory state after calving were detected in the present study, i.e. higher expression at wk 1 
compared with wk 2 for HP, SAA2 and SAA3. The decrease of the +APP genes at wk 2 is 
suggestive that cows recovered quickly from the post-partal inflammatory state and, possibly, 
that its intensity was not great enough to be affected by the NSAID treatment. This premise is 
supported by the lack of changes in the expression of STAT3 and NFKB1, tow key molecules of 
the inflammatory response (Hodge et al., 2005; Yoshida et al., 2004). Although the blood 
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concentration of the encoded proteins was not assessed, it is established in non-ruminants that 
changes in gene expression of APP in liver are closely related with concentrations in circulation 
(Kushner, 1988).  
Overall, as reported, the data indicate that treatment with NSAID did not help alleviate 
the hepatic inflammatory response; this result contrasts with the reported attenuation effect after 
early postpartal administration of acetyl-salicylate to confinement cows, another well-known 
NSAID (Bertoni et al., 2004). Failure for the NSAID, carprofen, to lessen the postcalving 
inflammatory response could a consequence of an inherently lower inflammatory state among 
cows of the current study as compared with the higher yielding cows used by Bertoni et al. 
(2004). 
Metabolic adaptation in Adipocytes. As in liver gene expression profiles, the 
administration of NSAID early postpartum did not affect metabolic adaptation in the adipose 
tissue. There was no interaction, TRT or time effect (P > 0.05) for genes involved in lipid 
metabolism and adipokine production. Only LEP was affected by time (P < 0.05) due to a 
general decrease at wk 2 compared with wk 1 postpartum. 
The NSAIDs are well known antagonists of cyclooxygenases (COX), which are 
responsible for the formation of important biological mediators called prostanoids, including 
prostaglandins, prostacyclin and thromboxane. Carprofen preferentially inhibits COX-2, 
interfering only to a very small extent with COX-1 activity (Miciletta et al., 2013). The COXs 
are enzymes that catalyze the conversion of arachidonic acid to prostaglandin endoperoxide H2, 
an important inflammation mediator used by COXs themselves to produce prostaglandins (i.e., 
PGD2, PGE2, PGF2α) (Morita, 2002). In non-ruminants, PGE2 is normally synthesized by the 
adipose tissue where it inhibits triacylglycerol breakdown (Richelsen, 1992). Thus, blocking its 
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synthesis early postpartum could be beneficial for cows, allowing them to better face the sudden 
state of NEB.  
Overall, the lack of changes at the transcription level and the modest decrease in body 
weight and body condition score during the first 2 wk postpartum in the cows studied (Meier et 
al., 2014) indicate that NSAID administration did not greatly affect lipid mobilization and 
metabolism. Similar studies using high-producing Holstein cows in confinement (Bertoni et al., 
2004, Farney et al., 2013b) reported greater milk production and blood NEFA in responses to the 
NSAIDs acetyl-salicylate or sodium-salicylate. The difference in response between those studies 
and the current one could be the specificity of the given NSAID on the COX target, i.e. salicylate 
can target both COX-1 and COX-2, a characteristic that could enhance its inhibition of 
prostaglandin synthesis. 
Inflammation and the adipose tissue.  Apart from tendencies (P < 0.10) detected for 
CCL2, IL6R and TLR4 there was no interaction (P > 0.05) detected for genes involved in the 
inflammatory response (Table 3.2). Time had an effect on TNF only, as its expression was 
markedly lower at wk 2 compared with wk 1 postpartum (P = 0.02).  Expression of CCL5, IL1B, 
IL6R and TLR4 was greater (P < 0.05) in NSAID cows during wk 1 and 2 post-calving. 
However, no TRT, time, or interaction effects (P > 0.05) were observed for the acute-phase 
genes HP and SAA3. 
The higher expression of CCL2, TLR4, and TNF in adipose tissue confirmed the 
existence of a local inflammatory response, underscoring the fact that this tissue is immune 
responsive, following the systemic inflammatory state postpartum. The upregulation of CCL2, a 
chemoattractant that participates in the process of macrophage recruitment into adipose tissue 
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could be an important trigger of the adipose tissue inflammation (Kanda et al., 2006). The signals 
causing the inflammatory response in adipose tissue after calving remain to be identified. 
In humans and other animal models, inflammation and its mediators have been linked to insulin 
resistance (Shoelson et al., 2006; Tilg and Moschen, 2008; Ikeoka and Krusinova, 2009). Insulin 
resistance is an adaptive mechanism in early lactation to prevent excess use of glucose by body 
tissues, and direct the greatest amount of glucose towards milk synthesis in the mammary gland 
(De Koster and Opsomer, 2013). In that context, the induced inflammatory stress postpartum 
could be helpful for the metabolic adaptations in early lactation that allows the mammary gland 
to increase the rate of milk synthesis. The greater expression induced by NSAID of genes 
connected with the inflammatory state (i.e., CCL5, IL1B, IL6R, TLR4) could have desensitized 
the adipose tissue to insulin signaling without the detrimental effect of a strong inflammatory 
state. 
It has been recently hypothesized that the inflammation experienced by cows during the 
peripartal period could be another homeorhetic adaptation to the lactating state (Farney et al., 
2013a), as administration of the NSAID salicylate, postpartum altered the metabolic adaptations 
to lactation. However, an excessive inflammatory response postpartum can lead to detrimental 
effects on cow production, fertility and health (Bertoni et al., 2008; Bionaz et al., 2007). A 
controlled and modulated postpartal inflammatory response should lead to minimal negative 
effects, while maintaining what seems to be a homeorhetic control mechanism; however, it must 
be emphasized that administration of NSAID early postpartum has led to inconsistent effects in 
terms of production outcomes (Bertoni et al., 2004; Farney et al., 2013a,b; Meier et al., 2014). 
The upregulation of CCL5 promotes macrophage recruitment and survival in the adipose tissue 
of non-ruminants (Keophiphath et al., 2010). Recent studies have demonstrated increased 
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accumulation of these immune cells in adipose tissue of obese rodents and humans, and suggest 
they may play a role in the development of insulin resistance (Weisberg et al., 2003; Xu et al., 
2003). The upregulation of TLR4 in adipose tissue also could initiate inflammation leading to 
insulin resistance (Shi et al., 2006; Song et al., 2006). An impairment of insulin signaling in 
NSAID cows also could have been caused by the greater IL1B mRNA expression, leading to a 
local elevation in concentration of this cytokine. Interleukin-1β is known to induce insulin 
resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression 
(Jager et al., 2007). When other indicators (i.e. HP, ALB, SAA2, SAA3 in liver) suggest an 
alleviation of the postpartal inflammation, the greater IL1B expression could be due to the 
selective inhibition by carprofen of COX-2. At late stages of inflammatory episodes, COX-2 
directs the synthesis of anti-inflammatory cyclopentenone prostaglandins, which are direct 
inhibitors of IkB kinase (Rossi et al., 2000). IkB kinase activates NF-kB, a nuclear transcription 
regulator that modulates the expression of several genes, including those involved in the 
inflammatory response (Schmida and Birbach, 2008).  
As previously discussed, other studies reported a greater fat depot mobilization after 
administration of NSAID early postpartum (Bertoni el al., 2004; Farney et al., 2013a,b). Even if 
greater plasma NEFA levels were not detected in NSAID cows (Meier et al., 2014), the gene 
expression data evidence a possible mechanism involving inflammation-induced lipolysis. For 
instance, the greater IL6R expression with NSAID in the present study possibly led to a greater 
sensitivity of the adipose tissue to IL-6, a pro-inflammatory cytokine, which is known to 
stimulate lipolysis in humans (Trujillo et al., 2004), rodents (Wallenius et al., 2002), and pigs 
(Yang et al., 2008), and is also known to enhance insulin resistance in adipocytes (Rotter et al., 
2003). Furthermore, a local increase in IL-1β concentration after carprofen injection due to a 
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greater IL1B expression also could have contributed to higher lipid mobilization (Feingold et al., 
1992; Doerrler et al., 1994). At least in non-ruminants, an increase in circulating IL-1 is known 
to stimulate IL-6 production in monocytes (Tosato and Jones, 1990). As CCL5 was upregulated 
in NSAID-treated cows and CCL2 expression was high in both treatment groups after calving, an 
increase in local monocyte concentrations in adipose tissue could be assumed, hence, leading to a 
local increase in IL-6 due to a possibly greater level of IL-1. If these mechanisms exist, they 
would support the role of NSAID administration postpartum on the modulation of lipid 
mobilization and its indirect contribution to greater glucose availability to the mammary gland. 
 
CONCLUSIONS 
Administration of NSAID in early lactation does not always produce a positive effect on bovine 
health, fertility, and production. In the present study, few changes at the molecular level were 
evident after treatment with carprofen early postpartum. The possibility that the cows in the 
study did not undergo a pronounced inflammatory state in early lactation (e.g., due to differences 
in production system and genetics) could have masked any positive effects of the treatment. 
Some insights, however, on the possible interaction between NSAID administration and 
periparturient cow inflammation and metabolism were apparent. They included the possible 
upregulation of hepatic gluconeogenesis and local inflammation in adipose tissue as a way to 
enhance lipolysis and nutrient availability to the mammary gland. Further research is required to 
better understand the interactions between NSAID and the stress that characterizes metabolic 
adaptations to lactation. 
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TABLES 
 
Table 3.1.  Hepatic gene expression (log2 back-transformed means) during the peripartal period 
untreated cows (Control) or those treated with a nonsteroidal anti-inflammatory drug (NSAID; 1.4 mg 
carprofen/kg BW) on d 1, 3, and 5 post-calving.  
 
  Group      
  Control  NSAID    P2  
Gene  11 2  1 2 SEM  TRT wk TRT*wk 
Fatty Acid Oxidation, Ketogenesis, VLDL Synthesis and Secretion, and GH/IGF1 Axis  
ACOX1  0.9 1.01  0.98 1.06 0.18  0.65 0.37 0.84 
APOB  0.86 0.91  0.89 0.96 0.14  0.64 0.44 0.88 
CPT1A  0.86 0.97  0.97 0.95 0.22  0.76 0.73 0.61 
GHR  0.93 1.00  0.93 1.07 0.13  0.76 0.14 0.62 
HMGSC2  0.92 1.08  0.91 1.01 0.23  0.82 0.37 0.85 
IGF1  2.26 2.82  2.04 2.53 0.26  0.62 0.13 0.98 
IGFALS3  0.84 1.05  0.71 0.85 0.27  0.41 0.15 0.9 
IGFBP1  1.07 1.48  1.18 0.98 0.33  0.59 0.69 0.14 
MTTP  0.79$ 0.76  1.06$ 0.96 0.14  0.04 0.42 0.73 
PPARA  0.93 1.00  1.16 1.21 0.23  0.22 0.70 0.92 
Carbohydrate Metabolism  
PC  1.21 1.00  1.47 1.11 0.25  0.48 0.09 0.75 
PCK1  0.76 0.87  0.85 1.06 0.21  0.25 0.27 0.81 
PDK4  0.47 0.59$  0.7 0.93$ 0.25  0.03 0.15 0.9 
Hepatokines  
ANGPTL4  0.65 0.62  0.97 0.67 0.29  0.27 0.28 0.40 
FGF213  0.61 0.51  0.51a 0.24b 0.54  0.36 0.08 0.28 
Inflammation and Intracellular Stress  
ALB  0.94 1.02  0.88 1.00 0.15  0.73 0.24 0.77 
HP  0.24a 0.03b  0.26a 0.07b 0.66  0.44 0.0001 0.29 
NFKB1  1.08 1.01  1.13 1.10 0.06  0.13 0.28 0.73 
SAA2  0.81a 0.20b  0.47a 0.15b 0.48  0.34 <.0001 0.52 
SAA33  0.4a 0.17b  0.23 0.14 0.45  0.32 0.02 0.48 
STAT3  0.97 0.77  1.09 0.98 0.18  0.22 0.13 0.56 
XBP1  0.72 0.58  0.59 0.52 0.17  0.26 0.09 0.66 
1Week from parturition 
2TRT = treatment. 
3Covariate was significant (P < 0.05). 
abSignificant difference (P < 0.05) among time points within same group. 
#Significant difference (P < 0.05) between groups at that time point. 
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Table 3.2.  Adipose gene expression (log2 back-transformed means) during the peripartal period in 
untreated cows (Control) or those treated with a nonsteroidal anti-inflammatory drug (NSAID; 1.4 mg 
carprofen/kg BW) on d 1, 3, and 5 post-calving.  
  Group      
  Control  NSAID    P2  
Gene  11 2  1 2 SEM  TRT wk TRT*wk 
Inflammation 
CCL2  2.12a 0.82b  1.22 1.7 0.51  0.81 0.39 0.08 
CCL5  0.76# 1.03  1.62# 1.49 0.28  0.004 0.60 0.36 
HP  1.25 0.78  1.17 0.60 0.62  0.71 0.18 0.82 
IL1B2  0.39$ 0.29#  1.09$ 1.04# 0.53  0.01 0.63 0.73 
IL62  1.41 0.86  1.17 0.85 0.41  0.75 0.12 0.73 
IL6R  0.67# 0.77$  1.42# 1.05$ 0.17  0.0001 0.54 0.09 
SAA32  0.47 0.41  0.36 0.28 0.47  0.39 0.47 0.83 
TLR4  0.86 0.76#  1.06a 1.86b# 0.31  0.04 0.23 0.07 
TNF  1.07a 0.54b  1.09 0.85 0.32  0.33 0.02 0.25 
Lipid Metabolism and Adipokines 
ADIPOQ  0.58 0.38  0.72 0.43 0.56  0.65 0.27 0.90 
FASN  0.19 0.14  0.14 0.15 0.53  0.74 0.66 0.41 
LEP  0.50 0.17  0.26 0.10 0.95  0.49 0.06 0.87 
PPARA  1.30 0.94  1.01 1.07 0.29  0.78 0.51 0.32 
PPARG3  0.71 0.54  0.94 0.84 0.42  0.15 0.57 0.81 
RXRA  1.31 0.96  1.14 1.3 0.21  0.55 0.57 0.16 
 
1Week from parturition 
2TRT = treatment. 
3Covariate was significant (P < 0.05). 
abSignificant difference (P < 0.05) among time points within same group. 
#Significant difference (P < 0.05) between groups at that time point. 
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CHAPTER 4: BODY CONDITION SCORE AND PLANE OF NUTRITION 
PREPARTUM AFFECT ADIPOSE TISSUE TRANSCRIPTOME REGULATORS OF 
METABOLISM AND INFLAMMATION IN GRAZING DAIRY COWS DURING THE 
TRANSITION PERIOD 
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ABSTRACT 
Recent studies demonstrating higher incidence of metabolic disorders after calving have 
challenged the management practice of increasing dietary energy density during the last ~3 wk 
prepartum. Despite the knowledge at the whole-animal level, the tissue-level mechanisms that 
are altered in response to feeding management prepartum remain unclear. Our hypothesis was 
that prepartum body condition score (BCS) in combination with feeding management play a 
central role in the peripartum changes associated with energy balance and inflammatory state. 
Twenty-eight mid-lactation grazing dairy cows of mixed age and breed were randomly allocated 
to one of four treatment groups in a 2 × 2 factorial arrangement: two prepartum BCS categories 
(4.0 and 5.0; based on a 10-point scale; BCS4, BCS5), obtained via differential feeding 
management during late-lactation, and two levels of energy intake during the 3 wk preceding 
calving (75 and 125% of estimated requirements). Subcutaneous adipose tissue was harvested 
via biopsy at -1, 1 and 4 wk relative to parturition. Quantitative PCR was used to measure 
mRNA and microRNA (miRNA) expression of targets related to fatty acid metabolism 
(lipogenesis, lipolysis), adipokine synthesis, and inflammation. Both, prepartum BCS and 
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feeding management had a significant effect on mRNA and miRNA expression throughout the 
peripartum period. Overfed BCS5 cows had the greatest prepartum expression of fatty acid 
synthase (FASN) and an overall greater expression of leptin (LEP). BCS5 was associated with 
greater overall adiponectin (ADIPOQ) and peroxisome proliferator-activated receptor gamma 
(PPARG), while overfeeding upregulated expression of proadipogenic miRNA. Higher 
postpartum expression of chemokine ligand 5 (CCL5) and the cytokines interleukin 6 (IL6) and 
tumor necrosis factor (TNF) was detected in overfed-BCS5 cows. Feed-restricted BCS4 cows 
had the highest overall interleukin 1 (IL1B) expression. Prepartum feed-restriction resulted in 
greater chemokine ligand 2 (CCL2) expression. Overall, changes in mRNA expression were 
consistent with the expression pattern of inflammation-related miRNA. These data shed light on 
molecular mechanisms underlying the effect of prepartum BCS and feeding management on 
metabolic and inflammatory status of adipose tissue during the peripartum period.  Data support 
the use of a controlled feed restriction prepartum in optimally-conditioned cows, while 
supporting the use of a higher-level of dietary energy in under-conditioned cows. 
 
INTRODUCTION 
Cows in early lactation experience a period of negative energy balance (NEB) due to the 
sudden increase in requirements of the mammary gland for milk production (Drackley, 1999). 
Nutritional management of the late pregnant non-lactating cow has been examined as a way to 
improve DMI, energy balance, immunometabolism, and health during the transition period. 
Traditional management provides “far-off” dry cows with a high-fiber/low-energy density ration, 
while in the last month of gestation (“close-up” dry period) the ration increases in energy density 
with a lower fiber content. However, studies from different research groups have demonstrated 
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that prepartum overfeeding of energy often results in prepartum hyperglycemia and 
hyperinsulinemia and marked postpartum adipose tissue mobilization (i.e., greater blood NEFA 
concentration) (Rukkwamsuk et al., 1999, Holtenius et al., 2003, Janovick et al., 2011, Ji et al., 
2014a, Khan et al., 2014). In addition, higher-energy close-up diets also have been associated 
with negative effects in postpartum health indices, underscoring possible detrimental effects of 
this management approach (Dann et al., 2006, Soliman et al., 2007, Graugnard et al., 2013, 
Shahzad et al., 2014). 
Although a number of studies aimed at understanding metabolic and molecular changes 
associated with dietary energy intake before calving have been performed, the contributing 
factors remain poorly understood. One animal factor that could potentially interact with 
prepartum level of feeding is cow BCS. The BCS provides a qualitative assessment of body fat 
and, due to its association with production parameters and the chances for a successful lactation 
(Waltner et al., 1993, Roche et al., 2005, Pires et al., 2013, Randall et al., 2015), it is recognized 
as an important variable in transition dairy cattle management (Roche et al., 2009). For example, 
not only “fat” cows are at a greater risk of metabolic disorders postpartum  (Hayirli et al., 2002, 
Holtenius et al., 2003, Randall et al., 2015), but also “thin” cows can be susceptible to failure to 
transition (Pires et al., 2013, Akbar et al., 2015). 
Despite the fact that BCS plays an important role in the metabolic response of the animal 
to lactation and its level is regulated through nutrition, cows with different level of adiposity are 
generally managed similarly during the prepartum period. Both BCS and feeding management 
can have a great impact on cow fat depots. Adipose tissue is an active component of the 
regulation of animal reserves through production of adipokines (Adamczak and Wiecek, 2013, 
McGown et al., 2014, Musi and Guardado-Mendoza, 2014). One of its features is the control of 
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inflammation in a localized manner through recruitment and regulation of the innate immune 
system, hence, making it an active immunological organ (Grant and Dixit, 2015). 
Besides the well-established role of changes in mRNA expression in controlling cellular 
pathways, recent studies have underscored that microRNA (miRNA) also are important for fat 
cell formation (adipogenesis) and regulation of their metabolic and endocrine functions (Arner 
and Kulyte, 2015). For example, beef cattle adipose miRNA profiling was recently correlated 
with fat depot location and function, underscoring the importance of miRNA (e.g., miR-378 and 
miR-143) in regulating adipocyte metabolism (Jin et al., 2009, Jin et al., 2010), also in response 
to diet (Romao et al., 2012).  
The recognition that cows experience a degree of inflammation around parturition 
(Bertoni et al., 2008, Trevisi et al., 2012) has led to the hypothesis of a homeorhetic role of 
inflammation as a physiological adaptation to lactation (Farney et al., 2013, Vailati Riboni et al., 
2015). Furthermore, in the context of inflammation, the miRNA signaling through complex 
networks involving transcription factors has been demonstrated (Arner and Kulyte, 2015). A 
good example of this is the miRNA regulatory circuits composed by miR-92a, miR-126, and 
miR-193b that control levels of the chemokine CCL2 in human adipose tissue (Arner et al., 
2012). However, regarding inflammation, miRNA not only regulate gene expression, but their 
expression patterns have been associated with levels of inflammatory molecules such as 
cytokines and the degree of immune cell infiltration (Kloting et al., 2009). 
  In the present study, gene and miRNA expression profiling were used to better 
understand the interaction between pre-calving BCS and plane of nutrition in the metabolism of 
adipose tissue. Specifically, we were interested in how these factors influence the adipose 
response to the physiological changes induced by the high metabolic demands of early lactation. 
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MATERIALS AND METHODS 
Animal Management 
Complete details of the experimental design are published elsewhere (Roche et al., 2015). 
Briefly, a group of 150 mid-lactation grazing dairy cows of mixed age and breed were enrolled 
in the experiment on 21st January 2013. Animals were allocated randomly to one of six treatment 
groups (25 cows per group) in a 2 × 3 factorial arrangement: two pre-calving BCS categories 
(4.0 and 5.0, BCS4 and BCS5; based on a 10-point scale, where 1 is emaciated and 10 obese; 
Roche et al. 2004) and three levels of energy intake during the three wk preceding calving (75, 
100 and 125% of estimated requirements; Roche et al. 2005). The different levels of energy 
intake were obtained by daily manipulation of pasture allowance, adjusting area allocation 
(m2/cow) in each group (Roche et al., 2015). Cows were randomly assigned to the six groups, 
balanced for age, breed (Holstein and Holstein x Jearsey), BCS at the time of enrollment, and 
expected calving date. For the current study only four groups with a subset of 28 animals (7 cows 
per group) were considered. These were cows with prepartum BCS4 fed to meet 75 (B4F75) or 
125 (B4F125) % of requirements, and cows with prepartum BCS5 fed to meet 75 (B5F75) or 
125 (B5F125) % of requirements. The subset groups were still balance for breed age and calving 
date. Average age and days in gestation at enrollment was 6.20 ± 2.18, and 259.32 ± 1.86. 
RNA Extraction and Quantitative PCR (qPCR) 
Adipose biopsy. Tissue was harvested during wk −1, 1, and 4 relative to parturition as 
described previously (Grala et al., 2013). Briefly, subcutaneous adipose tissue was collected 
posterior to the shoulder blade and approximately 10 cm down the withers. The site was clipped 
and cleansed with iodine before administering a local anesthetic (2% lignocaine). A 3-cm 
incision was made through the skin and 30 to 80 mg of adipose tissue removed by blunt 
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dissection. Biopsies were immediately placed in screw-capped, microcentrifuge tubes, snap-
frozen in liquid nitrogen, and stored at −80°C until RNA extraction. 
Total RNA Extraction, Target Genes, and qPCR. Complete details of these procedures 
are included in the supplemental material (Appendix B). Briefly, RNA samples were extracted 
from 0.2 g of frozen adipose tissue and used for cDNA synthesis using established protocols in 
our laboratory (Khan et al., 2014). The Quanta qScript microRNA cDNA Synthesis Kit (Quanta 
BioSciences, Inc., Gaithersburg, MD) was used for miRNA following the manufacturer’s 
protocols. The qPCR performed was SYBR Green-based, using a 7-point standard curve. Genes 
selected for transcript profiling are associated with fatty acid metabolism: fatty acid synthase 
(FASN), peroxisome proliferator-activated receptor gamma (PPARG); adipokines: adiponectin 
(ADIPOQ), leptin (LEP); and inflammation: chemokine (C-C motif) ligand 2 (CCL2), 
chemokine (C-C motif) ligand 5 (CCL5), haptoglobin (HP), interleukin-1β (IL1B), inteleukin-6 
(IL6), inteleukin-6 receptor (IL6R), retinoid X receptor alpha (RXRA), serum amyloid A3 
(SAA3), toll-like receptor 4 (TLR4), and tumor necrosis factor α (TNF). miRNA selected for 
expression profiling (Table 4.1) are associated with immune cell infiltration (miR-26b, miR-126, 
miR-132, miR-155, miR-193), inflammation and lipolysis (miR-99a, miR-145, miR-221), and 
positive regulation of adipogenesis (miR-103, miR-143, miR-378). 
Blood Collection and Analysis 
Blood was sampled by coccygeal venipuncture in correspondence to biopsy, using 
evacuated blood tubes containing a lithium heparin anticoagulant. Samples were placed 
immediately on ice and centrifuged within 30 min at 1,500 × g for 12 min at 4°C. Following 
centrifugation, aspirated plasma was stored at −20°C until assayed. 
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Blood NEFA and BHBA analysis was performed by Gribbles Veterinary Pathology Ltd. Blood 
metabolites were assayed using colorimetric techniques at 37°C with a Hitachi Modular P800 
analyzer (Roche Diagnostics, Indianapolis, IN). Plasma NEFA concentration (mmol/L) was 
measured using Wako Chemicals (Osaka, Japan) kit NEFA HR2 measuring oxidative 
condensation of 3-methyl-N-ethyl-N-β hydroxyethyl aniline with 4-aminoantipyrine, while 
plasma BHBA (mmol/L) concentrations was assessed using Roche reagent kits measuring the 
reduction of NAD to NADH during oxidation of d-3-hydroxybutyrate to acetoacetate. 
Statistical Analysis 
Both expression datasets (mRNA and miRNA) and blood data were analyzed in the same 
fashion. After normalization with the geometric mean of the internal control genes, the qPCR 
data were log2 transformed prior to statistical analysis to obtain a normal distribution, while 
NEFA and BHBA data were used as is. Statistical analysis was performed with SAS (v 9.3). 
Normalized, log2 transformed expression data, and blood metabolites data were subjected to 
ANOVA and analyzed using repeated measures ANOVA with PROC MIXED. The statistical 
model included time (T; -1, 1 and 4 wk postpartum), BCS (B; 4 and 5), feeding (F, 75% and 
125%) and their interactions (B*T, F*T and B*F*T) as fixed effects. Cow, nested within 
treatment, was the random effect. The Kenward-Roger statement was used for computing the 
denominator degrees of freedom, while spatial power was used as the covariance structure. Data 
were considered significant at a P ≤ 0.05 using the PDIFF statement in SAS. For ease of 
interpretation, the expression data reported in Tables 4.3 through 4.6 are the log2 back-
transformed LSM that resulted from the statistical analysis. 
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RESULTS 
NEFA and BHBA 
 Both NEFA and BHBA were affected by BCS (P < 0.05), with a higher overall 
concentration in BCS5 animals compared to BCS4, independently from prepartum feeding 
regime (Table 4.2). Feeding instead only affected BHBA concentration, with a greater overall 
concentration in animal fed 75% compared to 125%. Despite effects were found in both factors, 
their interaction was not significant in either metabolites (B*F, P > 0.05), even thou numerical 
differences are observable. Time, as expected, was significant for both metabolites. 
Gene Expression 
Adipokines and fatty acid metabolism. ADIPOQ was increased by BCS (B, P < 0.0001) 
due to a greater expression (P < 0.05) in BCS5. LEP was affected by BCS, pre-calving plane of 
nutrition and their interaction (B, F, B*F, P < 0.003) (Table 4.3). Its expression was greater in 
B5F75 and B5F125 cows, while B4F75 cows had the lowest expression and B4F125 cows an 
intermediate expression. Among the adipokines, time was significant only for LEP (T, P < 
0.0001) due to a decrease in expression postpartum (Table 4.4). However, the interaction with 
BCS (P < 0.004) revealed that from 1 to 4 wk BCS4 cows had decreased expression whereas 
BCS5 cows had similar LEP expression  (P < 0.05).  
Among the adipogenic/lipogenic genes, PPARG expression was greater (P < 0.05) in BCS5 
(Table 4.3) compared with BCS4 cows. Further, PPARG expression was higher (T, P < 0.05) 
around parturition (-1 and 1 wk) compared with wk 4 of lactation (Table 4.4). There was a triple 
interaction (B*F*T, P = 0.02) for FASN expression due to differences among feeding 
management groups at -1 and 4 wk around parturition coupled with the general decrease in 
expression postpartum for all cows (Table 4.4). Pre-calving, F125 cows had a greater (P < 0.05) 
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expression (~3-fold) compared with F75 cows regardless of BCS. However, when fed F75, the 
BCS5 cows had a greater expression compared with BCS4. In contrast, at 4 wk of lactation 
FASN expression was greater (P < 0.05) for B4F75 cows compared with B4F125 and B5F75. 
Compared with all other groups, B5F125 cows had an intermediate level of expression (Table 
4.4). 
RNA expression of inflammation and immune-related proteins and receptors. Among 
cytokine-encoding genes, IL1B was affected only by the interaction between BCS and feeding 
management (B*F, P = 0.05) due to the greater (P < 0.05) expression in B4F75 compared with 
B4F125 cows (Table 4.3). Cows with BCS5 had an intermediate expression level that did not 
differ (P > 0.05) due to feeding. A three-way interaction was detected (B*F*T, P < 0.005) for 
IL6 and TNF (Table 4). Both genes increased (P < 0.05) in expression postpartum across all 
groups except for B5F75, in which expression of TNF was constant over time (P > 0.05). IL6 
expression decreased immediately postpartum compared with -1 wk and then peaked at 4 wk of 
lactation (Table 4.4). Independently of feeding management, prepartum expression of IL6 was 
greater (P < 0.05) in BCS5 compared with BCS4 cows, while B5F75 cows had the greatest (P < 
0.05) expression of TNF. At 1 wk postpartum, both B4F75 and B5F125 groups had a higher (P < 
0.05) expression of both IL6 and TNF, but at 4 wk only TNF remained higher, while IL6 
expression was greater only in B5F75 cows (Table 4.4). 
Both acute-phase protein-related genes HP and SAA3 were affected by time (T, P < 0.004), as 
their expression increased after calving (Table 4.4). A three-way interaction (B*F*T, P = 0.006) 
and an effect of feeding level (F, P = 0.02) were detected for HP. In all groups HP expressions 
was higher at 1 and 4 wk postpartum, compared to prepartum. In BCS4 animals, disregarding 
feeding groups, the postpartum expression remained constant. However in BCS5F75 the 
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expression increased at 4 wk compared to 1wk, while in BCS5F125 it peaked at 1wk to then 
decrease at 4wk, to an intermediate level compared to the other two time points (Table 4.4).  
IL6R and TLR4, both cytokine receptor-encoding genes, were affected by time (T, P < 0.0001) 
due to greater expression postpartum. Both BCS and feeding management (B, F, P < 0.004) also 
affected IL6R and TLR4, as BCS5 or F75 cows had an overall greater (P < 0.05) expression. 
However, the interaction with time (B*T or F*T) underscored how this difference was only 
significant (P < 0.05) prepartum (Table 4.4). A three-way interaction was detected for TLR4, 
revealing how the response in B5F75 cows due to the higher (P < 0.05) expression at -1 wk 
drove the difference prepartum between management groups. The expression of TLR4 in B5F75 
cows was stable over time and without changes (P > 0.05) among time points. 
The expression of CCL2 was only affected by feeding management (F, P = 0.0005) due to higher 
expression in F75 cows. Expression of CCL5 had a significant BCS, time and three-way 
interaction (B, T, B*F*T, P < 0.0001) (Tables 4.3 and 4.4). Its expression was overall higher (P 
< 0.05) postpartum and greater (P < 0.05) in BCS5 cows independent of feeding, but the greatest 
(P < 0.05) expression was detected postpartum in B5F125 cows. 
RXRA was affected (P < 0.03) by all factors except time, for which only a tendency was detected 
(P = 0.08) (Tables 4.3 and 4.4). Its expression was overall greater (BCS, F P < 0.05) in BCS5 or 
F125 cows, and this was observed primarily prepartum. 
MicroRNA Expression 
Proadipogenic miRNA. An effect of time (T, P < 0.01) was detected for the expression 
of miR-378 and miR-103 due to a decrease (P < 0.05) postpartum (Table 6). Plane of nutrition 
affected both miR-378 and miR-143 (F, P < 0.004) due to greater expression (P < 0.05) in F125 
cows (Table 4.5). The expression of miR-143 also had a significant three-way interaction 
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(B*F*T, P = 0.03) due to greater expression over time in B5F125 cows. The expression of miR-
103 was affected by BCS alone (B, P = 0.007) or by the interaction with feeding (B*F, P = 
0.004). Its expression was overall greater in BCS5 cows, and even greater when these animals 
were fed 125% of requirements during the dry period (B5F125). 
The expression of miR-103 was greater overall in BCS5 cows (B, P = 0.007) and even greater 
when these animals were fed 125% of requirements during the dry period (B5F125; B*F, P = 
0.004). The expression of miR-103 was greatest in B5F125 cows (B*F, P = 0.004).  
Inflammation and lipolysis. Expression of miR-99a (T, B*T, P < 0.02) and miR-145 
(F*T, P = 0.04) decreased (P < 0.05) postpartum for BCS4 or F75 animals (Table 4.6). Feeding 
management affected expression (F, P = 0.02) of miR-145 and miR-99a in opposite directions, 
i.e. F75 increased (P < 0.05) miR-145 and decreased (P < 0.05) miR-99a relative to F125 cows 
(Table 4.5). For miR-145 the difference was mainly due to responses in the prepartum period 
(F*T, P = 0.04). For the expression of miR-221, BCS and feeding interacted differently across 
the groups (B*F, P = 0.01), as its expression was greater (P < 0.05) in B4F75 and B5F125 cows. 
Adipose infiltration of immune cells. miR-193 was only affected by time (T, P < 
0.0001), as its expression decreased (P < 0.05)  gradually from -1 to 4 wk relative to parturition 
(Table 4.6). The three-way interaction was significant (B*F*T, P < 0.04) for miR-155 and miR-
26b. For miR-155 this was due to an increase in expression (P < 0.05) postpartum and overall 
greater (P < 0.05) expression in BCS4 compared with BCS5 cows, and in F75 compared with 
F125 cows. Expression of miR-132 and miR-126 was affected by plane of nutrition (F, P < 
0.004) (Table 4.5). The former was greater (P < 0.05) in F75 cows, while the latter was greater in 
F125 cows (especially prepartum). Both miRNA also were affected by the interaction of BCS 
with time (B*T, P < 0.04). Expression of miR-132 was greater in BCS5 cows, and postpartum its 
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expression decreased to similar levels than BCS4 cows. Expression of miR-126 changed mainly 
due to time, with a decrease (P < 0.05) in expression immediately postpartum followed by an 
increase (P < 0.05) at 4 wk, at which point it reached prepartum levels only in BCS5 cows. This 
microRNA also was affected by the interaction of plane of nutrition and time (F*T, P = 0.01), 
mainly due to a higher (P < 0.05) expression prepartum in F125 cows, and to a decrease (P < 
0.05) in expression at 4 wk. In contrast, F75 cows maintained a constant level of expression (P > 
0.05) throughout the experimental period. 
 
DISCUSSION 
Results from the present study enhance the understanding of molecular mechanisms 
underlying some of the physiological responses associated with both the independent and 
combined effects of prepartum BCS and feeding management. The relationship between the 
immune and metabolic response of the adipose tissue was evident both at the mRNA and 
miRNA expression level, underscoring the existence of a “self-regulatory” mechanism within the 
adipose depot. Together, the data generated could help develop more mechanistic approaches for 
utilizing dry period feeding and BCS management to manipulate the physiological response of 
subcutaneous adipose tissue during the transition period.  
Adipocyte metabolism and adipokines. Around parturition, body reserves are mobilized 
extensively, i.e. there is little anabolism and substantial catabolism (Drackley, 1999). The 
expression pattern of FASN over time exemplifies this adaptation. This enzyme is mainly 
regulated through expression rather than post-transcriptional mechanisms (Bernard et al., 2008, 
Bionaz and Loor, 2008); thus, mRNA expression is a suitable indicator of its activity within 
adipocytes. The marked impact of prepartum overfeeding on FASN and the proadipogenic 
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miRNA studied (miR-378 and miR-143) appear important for driving adipogenesis in adipose 
tissue. Furthermore, the greater prepartal FASN expression when cows of BCS 5 compared with 
BCS 4 were underfed may indicate their adipose depots were “primed” to deposit fat. This idea 
is further supported by the effect of BCS on expression of PPARG and RXRA, two nuclear 
receptors involved in promoting adipocyte differentiation and hypertrophy (Metzger et al., 2005, 
Bionaz et al., 2013), and also the expression of miR-103, an upregulator of adipogenesis (Romao 
et al., 2011, Trajkovski et al., 2011).  
As exemplified by the responses in the BCS5 compared with BCS4 cows, the evident 
association between BCS and fat deposition might be due in part to greater “flexibility” of tissue 
pre-adipocytes to differentiate rather than enlargement of existing adipocytes (Kawada et al., 
2001). The greater expression of ADIPOQ in BCS5 cows lends support to this hypothesis. In 
non-ruminants, adiponectin improves insulin sensitivity and exerts some regulation over fatty 
acid metabolism (Brochu-Gaudreau et al., 2010). Its expression also is markedly increased 
during ruminant adipocyte differentiation (Roh et al., 2006). Thus, changes in ADIPOQ provide 
an indication of the degree of pre-adipocyte differentiation (Soliman et al., 2007).  
The BCS together with feeding management prepartum also influenced the expression of 
leptin, another adipokine. Leptin, produced mainly in white adipose tissue, is a protein that in 
rodents is involved in the regulation of energy intake, storage and expenditure (Chilliard et al., 
2005). In cows and heifers, leptin is positively associated with both BCS and nutrient status 
(Reist et al., 2003, Leon et al., 2004), which explains its greater expression in both BCS5 and 
overfed cows. However, cow adiposity had a greater role because BCS alone increased 
prepartum LEP expression by 4-fold. Given that leptin could elicit a lipolytic effect (Harris, 
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2014), its greater expression postpartum along with higher NEFA (Table 2) in cows with BCS5 
might be beneficial in terms of helping them cope with the typical NEB of early lactation. 
Inflammation and the adipocyte. The mild-to-high systemic inflammation around 
parturition may impair production (Bertoni et al., 2008). However, recent data suggest that, when 
controlled, the inflammatory phenomena play a homeorhetic role in the adaptations of the 
modern dairy cow to transitioning into lactation (Farney et al., 2013, Vailati Riboni et al., 2015). 
As indicated by the higher HP and SAA3 expression postpartum, cows in the current experiment 
most probably experienced a degree of peripartum inflammation. Both haptoglobin and serum 
amyloid A are well known pro-inflammatory biomarkers (Eckersall and Bell, 2010) mainly 
synthesized by the liver. However, it is well-established in non-ruminants that adipocytes also 
produce these proteins and they are recognized as adipokines (Trayhurn, 2005). The greater HP 
expression early postpartum in both B4F75 and B5F125 groups compared with their opposite 
feeding in the same BCS group is indicative of a higher degree of localized inflammation. Thus, 
avoiding high-dietary energy prepartum (Selim et al., 2014, Shahzad et al., 2014) at an optimal 
BCS during the dry period (BCS 5), while overfeeding under-conditioned cows during the close-
up dry period could help alleviate excessive adipose tissue inflammation after calving. As a 
result of the lower production of pro-inflammatory mediators, the lipolytic sensitivity of adipose 
may be reduced. In that context, the peak in HP expression detected in optimally-conditioned 
feed-restricted cows (B5F75) at 4 wk of lactation is noteworthy. Further research is needed to 
understand the biological mechanisms driving this response. 
Apart from the systemic environment, non-ruminant studies revealed that localized 
inflammation plays an important role in coordinating the physiology of the adipocyte. For 
instance, infiltration of fat depots by immune cells in obese individuals is one of the triggers of 
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localized inflammation (Surmi and Hasty, 2008). This occurs via the expression of chemokines 
(chemoattractant cytokines) such as CCL2/MCP-1 (C-C motif chemokine ligand 2/macrophage 
chemoattractant protein-1) or CCL5/RANTES (C-C motif chemokine ligand 5/regulated on 
activation, normal T cell expressed and secreted) (Neels and Olefsky, 2006). Although 
overfeeding generally increases chemokine expression, both in human and animal models 
(Lionetti et al., 2009, Ji et al., 2014b), feed-restriction in lactating goats also upregulated CCL2 
in adipose tissue (Faulconnier et al., 2011).  
Underfed animals are generally in NEB, and rely heavily on body reserves. Because 
inflammation induces lipolysis and insulin-resistance in non-ruminant adipocytes (Tilg and 
Moschen, 2008), the upregulation of CCL2 could serve as a homeostatic mechanism to reduce 
utilization of nutrients by adipose depots, hence, directing the greatest amount of glucose toward 
maintenance or milk synthesis (De Koster and Opsomer, 2013). This idea is supported by the 
upregulation of miR-155, miR-26b and miR-132 [all of which are markers of macrophage 
infiltration (Kloting et al., 2009)] in feed-restricted cows independently of BCS. The 
upregulation of these miRNA postpartum in all cows supports the idea of inflammation as a 
response to the physiological adaptations to lactation.  
In contrast to other markers of immune cell infiltration, there was an additive effect of 
dry period conditioning on miR-155, as in early lactation the feed-restricted BCS 4 cows had the 
greatest expression among all groups. Thus, feed-restricting thin cows prepartum could lead to 
an excess of localized inflammation that might impair the normal adaptation of the tissue to 
lactation. Based on the treatment effects detected, the expression of miR-126 (upregulated in 
overfed animals) and miR-193 (no change in relation to feeding management) did not seem to be 
associated with CCL2. In humans, both of these miRNA are involved in the transcriptional 
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regulation of CCL2 (Arner et al., 2012). This leads us to speculate that the same mechanism 
might not be present in bovine adipocytes. 
The downregulation of miR-99a along with upregulation of miR-145 especially 
prepartum in feed-restricted cows offers support to the hypothesis of induced local inflammation 
via the recruitment of immune cells, likely augmenting tissue lipolytic sensitivity. Because in 
humans miR-99a abundance is negatively correlated with concentration of free fatty acids within 
the adipocyte (Kloting et al., 2009) and miR-45 regulates adipocyte lipolysis through different 
mechanisms (Lorente-Cebrian et al., 2014), their expression patterns imply a higher degree of 
mobilization in feed-restricted cows, which is partly supported by the higher NEFA prepartum 
(Roche et al., 2015).  
In contrast to feeding level being a primary driver of CCL2 expression, prepartum cow 
adiposity (BCS) appeared to be the main effector of CCL5 expression. Compared with CCL2, 
CCL5 is a chemokine with a broader spectrum that is not only able to recruit monocytes and 
promote their survival (Keophiphath et al., 2010), but also mediates the trafficking and homing 
of T cells, basophils, eosinophils, natural killer cells, dendritic cells and mast cells (Appay and 
Rowland-Jones, 2001). As in the obesity model (Huber et al., 2008), the effect of BCS 5 on 
CCL5 expression could be attributed in part to the higher adiposity, because CCL2 also was 
numerically higher at BCS 5. Its expression was further increased postpartum in cows that 
underwent overfeeding at a BCS of 5 over the pre-calving period.  
The nuclear receptor RXRA can play a key role in the regulation of innate immunity by 
modulating expression of other chemokines (e.g. CCL6, CCL9) (Nunez et al., 2010). The fact 
that its expression followed the same trend as CCL5, with increased expression in BCS5 cows 
and overfed cows especially prepartum, could have contributed to excessive localized 
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inflammation, greater insulin resistance, and greater lipolytic sensitivity. Such effects could be 
even greater in cows with BCS higher than 5, as overconditioned cows normally seem to 
mobilize more body reserves; hence, they are more prone to metabolic disorders like ketosis 
(Pires et al., 2013; Roche et al., 2013). 
Adipose tissue is an active producer of cytokines, primarily by non-fat cells, and their 
release is enhanced in response to local inflammation (Fain, 2006). In turn, the cytokines 
released can impact adipose metabolism (Coppack, 2001). Because tumor necrosis factor α is 
one of the main cytokines produced by infiltrated immune cells, especially macrophages 
(Weisberg et al., 2003, Xu et al., 2003), and it increases lipolysis (Cawthorn and Sethi, 2008), the 
greater expression of TNF in cows with higher BCS that were overfed indicates they might be 
most susceptible to having pathological increases in blood NEFA. Interleukin-6, another 
cytokine known in non-ruminants for its lipolytic effects (Yang et al., 2008), also was 
upregulated early postpartum in the same animals. Regardless of time around parturition, the 
upregulation of IL6R in BCS 5 cows indicates that they were more susceptible to IL-6. Thus, as 
proven in overconditioned cows at parturition, an increase in the local sensitivity to IL-6 would 
lead to excess lipolysis in early lactation and threaten the liver, e.g. increasing triacylglycerol 
accumulation and impairing its functions (Roche et al., 2009, Akbar et al., 2015). In contrast to 
overfeeding, the postpartum pro-lipolytic effect of feed-restriction seems to be increased at a 
lower degree of adiposity. For example, expression of IL1B, encoding a cytokine involved in 
insulin resistance and lipolysis in adipocytes (Lagathu et al., 2006), was markedly increased in 
feed-restricted BCS 4 cows. This is another example of a prolonged effect of prepartum feeding 
management into early lactation. 
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Despite what is known thus far regarding the effect of BCS and plane of nutrition in the 
dry period, the combination of greater BCS (5) with feed-restriction prepartum seems to affect 
pre-calving expression of CCL5, TLR4, and IL6. Of particular interest, from the inflammation 
standpoint, is the lipopolysaccharide receptor TLR4 because in non-ruminants it links innate 
immunity with fatty acid–induced insulin resistance (Shi et al., 2006). The prepartal response in 
CCL5 and IL6 would be expected to trigger an inflammatory response close to calving, and the 
upregulation of TLR4 would induce insulin resistance, both of which favor lipid mobilization 
mechanisms in cows with optimal BCS. As such, the adaptations in these gene networks serve to 
prime the adipocytes for the demands of early lactation. It is noteworthy that the transcriptional 
response of these genes was lost postpartum. Thus, the link between these genes in relationship 
with BCS and dietary management prepartum needs further research. 
 
CONCLUSIONS 
Overfeeding optimally-conditioned cows during the last 3 wk prior to parturition primed 
adipose tissue for accretion of lipid and a robust localized inflammatory response, which upon 
parturition increases the probability for metabolic disorders, i.e. localized inflammation renders 
the adipocyte more susceptible to lipolytic signals that could result in greater flow of NEFA into 
liver. Similarly, prepartum nutrient restriction of thinner cows enhances the localized pro-
inflammatory response of adipocytes, hence, eliciting a similar negative outcome. Overall, the 
combined data indicate that a regime of nutrient restriction prepartum in optimally-conditioned 
cows avoids detrimental effects at the adipose tissue level, hence, physiologically priming the 
cow to the demands of lactation while avoiding a metabolically “lazy” phenotype. Instead 
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thinner animals seem to benefit from a higher plane of nutrition, with beneficial effects in terms 
of controlling localized inflammation. 
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TABLES 
 
Table 4.1. Details and functions of the miRNA targets analyzed in the current study. 
miRNA Function and/or expression pattern 
Infiltration of immune cells 
miR-26b Expression is associated with the number of macrophages infiltrating the fat depot 
Affected by levels of circulating TNF, leptin and resistin 
miR-126 Directly inhibits CCL2 expression 
miR-132 Expression levels are associated with the number of macrophages infiltrating fat depots  
Activates NF‐κB signalling and the transcription of IL8 and CCL2  
Lower expression is associated with increased secretion of IL-6  
miR-155 Expression levels are associated with the number of macrophages infiltrating fat depots 
miR-193 Indirectly inhibits CCL2 expression through a network of transcription factors  
 
Inflammation and lipolysis 
miR-99a Negative correlation with secretion of IL-6 and level of free fatty acids 
miR-145 Affects secretion of TNFα, regulating lipolysis 
miR-221 Lower expression is associated with high levels of TNFα 
 
Proadipogenic 
miR-103 Regulates expression of PPARG, PANK1, CAV1, FASN, ADIPOQ and FABP4 
miR-143 Regulates expression of ERK5, SLC2A4, TFAP2A, LIPE, PPARG, CEBPA, and FABP4 
miR-378 Targets PPARG expression through the MAPK1 pathway 
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Table 4.2. Effect of prepartum BCS and feeding management on plasma concentration of NEFA and BHBA in dairy cows during the 
transition period.  
 
     B*F   
 B  F  4 5  P-value1 
mmol/L 4 5 SE 75% 125% SE 75% 125% 75% 125% SE B F B*F T B*T F*T B*F*T 
NEFA  0.50x 0.72y 0,04 0,59 0,62 0,04 0.48x 0.51x 0.70y 0.73y 0,05 0,0004 0,62 0,99 <.0001 0,05 0,26 0,99 
BHBA  0.46x 0.60y 0,03 0.57x 0.49y 0,03 0.51x,z 0.42x 0.64y 0.56x,z 0,04 0,004 0,05 0,83 <.0001 0,1 0,01 0,57 
1T = time (week relative to parturition); B = BCS (1-10 scale); F = level of feeding prepartum relative to requirement (%); B*F*T = interaction of BCS, level of 
feeding prepartum relative to requirements (%), and time around parturition. 
x,y,z = significant difference among groups (P < 0.05). 
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Table 4.3. Effect of prepartum BCS and feeding management on subcutaneous adipose tissue expression (log2 back-transformed 
LSM) in dairy cows during the transition period.  
 
 
 
 
 
 
 B*F 
 P-value1 
 
 B  F  4  5 
 Gene  4 5  75% 125%  75% 125%  75% 125% SEM2 B F B*F 
Inflammation  
CCL2  2.16 2.82  3.39x 1.79y  2.97 1.57  3.88 2.04 0.44 0.13 0.0005 0.99 
CCL5  1.34x 2.88y  1.89 2.04  1.39 1.29  2.56 3.24 0.33 <.0001 0.58 0.28 
HP  0.17 0.25  0.28x 0.16y  0.26 0.11  0.30 0.22 0.17 0.13 0.02 0.31 
IL1B  0.99 0.93  1.05 0.88  1.21x 0.8y  0.91x,y 0.96x,y 0.10 0.66 0.13 0.05 
IL6  0.48x 0.79y  0.70 0.54  0.57 0.40  0.86 0.72 0.10 0.006 0.15 0.63 
IL6R  0.82x 1.08y  1.08x 0.82y  0.90 0.75  1.30 0.90 0.11 0.005 0.004 0.32 
RXRA  0.74x 1.19y  0.86x 1.02y  0.62x 0.87y  1.19z 1.19z 0.07 <.0001 0.03 0.03 
SAA3  0.53 0.39  0.42 0.49  0.52 0.55  0.34 0.43 0.12 0.27 0.61 0.77 
TLR4  1.02x 1.25y  1.22x 1.04y  1.09 0.95  1.38 1.14 0.08 0.0005 0.007 0.65 
TNF  0.78 0.93  0.87 0.83  0.90 0.68  0.84 1.03 0.10 0.07 0.66 0.01 
Adipokines and fatty acid metabolism  
ADIPOQ  0.72x 1.28y  0.87 1.05  0.59 0.88  1.29 1.27 0.11 <.0001 0.09 0.07 
FASN  0.15 0.17  0.13x 0.21y  0.12 0.19  0.13 0.23 0.17 0.33 0.0001 0.55 
LEP  0.12x 0.65y  0.17x 0.44y  0.05x 0.26y  0.57z 0.74z 0.33 <.0001 <.0001 0.003 
PPARG  0.86x 1.08y  0.94 0.99  0.81 0.93  1.10 1.07 0.09 0.008 0.52 0.33 
 
1 B = BCS (1-10 scale); F = level of feeding prepartum relative to requirements (%); B*F = interaction of BCS and level of feeding 
prepartum relative to requirements (%). 
2 SEM = greatest standard error of the mean. 
x,y,z = significant difference among groups (P < 0.05). 
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Table 4.4. Effect of the interaction among prepartum BCS, prepartum feeding management, and time around parturition on 
subcutaneous adipose tissue gene expression (log2 back-transformed LSM) in dairy cows during the transition period. 
 
Gene wk 
 
  
 
 B*F*T 
SEM2 
P-values1 
 
B*T  F*T  4  5 
T1 4 5  75% 125%  75% 125%  75% 125% T B*T F*T B*F*T 
Inflammation 
CCL2 
-1 2.11 1.63 2.72  2.41 1.84  1.57 1.70  3.72 1.99 
1.57 0.28 0.17 0.23 0.19 1 2.48 2.65 2.32  3.58 1.72  4.46 1.57  2.87 1.88 
4 2.87 2.32 3.54  4.52 1.82  3.74 1.44  5.46 2.29 
CCL5 
-1 1.09a 0.69 1.75  1.18 1.01  x0.52a x,z0.91a  y2.71 z1.12a 
1.53 <.0001 0.25 0.33 <.0001 1 2.23b 1.71 2.91  2.04 2.43  x2.11b x1.38b  x1.98 y4.26b 
4 3.11c 2.05 4.71  2.78 3.47  x,y2.48b x1.70b  y3.12 z7.10b 
HP 
-1 0.04a 0.04 0.05  0.06 0.03  x,y0.06a x0.02a  y0.07a x,y0.04a 
0.46 <.0001 0.83 0.2 0.0006 1 0.46b 0.35 0.61  0.49 0.43  x,z0.68b y0.18b  x,y0.36b z1.05b 
4 0.46b 0.40 0.54  0.73 0.29  x0.46b x0.34b  y1.17c x0.25c 
IL1B 
-1 0.93 1.05 0.82  1.03 0.84  1.36 0.81  0.78 0.87 
0.29 0.7 0.29 0.08 0.81 1 0.93 0.85 1.03  1.18 0.73  1.15 0.62  1.22 0.87 
4 1.02 1.08 0.96  0.96 1.09  1.15 1.01  0.80 1.16 
IL6 
-1 0.53 0.34 0.82  0.62 0.46  x,y0.4a x0.29a  y0.96a x,y0.71a 
0.41 0.44 0.16 0.29 0.002 1 0.66 0.52 0.83  0.64 0.68  x,z0.76b y0.36b  x,y0.53b z1.31b 
4 0.66 0.62 0.71  0.86 0.50  x,y0.61b y0.63b  x1.23c y,z0.41c 
IL6R 
-1 0.46a 0.39 0.55  x0.64 a y0.33a  0.49 0.31  0.85 0.36 
0.28 <.0001 0.52 0.011 0.73 1 1.38b 1.30 1.47  1.52b 1.26b  1.41 1.21  1.64 1.32 
4 1.31b 1.11 1.54  1.30b 1.31b  1.08 1.14  1.58 1.51 
RXRA 
-1 1.02 x0.66 y1.59a  x0.79 y1.32a  x0.40a y1.07a  z1.55a z1.63a 
0.20 0.08 0.0002 0.001 0.01 1 0.94 x0.81 y1.08b  0.92 0.96b  x0.79b x0.83a,b  x1.06b x1.11b 
4 0.86 x0.75 y0.98b  0.88 0.83b  x,y0.75b y0.75a  x1.04b x,y0.93b 
SAA3 
-1 0.31a 0.32 0.29  0.37 0.25  0.35 0.30  0.40 0.21 
0.37 0.004 0.7 0.06 0.4 1 0.60b 0.71 0.50  0.45 0.79  0.58 0.89  0.36 0.71 
4 0.51b 0.65 0.40  0.45 0.58  0.69 0.62  0.29 0.55 
TLR4 
-1 0.72a x0.55a y0.93a  x0.87a y0.59a  x0.59a x0.52a  y1.29 x0.67a 
0.19 <.0001 0.003 0.04 0.03 1 1.27b 1.24b 1.30b  1.32b 1.22b  1.38b 1.12 b  1.26 1.33b 
4 1.59c 1.54c 1.63c  1.60b 1.57b  1.60b 1.48 b  1.60 1.67b 
TNF 
-1 0.58a 0.51 0.65  0.68 0.49  x,y0.55a y0.48a  x0.86 y0.49a 
0.27 <.0001 0.87 0.11 0.005 
1 1.10b 1.04 1.16  1.04 1.16  x,y1.24b y0.88b  y0.88 x1.53b 
 
4 0.97b 0.88 1.07  0.92 1.02  x,y1.07b y0.73a,b  y0.79 x1.44b 
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Table 4.4. (cont) 
 
Adipokines and fatty acid metabolism 
ADIPOQ 
-1 1.13 0.95 1.35  0.99 1.29  0.69 1.32  1.43 1.26 
0.26 0.07 0.21 0.49 0.24 1 0.86 0.63 1.16  0.74 0.99  0.48 0.83  1.14 1.17 
4 0.91 0.61 1.34  0.90 0.92  0.61 0.62  1.31 1.37 
FASN 
-1 1.47a 1.22 1.78  x0.68a y3.22a  x0.47a y3.15a  z0.97a y3.29a 
0.78 <.0001 0.38 <.0001 0.02 1 0.05b 0.04 0.05  0.04b 0.05b  0.04b 0.05b  0.05b 0.05b 
4 0.06c 0.07 0.06  0.07b 0.06b  x0.09c y0.05b  y0.05b x,y0.08b 
LEP 
-1 1.83a x0.96a y3.49a  1.03 3.28  0.28 3.26  3.70 3.29 
1.32 <.0001 0.004 0.62 0.07 1 0.20b x0.11b y0.36b  0.14 0.29  0.07 0.17  0.28 0.47 
4 0.06c x0.02c y0.21b  0.04 0.09  0.01 0.03  0.17 0.27 
PPARG 
-1 1.15a 1.03 1.28  1.07 1.23  0.88 1.21  1.30 1.26 
0.19 0.0004 0.92 0.72 0.7361 1 1.03a 0.93 1.13  1.00 1.05  0.89 0.97  1.13 1.12 
4 0.77b 0.67 0.88  0.78 0.76  0.67 0.67  0.90 0.86 
 
1 T = time (week relative to parturition); B = BCS (1-10 scale); F = level of feeding prepartum relative to requirement (%); B*F*T = interaction of BCS, level of 
feeding prepartum relative to requirements (%), and time around parturition. 
2 SEM = greatest standard error of the mean. 
a,b,c = significant difference among time points, within group (P < 0.05).  
x,y,z = significant difference among groups within the same week relative to parturition (P < 0.05)
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Table 4.5. Effect of prepartum BCS and feeding management on subcutaneous adipose tissue microRNA expression (log2 back-
transformed LSM) in dairy cows during the transition period. 
  
 
 
 
 
 
 B*F 
 P-value1 
 
 B  F  4  5 
 Gene  4 5  75% 125%  75% 125%  75% 125% SEM2 B F B*F 
Infiltration of immune cells  
miR-26b  1.35 1.52  1.65x 1.24y  1.64 1.11  1.65 1.39 0.17 0.27 0.007 0.30 
miR-126  0.72 0.88   0.67x 0.94y   0.66 0.79   0.68 1.13 0.08 0.08 0.004 0.14 
miR-132  1.23 1.46  1.55x 1.15y  1.48 1.03  1.63 1.30 0.12 0.07 0.002 0.45 
miR-155  1.48x 1.19y   1.74x 1.01y   2.03 1.07   1.50 0.95 0.15 0.04 <.0001 0.37 
miR-193  1.05 1.05   1.08 1.03   1.02 1.09   1.15 0.97 0.11 0.99 0.50 0.16 
Inflammation and lipolysis 
miR-99a  0.96 0.93   0.85x 1.05y   0.88 1.04   0.82 1.05 0.09 0.70 0.02 0.64 
miR-145  1.23 1.40   1.50x 1.15y   1.43 1.06   1.56 1.25 0.12 0.23 0.02 0.70 
miR-221  1.24 1.33  1.29 1.28  1.37x,y 1.11x  1.20x 1.47y 0.09 0.33 0.93 0.01 
Proadipogenic  
miR-103   0.97x 1.16y   1.04 1.08   1.05x 0.90x   1.04x 1.30y 0.07 0.007 0.61 0.004 
miR-143   0.94 1.08  0.87x 1.16y  0.86 1.02  0.88 1.32 0.08 0.14 0.004 0.21 
miR-378   1.06 0.94   0.80x 1.25y   0.87 1.30   0.73 1.21 0.16 0.19 <.0001 0.58 
 
1 B = BCS (1-10 scale); F = level of feeding prepartum relative to requirements (%); B*F = interaction of BCS and level of feeding prepartum relative to 
requirements (%). 
2 SEM = greatest standard error of the mean. 
x,y,z = significant difference among groups (P < 0.05). 
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Table 4.6. Effect of the interaction among prepartum BCS, prepartum feeding management, and time around parturition on 
subcutaneous adipose tissue microRNA expression (log2 back-transformed LSM) in dairy cows during the transition period. 
 
Gene wk 
 
  
 
 B*F*T 
SEM2 
P value 
 
B*T  F*T  4  5 
T1 4 5  75% 125%  75% 125%  75% 125% T 
 
B*T F*T B*F*T 
Infiltration of immune cells 
miR-26b 
-1 0.91a x1.10 y0.76a  1.01 0.82  x1.37 x,y0.88  y0.74a y0.77a 
0.58 <.0001 0.005 0.07 0.04 1 1.69b 1.49 1.92b  2.31 1.24  x1.78 x1.25  y2.99b x1.24a 
4 1.89b x1.49 y2.39b   1.93 1.85   x,y1.81 y1.22   x2.05b x2.80b 
miR-126 
-1 0.81a,b 0.89a 0.73a  x0.58 y1.14a  0.72 1.11  0.46 1.16 
0.25 0.007 0.01 0.01 0.28 1 0.93a 0.73a,b 1.19b  x0.80 x1.09a  0.62 0.87  1.03 1.37 
4 0.66b 0.57 b 0.77a   0.65 0.67b   0.65 0.50   0.65 0.91 
miR-132 
-1 1.48 x1.17 y1.86a  1.82 1.20  1.64 0.84  2.02 1.72 
0.32 0.21 0.04 0.12 0.10 1 1.31 1.36 1.28b  1.62 1.07  1.77 1.04  1.48 1.10 
4 1.23 1.17 1.30b   1.27 1.20   1.11 1.24   1.45 1.16 
miR-155 
-1 0.99a 1.01 0.97   1.47 0.67   x1.46a y0.70a   x1.49a,b y0.63a 
0.44 <.0001 0.24 0.14 0.02 1 1.30b 1.60 1.05  1.65 1.02  x2.57b y1.00a  y1.06a y1.04b 
4 1.82c 2.00 1.67   2.19 1.52   x2.25a,b x,y1.77b   x2.13b y1.30b 
miR-193 
-1 1.63a 1.61 1.65  1.68 1.59  1.65 1.57  1.70 1.60 
0.29 <.0001 0.10 0.66 0.07 1 1.06b 1.18 0.95  1.13 0.99  1.27 1.09  1.01 0.89 
4 0.68c 0.62 0.74   0.67 0.69   0.51 0.75   0.88 0.63 
Inflammation and lipolysis 
miR-99a 
-1 1.11a x1.36a y0.91  0.87 1.41  1.09 1.69  0.70 1.17 
0.25 0.01 0.01 0.10 0.21 1 0.93a,b 0.87b 0.99  0.88 0.99  0.77 0.99  1.00 0.99 
4 0.81b 0.75b 0.88   0.79 0.83   0.82 0.68   0.77 1.01 
miR-145 
-1 1.41 1.26 1.58  x1.86a y1.07  1.80 0.88  1.93 1.30 
0.32 0.40 0.62 0.04 0.16 1 1.21 1.21 1.22  1.35b 1.10  1.45 1.01  1.26 1.19 
4 1.31 1.22 1.42   1.33b 1.30   1.13 1.32   1.58 1.27 
miR-221 
-1 1.30 1.13 1.49   1.45 1.16   1.49 0.86   1.41 1.57 
0.25 0.75 0.14 0.05 0.09 1 1.23 1.22 1.25  1.24 1.23  1.42 1.05  1.08 1.45 
4 1.31 1.36 1.27   1.18 1.46   1.22 1.52   1.15 1.40 
Proadipogenic 
miR-103 
-1 1.21a 1.08 1.35  1.24 1.17  1.34 0.87  1.16 1.57 
0.20 0.01 0.45 0.42 0.15 1 1.05a,b 0.93 1.19  1.04 1.06  0.99 0.87  1.09 1.29 
4 0.95b 0.91 0.98   0.88 1.02   0.88 0.95   0.88 1.08 
miR-143 
-1 1.05 1.05 1.05  0.81 1.36  x,y0.94 x,z1.18a,b  y0.70a  z1.58 
0.23 0.44 0.45 0.15 0.03 1 1.03 0.90 1.18  0.93 1.15  x0.74 x,y1.11a  y1.18b y1.18 
4 0.94 0.87 1.01   0.87 1.00   x,y0.92 x0.81b   x0.83a,b y1.24 
miR-378 
-1 1.86a 2.09 1.65  1.30 2.66  1.62 2.69  1.03 2.63 
0.43 <.0001 0.50 0.09 0.46 1 1.01b 1.09 0.94  0.82 1.25  0.89 1.34  0.76 1.16 
4 0.53c 0.52 0.54   0.47 0.59   0.45 0.61   0.49 0.58 
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Table 4.6 (cont) 
 
1 T = time (week relative to parturition); B = BCS (1-10 scale); F = level of feeding prepartum relative to requirement (%); B*F*T = interaction of BCS, level of 
feeding prepartum relative to requirements (%), and time around parturition. 
2 SEM = greatest standard error of the mean. 
a,b,c = significant difference among time points, within group (P < 0.05).  
x,y,z = significant difference among groups within the same week relative to parturition (P < 0.05).
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CHAPTER 5: PREPARTUM BODY CONDITION SCORE AND PLANE OF 
NUTRITION AFFECT THE HEPATIC TRANSCRIPTOME DURING THE 
TRANSITION PERIOD IN GRAZING DAIRY COWS 
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Crookenden, A. Heiser, S.L. Rodriguez Zas, J.R. Roche, and J.J. Loor. 2016. Prepartum body 
condition score and plane of nutrition affect the hepatic transcriptome during the transition 
period in grazing dairy cows. BMC Genomics, 17:854.
 
ABSTRACT 
Background 
A transcriptomic approach was used to evaluate potential interactions between prepartum body 
condition score (BCS) and feeding management in the weeks before calving on hepatic 
metabolism during the periparturient period.  
Methods 
Thirty-two mid-lactation grazing dairy cows of mixed age and breed were randomly allocated to 
one of four treatment groups in a 2 × 2 factorial arrangement: two prepartum BCS categories [4.0 
(thin, BCS4) and 5.0 (optimal, BCS5); based on a 10-point scale], and two levels of energy 
intake during the 3 wk preceding calving (75 and 125% of estimated requirements). Liver 
samples were obtained at -7, 7, and 28 d relative to parturition and subsequent RNA was 
hybridized to the Agilent 44K Bovine (V2) Microarray chip. The Dynamic Impact Approach was 
used for pathway analysis, and Ingenuity Pathway Analysis was used for gene network analysis.  
Results 
The greater number of differentially expressed genes in BCS4 cows in response to prepartum 
feed allowance (1071 vs 310, over the entire transition period) indicates that these animals were 
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more responsive to prepartum nutrition management than optimally-conditioned cows. However, 
independent of prepartum BCS, pathway analysis revealed that prepartal feeding level had a 
marked effect on carbohydrate, amino acid, lipid, and glycan metabolism. Altered carbohydrate 
and amino acid metabolism suggest a greater and more prolonged negative energy balance 
postpartum in BCS5 cows overfed prepartum. This is supported by opposite effects of prepartum 
feeding in BCS4 compared with BCS5 cows in pathways encompassing amino acid, vitamin, and 
co-factor metabolism. The prepartum feed restriction ameliorates the metabolic adaptation to the 
onset of lactation in BCS5 cows, while detrimentally affecting BCS4 cows, which seem to better 
adapt when overfed. Alterations in the glycosaminoglycans synthesis pathway support this idea, 
indicating better hepatic health status in feed-restricted BCS5 and overfed BCS4 cows. 
Furthermore, IPA network analysis suggests liver damage in feed-restricted thin cows, likely due 
to metabolic overload.  
Conclusion 
Overall, the data support the hypothesis that overfeeding in late-pregnancy should be limited to 
underconditioned cows, while cows with optimal degree of body condition should be maintained 
on an energy-restricted diet. 
 
BACKGROUND 
Nutritional management of the late pregnant dairy cow has been examined as a way to 
improve cow DMI and health during the transition period. The aim is to counteract the negative 
energy balance (NEB) that dairy cows experience postpartum, and ease their transition into 
lactation. Traditionally, management practices provided dry cows with a high-fiber/low-energy 
density ration (“far-off” diet), switching to a low-fiber/higher-energy density ration for the last 
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month of gestation (“close-up” diet). Different studies, however, have thus far demonstrated that 
this “close-up” approach often leads to prepartum hyperglycemia and hyperinsulinemia and 
greater blood non-esterified fatty acid (NEFA) concentrations (i.e., excess lipid mobilization 
postpartum) (Holtenius et al., 2003, Roche et al., 2005, Janovick et al., 2011, Roche et al., 2015). 
The move to “close-up” diets with greater energy density may also elicit detrimental effects on 
the postpartum health of the cow (Dann et al., 2006, Graugnard et al., 2013, Shahzad et al., 
2014).  
Similar outcomes in the postpartum period have been associated with the level of body 
condition score (BCS) at calving. Altered plasma concentrations of biomarkers of metabolic and 
inflammation were detected in some studies in overconditioned cows (Hayirli et al., 2002, 
Holtenius et al., 2003, Roche et al., 2013, Randall et al., 2015) and in “thin”, underconditioned 
cows (Pires et al., 2013, Roche et al., 2013, Akbar et al., 2015), indicating that both groups are at 
greater risk of developing metabolic or health disorders during transition. Thin cows experience 
more problems in a pasture-system (the present study) than in a TMR-based system, where the 
risk of overconditioning during the dry period is far greater (Roche et al., 2007, Roche et al., 
2009). For these reasons, assessment of BCS prepartum can provide a qualitative evaluation of 
the chances for an optimal transition, which, in turn, is closely associated with optimal 
production and the chances for a successful lactation (Roche et al., 2009). 
Despite the fact that both prepartum BCS and plane of nutrition play an important role in 
the metabolic response of the animal to lactation, cows are generally managed similarly 
prepartum. During the transition period, the high metabolic demands required for milk synthesis 
rely on homeorethic mechanisms in multiple tissues, all of which converge on the metabolic 
ability of the liver (Drackley, 1999). Previous studies have demonstrated the ability of “omics” 
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approaches for evaluating the effects of calving BCS (Akbar et al., 2014b, c) and feeding 
management (Loor et al., 2006, Shahzad et al., 2014) on the metabolic activity of the liver during 
the transition period. Therefore, in the present study, liver transcriptome profiling through 
microarray technology was undertaken to investigate the hypothesis that an interaction between 
precalving BCS and prepartum feeding management exists, and that it can affect the hepatic 
adaptations to lactation in grazing dairy cows. 
 
METHODS 
Experimental Design And Sample Collection  
Complete details of the experimental design are available elsewhere (Roche et al., 2015). 
Briefly, 150 mixed breed mid-lactation grazing dairy cows were balanced for age, breed, BCS at 
the time of enrollment, and expected calving date. Cows were randomly allocated to one of six 
treatment groups (25 cows per group) in a 2 × 3 factorial arrangement: two pre-calving BCS 
categories (4.0 and 5.0, BCS4 and BCS5; based on a 10-point scale, where 1 is emaciated and 10 
obese; Roche et al., 2004) and three levels of energy intake during the three wk preceding 
calving (75, 100, and 125% of estimated requirements; Roche et al., 2005). The different groups 
were obtained by daily manipulation of pasture allowance (Roche et al., 2015). 
A subset of 32 animals with the complete set of biopsies and plasma samples (8 cows in 
each of four treatment groups) was used for transcriptomic analysis. These were cows with 
prepartum BCS4 fed to meet 75 (B4F75) or 125 (B4F125) % of requirements, and cows with 
prepartum BCS5 fed to meet 75 (B5F75) or 125 (B5F125) % of requirements. The average cow 
age was 6.4 ± 2.3, 5.4 ± 2.3, 6.3 ± 2.6, and 4.8 ± 1.5 years for B4F75, B4F125, B5F75, and 
B5F125, respectively. Breed-wise, pure bred New Zealand Holsteins were 4, 2, 6, and 3, for 
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B4F75, B4F125, B5F75, and B5F125, respectively, with the remaining cows in each group being 
a mix-bred Jersey with an average percentage of New Zealand Holstein blood of 86 ± 10, 75 ± 
19, 69 ± 24, and 47 ± 31 %, for B4F75, B4F125, B5F75, and B5F125, respectively. 
The intermediate groups in both BCS classes (B4F100 and B5F100) were omitted from 
the present analysis as feeding to the exact requirements is rarely achievable in field conditions. 
In practice, multiple factors (e.g., pasture management and allocation, animal competition and 
social interaction) cause cows being mostly overfed or underfed. 
Liver tissue was harvested via percutaneous biopsy under local anesthesia at -7, 7, and 28 
d relative to parturition. Tissue samples were immediately snap frozen in liquid nitrogen and 
stored at -80°C until further analysis. Blood was sampled on the same days, prior to the biopsy, 
by coccygeal venipuncture using evacuated blood tubes containing a lithium heparin 
anticoagulant, and processed for plasma collection and determination of NEFA and BHBA. 
Assay information is reported in Supplemental file 1 (Appendix C). 
RNA Extraction And Microarray Performance 
Complete information about the procedures is reported in Supplemental file 1 (Appendix 
C). 
Statistical Analysis 
Statistical analysis for transcriptomic data was performed using SAS v9.3 (SAS Institute 
Inc.). Data from a total of 48 microarrays were adjusted for dye and array effects (Lowess 
Normalization and array centering). A MIXED model with repeated measures was then fitted to 
the normalized log2-tranformed adjusted ratios using Proc MIXED, according to the following 
model: 
𝑌𝑖𝑗𝑘𝑙𝑚 =  𝜇 +  𝑇𝑖 +  𝐵𝑗 +  𝐹𝑘  +  𝑇𝐵𝑖𝑗  +  𝑇𝐹𝑖𝑘  +  𝐵𝐹𝑗𝑘  +  𝑇𝐵𝐹𝑖𝑗𝑘  +  𝐶𝑙  +  𝑒𝑖𝑗𝑘𝑙𝑚 
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The model for Yijklm (dye-array adjusted expression) included the overall mean (μ), the 
fixed effects of time (Ti, −7, 7, and 28 d), prepartum BCS (Bj, 4 and 5), prepartum feeding 
management (Fk, 75 and 125%), and their interactions (TBij, TFik, BFjk, TBFijk). Cow (Cl) was 
considered an uncorrelated random effect, and eijklm represent the residual error. The raw P-
values were adjusted for the number of genes tested using Benjamini and Hochberg’s false 
discovery rate (FDR; Benjamini and Hochberg, 1995) to account for multiple comparisons. 
Blood data were subjected to ANOVA in SAS (v9.3) and analyzed with PROC MIXED, 
fitting the same statistical model as used for transcriptome data. Time, BCS, feeding, and their 
interactions were considered as fixed effects, while cow, nested within treatment, was the 
random effect. The Kenward-Roger statement was used for computing the denominator degrees 
of freedom, while spatial power was used as the covariance structure. Data were considered 
significant at P ≤ 0.05 using the PDIFF statement. 
Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway Analysis 
The dynamic impact approach (DIA) was used for KEGG pathway analysis of 
differentially expressed genes (DEG). The DIA calculates the overall effect (relevance of a given 
pathway) and flux (direction of effect), thus allowing evaluation of transcriptome profiles in a 
more holistic fashion. The detailed methodology of DIA is described elsewhere (Bionaz et al., 
2012). Briefly, the whole dataset with Entrez gene ID, fold-change (FC) (≤ −1.5 and ≥ 1.5), and 
raw P-value (≤ 0.01) was uploaded to DIA. For the analyses, a minimum of 30% annotated 
genes on the microarray versus the whole genome (Bionaz et al., 2012) was selected. 
Transcription Regulators and Gene Network Analysis 
Ingenuity pathway analysis (IPA) software (Qiagen) was used to analyze the upstream 
transcription regulators and their connections with other downstream genes that were 
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differentially expressed. For this purpose, a list of DEG, with the same thresholds used for DIA 
analysis, was uploaded into IPA. However, for IPA analysis, the time effect was not included to 
focus on overall interaction of BCS and prepartum feeding management along the whole 
transition period. 
Verification of Microarray Results 
 To verify some of the key findings from the microarray and bioinformatics analysis, the 
expression levels of 11 genes, including eight and three DEG for the comparisons 
B4F125vsB4F75 and B5F125vsB5F75, respectively, were analyzed using real-time quantitative 
PCR. Because of the higher number of detected DEG, validation was performed only on samples 
obtained at 7 days postpartum. Complete information about the procedures is reported in 
Supplemental file 1 (Appendix C), together with the list of analyzed genes and respective 
pathways annotated via DIA. Per each comparison a fold-change was calculated from the 
normalized relative mRNA abundance obtained from each gene with its own standard curve, and 
compared with the fold-change from the microarray analysis. A Pearson correlation using the 
proc CORR procedure in SAS (v9.3) was then run to establish similarity between the two 
analyses. Results are reported in Figure 5.6.  
 
RESULTS AND DISCUSSION 
Despite the fact that BCS is linked with the metabolic response to lactation and its level is 
regulated through nutrition, cows with different levels of adiposity are generally managed 
similarly during the prepartum period. In light of this, the present manuscript focuses on the pre- 
and postpartum (-7, 7, and 28 d) metabolic effect of different prepartum feeding regimes within 
BCS groups (B4F125 vs B4F75, and B5F125 vs B5F75). Time was not considered in the 
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discussion of transcription regulator and gene network analysis; instead, the focus was on the 
overall effect of BCS and feeding management, using the same comparisons as in the DIA 
analysis. Differentially expressed genes were determined as reported previously (Piantoni et al., 
2012, Akbar et al., 2014a), applying first a stringent P value cut-off of P ≤ 0.01 to the data, and 
then an FC threshold of ≤ −1.5 and ≥ 1.5. Validation for this approach, which does not take into 
account multiple testing corrections, was reported previously (Guo et al., 2006, Shi et al., 2008). 
The resulting number of DEG is reported in Table 5.1. The five main areas among the KEGG 
categories and subcategories that were enriched with DEG are reported in Figure 5.1.  Among 
these, the following discussion will only concern the ‘metabolism’ category, with a focus on the 
25 metabolic pathways that were most-impacted by treatment (Figure 5.2 and 3), emphasizing 
the effect of prepartum diet in combination with prepartum BCS. The term “impact” refers to the 
biological importance of a given pathway as a function of the change in expression of genes 
composing the pathway (proportion of DEG and their magnitude) in response to a treatment, 
condition, or change in physiological state (Bionaz et al., 2012). Consequently, the direction of 
the impact, or flux, characterizes the average change in expression as up-regulation/activation, 
down-regulation/inhibition, or no change. 
The effect of body condition score 
The hepatic transcriptome of BCS4 compared with BCS5 cows was more impacted by 
prepartum feeding management in the early postpartum (7 d), i.e. during the homeorethic 
metabolic shift that the cow experiences in response to the onset of lactation. According to 
established management standards (Roche et al., 2009), BCS5 cows are considered optimally-
conditioned at parturition, while BCS4 cows are underconditioned. Thus, the fact that the 
number of DEG detected due to different prepartum feeding management was on average 3 
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higher in BCS4 than BCS5 cows underscores how transition cow nutrition could be more 
important in underconditioned animals. 
In both BCS4 and BCS5 cows, feeding at 125% of requirements upregulated the 
prepartum metabolism-related transcriptome (Flux value in Figure 5.1). However, as the change 
in flux indicates, immediately postpartum (7 d) BCS4 cows benefitted from the greater feed 
allowance (125% vs. 75%), because there was an overall activation of metabolic pathways. In 
contrast, when BCS5 cows were overfed during the dry period, the same pathways were 
inhibited early post-partum (Figure 5.2). This indicates that a greater feed allowance prepartum 
might have elicited a non-desirable effect on optimally-conditioned cows, rendering them 
“metabolically-lazy” during the metabolically-demanding transition to lactation. 
Carbohydrate metabolism. Bell (1995) estimated a marked increase in demand for 
glucose during the transition period. Because glucose and related metabolites constitute the 
fulcrum of ‘Carbohydrate metabolism’ in the cow, an impact (or overall effect based on changes 
in gene expression) on this pathway was expected and evident right after parturition regardless of 
BCS (Figure 5.1). However, only BCS4 cows had a greater impact (or significant change) of 
feeding management on ‘Carbohydrate metabolism’, with half of the subcategories impacted at 7 
d (Supplemental Table C.7). 
Among the most-impacted pathways (i.e. of high biological relevance based on 
transcriptome), ‘Pyruvate metabolism’ was activated at 7 d postpartum when cows were fed 75% 
of requirements before calving, regardless of BCS, although the timing of changes to volatile 
fatty acid (VFA) metabolism was BCS-dependent. Metabolism of propionate and butyrate was 
impacted shortly after parturition (7 d) in BCS4, and at the end of the transition period (28 d) in 
BCS5 cows. For both BCS groups, overfeeding prepartum led to the activation of VFA 
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pathways. When cows were underfed prepartum in both BCS4 and 5, the high impact and flux of 
‘Pyruvate metabolism’ early postpartum were due to the high expression of the cytosolic form of 
malic enzyme (ME1) (Supplemental Table C.2 and C.5). Malic enzyme activity supplies 
NADPH for fatty acid biosynthesis, particularly in adipose tissue (Laliotis et al., 2010); however, 
its role in bovine liver is unclear, as the liver is not a lipogenic organ in this species (Bell, 1979). 
Furthermore, the idea that ‘Pyruvate metabolism’ serves to provide precursors for 
gluconeogenesis through oxaloacetate is inconsistent with the positive flux (activation) of the 
‘Gluconeogenesis/Glycolysis’ in the BCS4 cows. In fact, data indicated an induction of this 
pathway in B4F125 cows. Thus, we hypothesize that, independently of BCS, the impact on 
‘Pyruvate metabolism’ due to changes in ME1 expression could be related to the more 
pronounced postpartum NEB in cows overfed prepartum. This is supported, at least in part, by 
the lower activity of liver malic enzyme during starvation in ruminants (Martin et al., 1973). 
However, when interpreting the expression profile of BCS4 cows, the fact that VFA 
production is tightly linked with DMI (greater intake, greater VFA production) and that both 
‘Propanoate metabolism’ and ‘Butanoate metabolism’ early postpartum were upregulated in 
B4F125 cows seems to argue against our hypothesis of a more pronounced postpartum NEB in 
generally overfed cows prepartum. In fact, these data (pathways of VFA metabolism, 
Gluconeogenesis and Fatty acid biosynthesis) oppositely indicate a greater postpartum DMI, 
which would lead to a less pronounced NEB in underconditioned cows when overfed rather than 
feed restricted during the transition period. The increase in impact of the VFA pathways in BCS5 
at 28 d cows, instead, agrees with a more prolonged NEB when overfeeding prepartum (Roche et 
al., 2015). 
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Lipid metabolism. Despite the lower adiposity in leaner than optimally-conditioned cows 
(Figure 5.1), ‘lipid metabolism’ was more impacted as a consequence of prepartum nutrition 
management in BCS4 than BCS5 cows. Furthermore, the changes in flux early postpartum 
indicated that feeding BCS4 cows at 125% of requirements had an activation effect, but in BCS5 
cows it had a slight inhibitory effect. Also, because plasma NEFA were overall higher in BCS5 
cows compared with BCS4 (Table 5.2), the slight inhibition of lipid metabolism in BCS5 cows 
resulting from prepartum overfeeding could compromise the ability of the liver to handle 
mobilized fatty acids in early lactation. In contrast, despite the lower hepatic flux of NEFA, 
prepartum overfeeding seems to have ‘prepared’ the liver of under-conditioned cows by 
matching post-partum lipolysis with an up-regulation of lipid metabolism. 
Within the top impacted pathways (Figure 5.2 and 3), none overlapped between the two 
BCS categories underscoring that prepartum nutrition management had a unique effect that was 
dependent on degree of adiposity. A complete discussion for each comparison of the pathways 
involved in the “Lipid Metabolism” category is available in Supplemental File 1 (Appendix C). 
Amino acid metabolism. Although cows mobilize less energy from muscle protein than 
from fat reserves, muscle protein mobilization occurs mainly in the first few weeks after calving 
(Tamminga et al., 1997, Knegsel et al., 2007). Muscle catabolism is of great importance during 
NEB, not only as a “provider” of amino acids for milk protein synthesis, but also of 
gluconeogenic precursors to the liver (Reynolds et al., 2003).  
In both BCS groups, ‘amino acid (AA) metabolism’ was among the most-impacted 
categories (Figure 5.1), as cows experienced an activation of the related pathways all through the 
transition period. However, when feeding management was considered, clear differences 
emerged between groups. In fact, prepartum and early postpartum, the fluxes indicated a greater 
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activation of AA metabolism in BCS4 cows when fed 125% of requirements, while in BCS5 
cows it occurred when fed at 75%. At 28 d postpartum, feeding at 125% seemed to activate this 
pathway in both BCS groups. 
Independently of BCS, the ‘Alanine, Aspartate, and Glutamate metabolism’ pathway was 
impacted after parturition. Because this pathway revolves around the citric acid cycle, as the 
three amino acids are all gluconeogenic, its link with muscle protein catabolism is logical. This is 
supported by published data on free amino acid concentrations in muscle (and similar trends in 
plasma), where Ala, Asp and Glu experience an average ~2-fold increase at 3 wk postpartum 
compared with 1 wk prepartum (Meijer et al., 1995).  
The ‘β-Alanine metabolism’ pathway is closely linked with ‘Alanine, Aspartate, and 
Glutamate metabolism’, because L-Asp can be converted to β-Alanine. The impact and flux of 
the two pathways, in fact, matched very closely (Figure 5.2 and 3).  β-Alanine could be used to 
synthesize carnosine. Among its biological activities, carnosine can scavenge reactive oxygen 
and nitrogen species (Hipkiss, 2009). In liver tissue it can also act as an antioxidant by increasing 
vitamin E and Zn-Superoxide dismutase activity (Aydin et al., 2010). Thus, a putative increase in 
hepatic concentration of carnosine in B5F125 cows at 28 d might be connected to a greater need 
of antioxidants due to a possible heightened state of oxidative stress. Unlike B5F125 cows, a 
possible increase of carnosine in B4F125 cows supports the hypothesis discussed in subsequent 
sections (B4F125 vs B4F75 – Amino acid metabolism) of a concerted activation of protective 
mechanisms to account for the responses in pathways related to glutathione, taurine and 
hypotaurine, and selenoamino acid metabolism. 
Glycan biosynthesis and metabolism. Together with ‘Carbohydrate’ and ‘Amino acid 
metabolism’, this subcategory contains most of the top impacted metabolic pathways. Glycans 
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are carbohydrates linked with lipid and protein moieties to form glycolipids and glycoproteins 
that can act as signaling molecules (Etzler and Esko, 2009). Despite previous work with dairy 
cows (Bionaz et al., 2012, Shahzad et al., 2014, Shahzad et al., 2015) demonstrating substantial 
changes in several glycan-related pathways in liver tissue during the transition period, not much 
attention has been placed on glycan metabolism. However, a review of the literature highlighted 
that there has been a marked increase in glycomic studies in humans (Bertozzi and Sasisekharan, 
2009), highlighting their importance. Further research will soon be required to understand the 
role of glycans in dairy cow liver during the transition period, as, in fact, glycan modifications of 
intracellular and extracellular proteins have critical functions in almost all biological pathways 
(Cummings and Pierce, 2014). 
The most-impacted glycan pathways in our experiment included both biosynthesis 
[Glycosaminoglycan (GAG), Glycosylphosphatidylinositol (GPI)-anchor, O- and N-Glycan] 
and degradation (Glycosaminoglycan, other glycans) (Figure 5.2 and 3). However, the 
degradation pathways were impacted in response to feeding management only in BCS5 cows. 
Glycosaminoglycans are the most abundant heteropolysaccharides in the body (Sasisekharan et 
al., 2006). Based on core disaccharide structures, GAG are classified into heparin sulfate, 
chondroitin sulfate, keratin sulfate, and hyaluronan (Sasisekharan et al., 2006). Sulfated GAG are 
key players in both molecular and cellular events of the regulation of inflammation (Pomin, 
2015). Most importantly, they display anti-inflammatory functions in humans (Pomin, 2015). 
The synthesis of all three sulfated classes was affected by feeding management in both BCS4 
and BCS5 cows. However, feeding at 125% of requirements activated the synthesis pathways in 
BCS4 cows, while it inhibited it in BCS5 cows. Furthermore, the overfeeding approach induced 
the degradation of GAG in BCS5 cows.  
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When you consider the three classes of sulfated glycosaminoglycans, data indicated that 
increasing dietary allowance prepartum in BCS4 cows induced GAG synthesis throughout the 
transition period. Because the transition period is characterized by a systemic level of 
inflammation (Trevisi et al., 2012), from sub-acute to acute, an increased synthesis of anti-
inflammatory compounds could be beneficial and help reduce any detrimental effect while 
maintaining its physiological homeorhetic properties. In contrast, overfeeding seemed to reduce 
sulfated GAG synthesis in optimally-conditioned cows (BCS 5), supporting the idea that a 
restricted feeding prepartum might be a better option for fatter cows. 
Ingenuity pathway analysis. Using the same DIA thresholds and cutoffs comparing 
overfeeding with feed restriction within BCS groups, the IPA analysis identified 16 and 44 
transcription regulators in BCS5 and BCS4. After considering only those with FC ≥ |1.5|, there 
was 1 identified transcription regulator for B5F125 compared with B5F75, and 5 for B4F125 
compared with B4F75, with 2 and 32 downstream DEG affected. Prepartum overfeeding led to 
the downregulation of the 6 transcription factors, 5 and 1 for BCS4 and BCS5 respectively, 
which are somewhat connected with cell cycle and proliferation and tissue development. In 
BCS5 cows, the small network around CUX1 is ambiguous as the two affected downstream 
genes (ECT2 and WNT6) are both involved in cell proliferation and liver regeneration, but have 
opposite effects on the regulation of these processes. Thus, it was concluded that feeding level 
did not affect hepatocyte transcriptome regulators in optimally-conditioned cows. However, in 
BCS4 cows, probably due to the greater number of DEG, the network around the transcription 
regulators ERG, LHX1, MYOD1, SIM1, and SOX2 is more consistent in its direction; hence, 
more defined regulatory patterns could be discerned. More detailed information about the 
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upstream analysis is reported in Table 5.3, while the graphic networks are in Figure 5.4 
(B4F125vsB4F75) and 5 (B5F125vsB5F75). 
 
B4F125 vs B4F75 
Carbohydrate metabolism. ‘Galactose metabolism’ was affected postpartum by feeding 
management, with an increase in impact from 7 to 28 d postpartum. Flux was positive 
(activation) at 7 d and negative (inhibition) at 28 d, underscoring an interaction between 
prepartum feeding and time postpartum. At 28 d LALBA (Lactalbumin, Alpha-) was responsible 
for the negative flux. Because LALBA is essential for the synthesis of lactose, the fact that 
lactose production takes place only in mammary cells complicates the interpretation of 
‘Galactose metabolism’ and its impact on liver. However, early postpartum (7 d), PFKL 
(Phosphofructokinase) was responsible for the pathway activation. Among ‘Galactose 
metabolism’ related genes, PFKL leads to the formation of tagatose-6P, which, in rat hepatocytes 
has been proven to protect against pro-oxidant-induced cell injury (Valeri et al., 1997). This, 
again, supports the hypothesis, discussed in subsequent sections (B4F125 vs B4F75 – Amino 
acid metabolism), that there is an activation of protective mechanisms against oxidative damage 
in B4F125 cows. 
Amino acid metabolism. Unique to the BCS4 group was the activation one week after 
parturition of three amino acid-related pathways involved in antioxidant status (Figure 5.2). 
‘Glutathione metabolism’ and ‘Selenoamino acid metabolism’ were both induced in BCS4 cows 
fed 75%, while ‘Taurine and Hypotaurine metabolism’ was induced when cows were fed 125% 
of requirements. Among the DEG with a FC ≥ |3| (Supplemental Table C.2), GPX3 (Glutathione 
Peroxidase 3) and MARS (methionyl-tRNA synthetase) were the main drivers for the impact and 
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flux of the first two pathways. Although MARS in the ‘Selenoamino acid metabolism’ catalyzes 
the incorporation of Se into proteins as seleno-Met (SeMet), this form of Met functions mainly 
for storage of selenium, which, once released during turnover, can be incorporated by the same 
pathway into seleno-Cys, a fundamental component of GPX3. Because glutathione peroxidase 
protects the organism from oxidative damage, we hypothesize that the induction of GPX3 and 
the glutathione and selenoamino acid pathways in B4F75 cows reflects greater oxidative stress 
conditions postpartum when cows were feed restricted pre-calving, i.e. this management 
approach is likely not suitable for underconditioned cows. Even if mainly a storage form of Se, 
SeMet has been demonstrated to protect bovine mammary epithelial cells from H2O2-induced 
apoptosis and increase proliferation and cell viability under conditions of oxidative stress 
(Miranda et al., 2011). A similar mechanism could be present in hepatocytes.  
In contrast to feeding 75% of requirements, feeding 125% may have strengthened hepatic 
antioxidant capacity by increasing the taurine and hypotaurine pool. In fact GAD2 (glutamate 
decarboxylase 2; Supplemental table C.2) was upregulated in B4F125 cows, leading to the 
possible formation of the two antioxidants. By modulating gene expression, taurine has a 
beneficial effect on liver health, as it alleviates hepatic TAG accumulation (at least in non-
ruminants). It acts by enhancing the expression of MTTP (microsomal triglyceride transfer 
protein), which improves hepatic lipid efflux. It also can enhance PPARA (peroxisome 
proliferator-activated receptor α) expression, and, in turn, increase hepatic mitochondrial and 
peroxisomal lipid (Bonfleur et al., 2015). In our dataset of affected genes, only MTTP was 
significantly up-regulated (FC = 1.3, P < 0.01, data not shown) by overfeeding lean cows. 
The main difference between feeding management strategies was that in B4F75, the 
impact was due to an enzyme (GPX3) directly involved in the antioxidant system and production 
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of SeMet, while in B4F125 the antioxidant pool was increased. Thus, we consider the first 
scenario a response to stress and the second scenario a “build up” of a defense mechanism. In 
conclusion, we believe that, overfeeding underconditioned cows prepartum could improve liver 
health postpartum at least in part by enhancing hepatic handling of tissue-mobilized fatty acids, 
and also by building a greater antioxidant defense against oxidative stress in the postpartum. 
Glycan biosynthesis and metabolism. Both “O-glycans” and “GPI-anchor biosynthesis” 
were activated early postpartum by the prepartum increased feed allowance. O-glycans play a 
role in mammalian Notch signaling (Stanley, 2014), which is important for the regulation of the 
complex interactions between liver cell types involved in tissue repair (Geisler and Strazzabosco, 
2015). Because hepatocytes experience an increased work load after calving due to a shift in 
metabolism (Drackley, 1999), an increase in differentiation and repair through the Notch 
pathway stimulated by O-glycans might be a mechanism to support high hepatocyte turnover. 
The fact that a persistent activation of Notch signaling is associated with liver malignancies in 
mouse models (Geisler and Strazzabosco, 2015) might explain why at 28 d postpartum the 
impact of the pathway was reduced and the flux became slightly negative, especially in B4F125 
cows.  
GPI is a glycolipid that can be attached to the C-terminus of a protein during 
posttranslational modification, forming the so called GPI-anchored proteins (Sangiorgio et al., 
2004). In the context of the transition period, a GPI anchor is used by hepatocytes to bring the 
high-density lipoprotein (HDL) binding protein into contact with the blood stream (Dallinga-
Thie et al., 2010). HDLs contain little TAG but a large amount of cholesterol; thus, an increase 
in their uptake could, hypothetically, result in a greater tissue cholesterol concentration. 
Cholesterol is also a component of very low density lipoproteins (VLDL) and its concentration 
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can regulate liver apolipoprotein B synthesis (ApoB), another indispensable component of 
VLDL, during hepatic lipid export (Thompson et al., 1996). Although APOB was upregulated 
1.2-fold it did not reach statistical significance (P = 0.10), but it should be kept in mind that 
synthesis of APOB is primarily regulated at the post-translational level (Davidson and Shelness, 
2000). Immediately post-partum cows increase adipose tissue lipolysis (Drackley, 1999) 
therefore, an increase of VLDL synthesis could help the liver of B4F125 cows repackage 
mobilized fat, thereby avoiding the detrimental effect of hepatic TAG accumulation. 
Metabolism of cofactors and vitamins. The postpartum impact of ‘Retinol metabolism’ 
detected in B4F125 cows reinforces the idea (as previously hypothesized) that modest 
overfeeding in underconditioned cows in the dry period leads to better DMI and, possibly, a 
lower degree of NEB in early lactation because there were no differences in milk production 
detected (Roche et al., 2015). The same hypothesis of a better energy status postpartum in 
B4F125 than B4F75 cows emerges when examining the pattern of ‘Nicotinate and nicotinamide 
metabolism’. Flux through ‘Nicotinate and nicotinamide metabolism’ leads to the synthesis of 
some of the most-important mediators of energy metabolism reactions, the nicotinamide adenine 
dinucleotides (NADs) family, which includes NAD+, NADH, and the phosphorylated versions 
NADP+ and NADPH. The sustained upregulation of ‘Nicotinate and nicotinamide metabolism’ 
postpartum indicates a beneficial effect of prepartum overfeeding in underconditioned cows, i.e. 
a greater amount of these mediators would indicate that they are better able to cope with the 
energetic metabolic demand of early lactation. Among them, NAD+ might play the most-
important role, as it is necessary to maintain the hepatic fatty acid oxidative capacity (Schulz, 
1991) and also because the lipogenic capacity of ruminant liver is quite low (Bell, 1979). The 
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involvement of NADPH in the cellular antioxidant system (Ying, 2008) might also indicate a 
better oxidative status of B4F125 compared with B4F75 cows. 
Alterations in ‘Folate biosynthesis’, ‘One carbon pool by folate’, and ‘Vitamin B6 
metabolism’ also revealed a possible positive effect of prepartum overfeeding in 
underconditioned cows. It is important to note that these three pathways are connected with the 
Met cycle. Folate, through 5-methyl tetrahydrofolate and vitamin B6, can, in fact, donate the 
methyl group required by Met synthase to synthesize Met from homocysteine (Selhub, 2002). 
Furthermore, vitamin B6 is a cofactor of cystathionine β-synthase and cystathionine γ-lyase that 
lead to the formation of cystathione (Ramakrishnan et al., 2006), a precursor for the antioxidants 
glutathione, taurine, and hypotaurine. The changes detected in these three pathways seem to 
indicate a greater flux through the Met cycle, with a potential increase in the availability of Met 
and antioxidants. This hypothetical effect, through the Met cycle, also could explain the increase 
in activation of ‘Taurine and Hypotaurine metabolism’ in early lactation in B4F125 cows.  
It is well known that Met, together with Lys, is one of the most-limiting AA in a wide 
range of dairy diets (NRC, 2001). Methionine is typically first-limiting and its supplementation 
alone is able to improve not only overall lactation performance, but also improves antioxidant 
status and overall immune function and inflammation status in transition dairy cows (Osorio et 
al., 2013, 2014a, Osorio et al., 2014b). Hence, some of the observed beneficial effects of 
overfeeding underconditioned cows prepartum could be related to an improved Met and 
antioxidant balance in early lactation. 
Ingenuity pathway analysis. Judging by the upregulation in B4F75 cows of ANGPT1, 
DAG1, HDAC6, MEIS1, RBH38, and RYR1 (Figure 5.4), the prepartum feed restriction could 
have resulted in some type of liver damage, including apoptosis. This idea agrees with the 
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induction of the ‘Apoptosis’ pathway in B4F75 cows revealed by the DIA output (Supplemental 
file 2, Appendix C). In parallel, the liver of these cows seemed to experience an inflammatory 
state at least in part due to lower ALB, greater CXCR4 and CD86, all coupled with the induction 
of the cholinergic anti-inflammatory pathway (ACHE, CHRNG) and together with upregulation 
of genes associated with oxidative stress (ATP7A, GPX3, TMIGD1). In contrast, as judged by the 
upregulation of genes involved in growth, proliferation, and differentiation (BCL9L, FMNL2, 
PTPN4, SP1, ZKSCAN1) in B4F125 cows, the overfeeding of underconditioned cows prepartum 
appeared to result in a healthier liver.  
To some extent the compromised state of the liver in B4F75 cows is further evidenced 
from results of the IPA network analysis. The downregulation of ALB and FABP7 suggests a 
lower ability to handle the mobilized fatty acids during the transition to lactation, perhaps 
enhancing the susceptibility of the liver to accumulate lipid at times of high NEFA concentration 
in the circulation (e.g. early postpartum). The upregulation of PKIB (CAMP-Dependent Protein 
Kinase Inhibitor Beta), a potential inhibitor of protein kinase A (PKA) (Dalton and Dewey, 
2006), is also noteworthy, because PKA is a direct activator of the gluconeogenic pathway in 
non-ruminant liver (Desvergne et al., 2006, Rui, 2014). Thus, the greater expression of PKIB in 
B4F75 cows could have impaired hepatic gluconeogenesis. In contrast, the lower expression of 
PKIB in B4F125 cows would have helped increase the intracellular glucose pool. 
B5F125 vs B5F75 
Carbohydrate metabolism. Overfeeding cows in the prepartum period had an effect on 
‘TCA cycle’ and ‘Inositol phosphate metabolism’. It is plausible that the activation of the TCA 
cycle prepartum was a result of the higher dietary energy supply; in comparison, however, the 
activation early postpartum of ‘Inositol phosphate metabolism’ might have been related with an 
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inflammatory state induced by prepartum overfeeding. In fact, this pathway was primarily 
affected by the upregulation of IPPK (inositol-pentakisphosphate 2-kinase) in B5F125 compared 
with B5F75 cows. The IPPK protein catalyzes the formation of inositol hexakisphosphate 
(InsP6), a ubiquitous and abundant cytosolic inositiol phosphate. In humans, InsP6 primes and 
stimulates neutrophil respiratory burst (Eggleton et al., 1991, Kitchen et al., 1996); thus, we 
speculate that this metabolite could participate in the inflammatory response. However, both in 
vitro and in vivo, Insp6 inhibits L- and P-selectin function (Cecconi et al., 1994). Thus, if InsP6 
produced by the liver is secreted into blood it could impair neutrophil infiltration by 
downregulating the attachment molecules, thus, leading to reduced neutrophil functions when 
optimally-conditioned cows are overfed prepartum. 
Amino acid metabolism. Contrary to BCS4, in BCS5 cows the ‘Alanine, Aspartate, and 
Glutamate metabolism’ pathway was impacted only at the end of the transition period (28 d), and 
was activated by overfeeding (B5F125). Because BCS5 cows calved with better body condition 
than BCS4, they would have been better able to cope with the NEB by drawing from the more 
abundant lipid reserves, as indicated by the higher NEFA concentrations (Table 5.2). The late 
activation of this amino acid pathway, as hypothesized when discussing VFA metabolism (The 
effect of body condition – Carbohydrate metabolism), might have been due to a prolonged 
postpartum NEB in the overfed BCS5 cows, which could lead to mobilization of muscle protein. 
This hypothesis is supported by data indicating that overconditioned cows have a more 
pronounced drop in DMI after calving and a more intense NEB compared with cows fed to or 
slightly below requirements during the dry period (Ji et al., 2014, Khan et al., 2014, Roche et al., 
2015). 
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Among the most-impacted metabolic pathways, the metabolism of Arg and Pro and of the 
three branched-chained amino acids (BCAA), valine, leucine, and isoleucine were highly 
impacted (Figure 5.3). The impact and flux of the ’Arginine and Proline metabolism’ pathway 
prepartum was caused by the differential expression (FC = -3) of CKMT1B (Creatine kinase, 
mitochondrial 1B), which encodes an enzyme responsible for the formation of phosphocreatine 
(PCr). In normal conditions PCr is then transported to the muscle as energy storage to facilitate a 
quick muscle response (Wallimann et al., 1992). Because the putative increase of PCr appears to 
have occurred prepartum in B5F75 cows, feed restriction in optimally-conditioned cows seems 
to position the cow in a better energy state compared with overfeeding, i.e. the liver would have 
extra energy to store as PCr in muscle. Furthermore, it can be hypothesized that a local increase 
of PCr would be useful to the liver as an “energy buffer” in the metabolically-demanding 
postpartum period. Also, the ‘Arginine and Proline Pathway’ was induced early postpartum in 
B5F75 cows compared with B5F125. Both amino acids are gluconeogenic; thus, it seems that 
prepartum feed-restricted optimally-conditioned cows were in a better energy state compared 
with overfed cows early in the postpartum. The same pathway is also used to produce putrescine, 
a polyamine with growth factor-like functions on liver regeneration and DNA synthesis 
(Fujiwara and Nagoshi, 1998). An increase in its concentration would promote a faster turnover 
of hepatocytes under the metabolic load of early lactation, possibly resulting in a more active and 
responsive liver. 
The BCAA metabolism pathway was impacted due to differences in the prepartum diet. 
The main affected gene (FC < -3, Supplemental table C.5) for both the catabolic and anabolic 
branches of the BCAA pathway at 7 d postpartum was BCAT1 (Branched Chain Amino-Acid 
Transaminase 1, Cytosolic), which can catalyze both the deamination and amination of BCAA 
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and related keto-acids. Recently, a higher postpartum plasma concentration of BCAA 
(specifically Val and Iso) in TMR-fed dairy cows was linked to greater liver function and a 
possible better responsiveness of the immune system (Zhou et al., 2016). In the present study, 
plasma AA data were not collected, but it is plausible that an increase in hepatic BCAA 
biosynthesis in B5F75 cows led to similar results, indicating how feed restriction would be more 
appropriate for optimally-conditioned cows. Furthermore, the fact that the ’BCAA degradation’ 
pathway was induced at 28 d in B5F125 cows reflects a prolonged NEB in overfed optimally-
conditioned cows, which induced protein mobilization, supporting, again, our claim for 
prepartum feed restriction in BCS5 cow. 
Glycan biosynthesis and metabolism. Feeding BCS5 cows at 125% of requirements 
prepartum induced an activation of the ’N-glycan biosynthesis’ and ’Other glycan degradation’ 
pathways early postpartum. A proposed role of N-Glycan biosynthesis in the liver is to handle 
the misfolded proteins in the endoplasmic reticulum (ER) during periods of stress (Fagioli and 
Sitia, 2001). As the ‘Protein processing in the endoplasmic reticulum’ pathway followed the 
same pattern as N-glycan biosynthesis (Supplemental Table C.7), this might be indicative of a 
greater degree of ER stress in optimally-conditioned cows fed to 125% of requirements 
prepartum. Because a similar induction of ER stress was also previously reported as a 
consequence of prepartum overfeeding (Khan et al., 2014, Shahzad et al., 2014), our data further 
indicate that a slight feed-restriction might be a better approach for these cows. 
The ’Other glycan degradation’ pathway was highly-impacted early postpartum due to a 
relatively small activation in B5F125 versus B5F75 cows. This pathway concerns the 
degradation of N-glycans and glycosphingolipids. Because pathways concerning 
glycosphingolipid biosynthesis were not affected (Supplemental Table C.7), it is assumed that 
121 
 
their liver concentration, and not that of N-glycans, which had a positive biosynthesis, decreased. 
These changes might be biologically relevant in transition cows, because mice fed a high-fat diet, 
in which glycan synthesis was suppressed (Bijl et al., 2009, Zhao et al., 2009), had a decrease in 
liver accumulation of triacylglycerol along with a reduced hepatocyte expression of several 
genes associated with steatosis; this included those involved in lipogenesis, gluconeogenesis, and 
inflammation. Studies from different research groups have demonstrated that prepartum over-
allowance of energy results in prepartum hyperglycemia and hyperinsulinemia and marked 
postpartum adipose tissue mobilization (i.e., greater blood NEFA concentration) (Rukkwamsuk 
et al., 1999, Holtenius et al., 2003, Roche et al., 2005, Janovick et al., 2011, Khan et al., 2014, 
Roche et al., 2015). Thus, the reduction in hepatic levels of glycosphingolipids early postpartum 
could be a mechanism to counteract the development of lipidosis in B5F125 cows due to the 
possible accumulation of lipid in the liver. 
Metabolism of cofactors and vitamins.  The physiological levels of retinol (vitamin A) 
and its precursor β-carotene are tightly correlated with dietary intake (Daley et al., 2010). 
Similarly, thiamine (vitamin B1) production depends on the dietary availability of cobalt (Co), 
and on ruminal microbial activity and microbial biomass, which are connected to DMI. Thus, 
because F125 cows were allowed a greater availability of pasture, which is naturally rich in β-
carotene and a possible source of Co, the activation of ’Retinol metabolism’ and ‘Thiamine 
metabolism’ in B5F125 cows prepartum could be related to the greater pasture allowance owing 
to the experimental design.  
The postpartum inhibition of ’Pantothenate and CoA biosynthesis’ seems to indicate that 
the feed restriction in the late dry period could enhance the energy status of optimally-
conditioned cows (BCS5). Panthothenate is synthetized in the body as a component of 
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Coenzyme A (CoA), an indispensable cofactor in synthesis and oxidation of fatty acids (Mahler, 
1953). Furthermore, CoA is a component of acetyl-CoA, the crossover molecule in cellular 
metabolism (Pietrocola et al., 2015). With an apparent increase in production of CoA, B5F75 
cows would have been able to better handle the mobilized adipose fatty acids, and more 
effectively coordinate the metabolic shift that occurs at calving.  
 
CONCLUSIONS 
 As hypothesized, the effect of prepartum plane of nutrition on hepatic function was 
dependent on the BCS of the cow, underscoring how these management tools need to be 
evaluated together to optimize the biological adaptations of the cow during the peripartum 
period. The more pronounced transcriptome changes in underconditioned cows highlighted that 
they are more sensitive to prepartum feeding level/allocation than optimally-conditioned cows. 
Similarly, the bioinformatics analysis revealed transcriptome signatures that indicate a greater 
and potentially more prolonged NEB in overfed optimally-conditioned cows and also in feed-
restricted underconditioned cows. Based on gene network analysis, the latter group might be 
more prone to liver dysfunction. The data indicate a less pronounced mobilization and better 
handling of NEFA in overfed underconditioned cows. Overall, results indicate that overfeeding 
in late-pregnancy should be limited to underconditioned cows, while cows with optimal degree 
of body condition and those with greater than optimal condition should be maintained on a 
restricted energy diet. 
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CD86, CD86 Antigen, B-Lymphocyte Antigen B7-2; CHRNG, Cholinergic Receptor Nicotinic 
Gamma Subunit; CKMT1B, Creatine Kinase, Mitochondrial 1B; CoA, Coenzyme A; CUX1, 
Cut Like Homeobox 1; CXCR4, C-X-C Motif Chemokine Receptor 4; DAG1, Dystroglycan 1; 
DEG, Differentially Expressed Gene; DIA, Dynamic Impact Approach; DMI, Dry Matter 
Intake; ECT2, Epithelial Cell Transforming 2; ER, Endoplasmatic Reticulum; ERG, 
Erythroblast Transformation-Specific Transcription Factor ERG Variant 10; FABP7, Fatty Acid 
Binding Protein 7; FC, Fold Change; FMNL2, Formin Like 2; GAG, Glycosaminoglycan; GPI, 
Glycosylphosphatidylinositol; GPX3, Glutathione Peroxidase 3; HDAC6, Histone Deacetylase 
6; HDL, High Density Lipoprotein; Insp6, Inositol Hexakisphosphate; IPA, Ingenuity Pathway 
Analysis; KEGG, Kyoto Encyclopedia of Genes and Genome; LALBA, Lactalbumin Alpha; 
LHX1, LIM Homeobox 1; MARS, Methionyl-TRNA Synthetase; ME1, Malic Enzyme 1; 
MEIS1, Meis Homeobox 1; MTTP, Microsomal Triglyceride Transfer Protein; MYOD1, 
Myogenic Differentiation 1; NAD, Nicotinamide Adenine Dinucleotide; NEB, Negative Energy 
Balance; NEFA, Non Esterified Fatty Acids; PCr, Phosphocreatine; PFKL, 
Phosphofructokinase, Liver Type; PKA, Protein Kinase A; PKIB, CAMP-Dependent Protein 
Kinase Inhibitor Beta; PPARA, Peroxisome Proliferator Activated Receptor Alpha; PTPN4, 
Protein Tyrosine Phosphatase, Non-Receptor Type 4; RBM38, RNA Binding Motif Protein 38; 
RYR1, Ryanodine Receptor 1; SeMet, Seleno-Methionine; SIM1, Single-Minded Family BHLH 
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Transcription Factor 1; SOX2, SRY-Box 2; SP1, Sp1 Transcription Factor; TAG, 
Triacylglycerol; TMIGD1, Transmembrane And Immunoglobulin Domain Containing 1; TMR, 
Total Mixed Ratio; VFA, Volatile Fatty Acid; VLDL, Very Low Density Lipoprotein; WNT6, 
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TABLES AND FIGURES 
 
Table 5.1. Number of differentially expressed genes, used for DIA and IPA analysis, for each 
considered comparison after applying a P value cutoff of ≤ 0.01 and a fold change threshold at 
≤ / ≥ ± 1.5 
 
Comparison Wk1 Up Down Total 
DIA     
B4F125 vs B4F75 -7 62 63 125 
 
7 336 229 565 
 
28 147 234 381 
B5F125 vs B5F75 -7 31 43 74 
 
7 99 106 205 
 
28 15 16 31 
IPA     
B4F125 vs B4F75 n.a. 69 174 243 
B5F125 vs B5F75 n.a. 56 62 118 
1 Time factor was used only for DIA analysis, while IPA analysis focused on the overall effect during the whole 
transition period. 
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Table 5.2. Effect of prepartum body condition score (BCS) and feeding management on 
plasma concentration of NEFA and BHBA in dairy cows during the transition period.  
 
 B  F  P-value1 
mmol/L 4 5  75% 125% SE B F B*F T B*T F*T B*F*T 
NEFA  0.50x 0.72y  0.59 0.62 0.04 0.0004 0.62 0.99 <0.0001 0.05 0.26 0.99 
BHBA  0.46x 0.60y  0.57x 0.49y 0.03 0.004 0.05 0.83 <0.0001 0.10 0.01 0.57 
1T = time (week relative to parturition); B = BCS (1-10 scale); F = level of feeding prepartum relative to 
requirement (%); B*F*T = interaction of BCS, level of feeding prepartum relative to requirements (%), and time 
around parturition. 
x,y,z = significant difference among groups (P < 0.05) 
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Table 5.3. Upstream differentially expressed transcription regulators and their target genes 
with fold change (FC) ≥ |3|. 
 
Transcription regulator FC Target genes and responses within the specific comparison 
B4F125 vs B4F75   
SIM1 -1.980 ↑AOX1, ↑CBFB, ↓CD86, ↓GPX3, ↓PKIB, ↑STRN, ↓THEG 
SOX2 -1.766 ↑ALB, ↓ANGPT1, ↑APCDD1, ↑BCL9L, ↓CST6, ↓CXCR4, 
↓FABP7, ↓MEIS1 
MYOD1 -1.641 ↓ACHE, ↓ATP7A, ↓CHRNG, ↓DAG1, ↓RBM38, ↓RYR1, ↑SP1 
ERG -1.552 ↓CXCR4, ↓EZH2, ↑FMNL2, ↓HDAC6, ↓ITGA6, ↑ PTPN4 
LHX1 -1.505 ↓SIM1, ↑SOSTDC1, ↓TMIGD1, ↑ZKSCAN1 
B5F125 vs B5F75   
CUX1 -2.035 ↓ECT2, ↑WNT6 
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Figure 5.1. Summary of KEGG metabolic subcategories resulting from the DIA analysis in 
liver of BCS 4 and 5 cows fed 125% of requirements prepartum compared with 75%. For each 
sampling time, the columns represent the effect (impact) and flux responses. The transparent 
bars represent the effect value (0 to 30), and the flux columns represent negative (−) and 
positive (+) flux (−30 to +30) based on the direction of the effect. The negative flux (green 
bars) indicates an upregulation in B4F75 or B5F75 cows, while the positive flux (red bars) 
indicates an upregulation in B4F125 or B5F125 cows. 
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Figure 5.2. Dynamic Impact Approach (DIA) results (Impact and Direction of the Impact) for 
the most impacted metabolic KEGG pathways (Top 25), grouped in sub-categories of pathways, 
in BCS 4 cows fed 125% compared with 75% of requirements prepartum. Lines represent the 
Impact (0-100) along the transition period, while bars show the Direction of the Impact (−100 - 
+100) (red = upregulation, green = downregulation, in B4F125 vs B4F75). 
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Figure 5.3. Dynamic Impact Approach (DIA) results (Impact and Direction of the Impact) for 
the most impacted metabolic KEGG pathways (Top 23), grouped in sub-categories of pathways, 
in BCS 5 cows fed 125% compared with 75% of requirements prepartum. Lines represent the 
Impact (0-50) along the transition period, while bars show the Direction of the Impact (−50 - 
+50) (red = upregulation, green = downregulation, in B5F125 vs B5F75). 
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Figure 5.4. Ingenuity Pathway Analysis (IPA) upstream network analysis of differentially 
expressed genes in liver of B4F125 cows compared to B4F75. Upstream regulators are located at 
the center of the network, and the downstream target genes are located at the periphery. The 
arrow represents the direction of the target molecule. The red color represents upregulation of 
genes in B4F125, and green color represents upregulation of genes in B4F75. The detailed IPA 
legend can be found in Supplemental figure C.1. 
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Figure 5.5. Ingenuity Pathway Analysis (IPA) upstream network analysis of differentially 
expressed genes in liver of B5F125 cows compared to B5F75. Upstream regulators are located at 
the center of the network, and the downstream target genes are located at the periphery. The 
arrow represents the direction of the target molecule. The red color represents upregulation of 
genes in B5F125, and green color represents upregulation of genes in B5F75. The detailed IPA 
legend can be found in Supplemental figure C.1 
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Figure 5.6. Correlation between qPCR and microarray expression fold change results. 
Upregulated genes are highlighted in red, while downregulated genes are in green. Black circles 
represent genes validated for the comparison B4F125vsB4F75, while white circles represent 
genes validated for the comparisons B5F125vsB5F75. 
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CHAPTER 6: FAR-OFF AND CLOSE-UP DRY MATTER INTAKE MODULATE 
INDICATORS OF IMMUNOMETABOLIC ADAPTATIONS TO LACTATION IN 
SUBCUTANEOUS ADIPOSE TISSUE OF PASTURE-BASED TRANSITION DAIRY 
COWS 
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ABSTRACT 
The common practice of increasing dietary energy density during the “close-up” dry 
period (last ~3 wk prepartum) has been recently associated with a higher incidence of metabolic 
disorders after calving. Despite these reports, over-feeding of metabolizable energy (ME) during 
the ‘far-off’, non-lactating period is a common management policy aimed at achieving optimum 
calving body condition score (BCS) in pasture-based systems, as cows are generally thinner than 
TMR cows at the end of lactation. Our hypothesis was that both far-off and close-up overfeeding 
influence the peripartum adipose tissue changes associated with energy balance and 
inflammatory state. Sixty mid-lactation, grazing dairy cows of mixed age and breed were 
randomly allocated to one of two groups that were managed through late lactation to achieve a 
low and high BCS (approximately 4.25 and 5.0 on a 10-point scale) at dry-off. The low BCS 
cows were then overfed ME to ensure that they achieved the same BCS as the higher BCS group 
by calving. Within each rate of BCS gain treatment, cows were offered either 65, 90, or 120% of 
their pre-calving ME requirements for three weeks pre-calving in a 2 x 3 factorial arrangement of 
treatments (i.e., 10 cows/treatment). Subcutaneous adipose tissue was collected via biopsy at -1, 
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1 and 4 wk relative to parturition. Quantitative PCR was used to measure mRNA and microRNA 
(miRNA) expression of targets related to adipogenesis and inflammation. Cows overfed in the 
far-off period had increased expression of miR-143 and miR-378 prepartum (-1 wk) indicating 
greater adipogenesis, consistent with their rapid gain in BCS following dry-off. Furthermore, the 
lower postpartum expression of IL6, TNF, TLR4, TLR9, and miR-145, and a higher abundance of 
miR-99a indicated lower body fat mobilization in early lactation in the same group. In the close-
up period, feeding either 65 or 120% of ME requirements caused changes in FASN, IL1B, IL6R, 
TLR9, and the miRNA miR-143, miR-155, and miR-378. Their respective expression patterns 
indicate a tentative negative-feedback mechanism in metabolically compromised, feed-restricted 
cows, and a possible immune-related stimulation of lipolysis in apparently static adipocytes in 
overfed cows. Data from cows fed 90% of ME requirements indicate the existence of a balance 
between lipolytic (inflammatory-related) and anti-lipolytic signals, in order to prime the 
mobilization machinery in light of imminent lactation. Overall, results indicate that far-off dry 
cow nutrition influences peripartum adipose tissue metabolism, with neither strategy negatively 
affecting the physiological adaptation to lactation. Furthermore, to ensure a favorable transition, 
cows should be subjected to a small feed restriction in the close-up period, irrespective of far-off 
nutritional management.  
 
INTRODUCTION 
The body condition score (BCS) of a dairy cow is an assessment of the amount of body 
fat that it possesses. It is an important factor in dairy cattle management (Roche et al., 2009), due 
to its association with production and reproduction parameters and the chances for a successful 
lactation (Waltner et al., 1993, Roche et al., 2005, Pires et al., 2013, Randall et al., 2015). The 
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progression of BCS in a TMR-based system during the lactation cycle (e.g. intercalving) is 
inversely related with the lactation curve (i.e. it declines to a nadir 40 to 100 d after calving as 
milk production peaks, before increasing again as milk production declines; Roche et al., 2009). 
However, in seasonal spring-calving cows grazing fresh pasture, a second period of loss in mid-
lactation (Roche et al., 2007) leads to thinner cows at the end of lactation, compared with 
counterparts fed a TMR (Roche et al., 2007).  
To avoid the detrimental physiological and metabolic effects of calving with a low BCS 
(Pires et al., 2013, Akbar et al., 2015), cows in pasture-based systems have to consume 
metabolizable energy (ME) in excess of requirements during the “far-off” non-lactating period 
(>4 wk before calving) to achieve optimal calving BCS targets (Roche et al., 2009). However, 
Dann et al. (2006), working with TMR-fed cows, provided evidence that overfeeding in the far-
off  period might increase the risk of metabolic dysfunction during early lactation. 
To further complicate peripartal nutritional management, cows are historically allowed ad 
libitum access to energy-dense feeds during the weeks before calving (Boutflour, 1928, i.e., 
during the so-called “close-up” dry period), thereby ensuring that cows do not lose condition pre-
calving. Recent studies from different research groups have demonstrated, however, that this 
practice can lead to undesired outcomes including detrimental metabolic shifts such as increased 
postpartum blood FA concentration (Rukkwamsuk et al., 1999, Holtenius et al., 2003, Janovick 
et al., 2011, Ji et al., 2014, Khan et al., 2014) and poorer postpartum health indices (Dann et al., 
2006, Soliman et al., 2007, Graugnard et al., 2013, Shahzad et al., 2014). 
Adipose tissue plays an important role in the cow’s adaptation to lactation and its 
metabolism is directly linked and responsive to DMI (McNamara, 1991, 1997). Furthermore, 
data from non-ruminants underscore that it plays an active role in its “self-regulation” [e.g. 
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through the production of adipokines, (Adamczak and Wiecek, 2013, McGown et al., 2014, Musi 
and Guardado-Mendoza, 2014)]. Among its self-regulating features, adipose has the ability to 
generate a local inflammatory response, also (in human and mice models) through the 
recruitment and regulation of the innate immune system (Grant and Dixit, 2015); leading 
scientists to hypothesize a homeorhetic role of inflammation as a physiological adaptation to 
lactation (Farney et al., 2013, Vailati Riboni et al., 2015, Vailati Riboni et al., 2016). 
A recent study (Arner and Kulyte, 2015) investigated the involvement of microRNA (miRNA) 
in fat cell formation (adipogenesis) and regulation of metabolic and endocrine functions; the 
results demonstrated how adipocyte metabolic pathways are not only controlled by the well-
established changes in mRNA expression, but that miRNA signaling through complex networks 
involving transcription factors plays an important role in the control of inflammation.  
Furthermore, miRNA expression patterns in humans have also been associated with levels of 
inflammatory molecules (e.g. cytokines) and the degree of immune cell infiltration (Kloting et 
al., 2009). 
We previously demonstrated that prepartum BCS and level of nutrition in grazing cows 
can affect adipose tissue adaptation to lactation through complex immunometabolic pathways 
(Vailati-Riboni et al., 2016). Overfeeding optimally-conditioned cows during close-up primed 
adipose tissue for accretion of lipid and caused a robust localized inflammatory response, which 
upon parturition may increase the probability for metabolic disorders. We hypothesized that far-
off overfeeding could impair the adipose tissue adaptation to lactation, with further detrimental 
effects, or mitigation of these, when combined with close-up overfeeding, or feed-restriction, 
respectively. In the present study, gene and miRNA expression profiling were used to further 
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understand the adipose responses to the physiological changes induced by the high metabolic 
demands of early lactation, and their interaction with far-off and close-up nutritional strategies.  
 
MATERIALS AND METHODS 
Animal Management 
Complete details of the experimental design are reported elsewhere (Roche et al., 2017). 
Briefly, a group of 150 mid-lactation dairy cows (that passed a veterinary clinical examination, 
which included a full pathology health panel) of mixed age and breed (Holstein-Friesian, Jersey, 
Holstein-Friesian x Jersey) were allocated randomly to one of two treatment groups (75 cows per 
group) 18 wk before planned start of calving, and managed through late lactation to achieve a 
high and low BCS (approximately 4.75 and 4.25, on a 10-point scale, where 1 is emaciated and 
10 obese; Roche et al. 2004). Consequently, to reach optimal calving BCS (5.00, Roche et al. 
2004), the high BCS group had <0.25 BCS units to gain during the 5 wk far-off period (Slow 
BCS gain), while the low BCS cows were overfed to ensure a gain of 0.75-1.0 BCS units in the 
same period (Fast BCS gain). From approximately 3 wk before calving, cows within each BCS 
gain group were randomly assigned in a 2 x 3 factorial arrangement of treatments to one of three 
feeding level categories: 65, 90, and 120% of estimated ME requirements (Feed65, Feed90, and 
Feed120, respectively). Although cow allocation to treatment was random, groups were assessed 
to ensure they were balanced for age, breed, BCS at the time of enrolment, and expected calving 
date. For the current study, only a subset of 60 animals (10 cows per group) with adipose tissue 
biopsy samples available were considered. 
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RNA extraction and Quantitative PCR (qPCR) 
Complete details of these procedures are included in the supplemental material. Briefly, 
subcutaneous adipose tissue was collected posterior to the shoulder blade and approximately 10 
cm down the withers during wk −1, 1, and 4 relative to parturition as described previously (Grala 
et al., 2013). Average sampling date (mean ± SD) for wk -1, 1, and 4 was -10.4 ± 2.4, 6.4 ± 0.9, 
and 27.4 ± 0.9 days relative to parturition, respectively. RNA samples were extracted from the 
frozen tissue and used for cDNA synthesis using established protocols in our laboratory (Vailati 
Riboni et al., 2016). The Quanta qScript microRNA cDNA Synthesis Kit (Quanta BioSciences, 
Inc., Gaithersburg, MD) was used for miRNA following the manufacturer’s protocols. The 
qPCR performed was SYBR Green-based, using a 7-point standard curve obtained from a diluted 
cDNA pool of all samples. Genes selected for transcript profiling are associated with fatty acid 
metabolism: fatty acid synthase (FASN), peroxisome proliferator-activated receptor gamma 
(PPARG); adipokines: adiponectin (ADIPOQ); and inflammation: chemokine (C-C motif) ligand 
2 (CCL2), chemokine (C-C motif) ligand 5 (CCL5), haptoglobin (HP), interleukin-1β (IL1B), 
inteleukin-6 (IL6), inteleukin-6 receptor (IL6R), retinoid X receptor alpha (RXRA), serum 
amyloid A3 (SAA3), toll-like receptor 4 (TLR4), toll-like receptor 9 (TLR9), and tumor necrosis 
factor α (TNF). The miRNA selected for expression profiling are associated with immune cell 
infiltration (miR-26b, miR-126, miR-132, miR-155, miR-193b), inflammation and lipolysis 
(miR-99a, miR-145, miR-221), and positive regulation of adipogenesis (miR-103, miR-143, 
miR-378). The specific function of each target miRNA is reported in Table 6.1, including the 
model system in which the function was assessed. Primer sequences and qPCR performances are 
reported in the supplemental material. 
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Blood sampling and analysis 
 Blood was sampled by coccygeal venipuncture using evacuated blood tubes containing 
lithium heparin anticoagulant. Samples were placed immediately on ice and centrifuged within 
30 min at 1,500 × g for 12 min at 4 °C. Following centrifugation, aspirated plasma was stored at 
−20 °C until assayed. 
Blood free fatty acids (FA) and BHB were assayed using colorimetric techniques at 37 °C with a 
Hitachi Modular P800 analyzer (Roche Diagnostics, Indianapolis, IN). Plasma FA concentration 
(mmol/L) was measured using the Wako Chemicals (Osaka, Japan) kit NEFA HR2 measuring 
oxidative condensation of 3-methyl-N-ethyl-N-β hydroxyethyl aniline with 4-aminoantipyrine, 
while plasma BHB (mmol/L) concentration was assessed using Roche reagent kits measuring the 
reduction of NAD to NADH during oxidation of d-3-hydroxybutyrate to acetoacetate. 
Cholesterol was measured using a commercially-available fluorimetric kit (Cayman Chemical 
Company, East Ellsworth Road, Ann Arbor, U.S.A.). 
Statistical Analysis 
After normalization with the geometric mean of the internal control genes, qPCR data 
(mRNA and miRNA) were log2 transformed prior to statistical analysis to obtain a normal 
distribution. Statistical analysis was performed with SAS. Data were subjected to ANOVA and 
analyzed using repeated measures ANOVA with PROC MIXED. The statistical model included 
time (T; -1, 1 and 4 wk postpartum), far-off management (FO; Slow and Fast), close-up feeding 
(CU, 65, 90 and 120%) and their interactions (FO*T, CU*T and FO*CU*T) as fixed effects. 
Cow, nested within treatment, was the random effect. The Kenward-Roger statement was used 
for computing the denominator degrees of freedom, while spatial power was used as the 
covariance structure. Data were considered significant at a P ≤ 0.05 using the PDIFF statement 
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in SAS. For ease of interpretation, expression data reported in Tables 6.2 through 6.5 are the log2 
back-transformed LSM that resulted from the statistical analysis. Standard errors were also 
adequately back-transformed. The three-way interaction LSM is not reported in the tables, and 
can be found in the supplemental material. 
 
RESULTS 
Gene expression 
Infiltration of immune cells. There was no effect of feeding strategy or time on CCL5 
(T, FO, CU, and interactions, P > 0.05), while CCL2 expression was affected by close-up 
feeding (CU, P < 0.05) (Table 6.2), time (T, P < 0.05), and their interaction (CU*T, P < 0.05) 
(Table 6.3). Expression of CCL2 was greater prepartum in Feed120 cows, compared with Feed65 
and Feed90. Early postpartum (1 wk), both Feed120 and Feed90 cows had a greater CCL2 
expression than Feed65 cows, but there was no detected effect of treatment later on (4 wk). This 
outcomes was due to the different progression in time; compared with prepartum, Feed90 cows 
experienced a strong upregulation (P < 0.05) of CCL2 at both 1 and 4 wk postpartum time 
points, while the same increase (P < 0.05) in Feed65 cows did not materialize until the 4 wk 
postpartum. Expression of CCL2 in Feed120 cows did not change (P > 0.05) during the 
peripartum period. 
Inflammation and lipolysis-related proteins and receptors. Parturition affected 
expression of HP and SAA3 (T, P < 0.05) due to an upregulation early postpartum independently 
from experimental groups (P < 0.05) (Table 6.3). IL6, TLR4, and TLR9 were affected by far-off 
management (FO, P < 0.05), as SlowBCS cows had a greater expression (P < 0.05) compared 
with FastBCS cows (Table 6.2). For TLR4, however, a FO*T interaction (P = 0.05) indicated 
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that this effect was only present prepartum (Table 6.3). Close-up feeding also affected expression 
of IL1B (CU, P < 0.05), IL6R, TLR4, TLR9 (CU, CU*T, P < 0.05), IL6 and TNF (CU*T, P < 
0.05) (Table 6.2 and 6.3). Compared with the other two groups, overfed cows (Feed120) had 
lower expression (P < 0.05) of IL1B, TLR9 and IL6R. However, when time is taken into 
consideration, this effect was only present for IL6R and TLR9 postpartum (wk 1 and 4), as 
prepartum (wk -1) both Feed90 and Feed120 had a lower expression (P < 0.05) compared with 
Feed65. Feed90 cows had increased the expression (P < 0.05) of IL1B over the entire period, IL6 
early postpartum (wk 1), TLR4 overall postpartum (wk 1 and 4), and TNF late postpartum (wk 
4). An interaction between FO and CU was detected for IL1B and TNF (FO*CU, P < 0.01) 
(Table 6.3). Overfeeding SlowBCS or feed-restricting FastBCS cows led to lower (P < 0.05) 
expression of these genes. Furthermore, TNF expression also was significant for the three-way 
interaction (FO*CU*T, P < 0.05) (Supplemental Figure 1). In SlowBCS cows, overfeeding 
decreased TNF expression at wk 4 postpartum; however, in FastBCS cows, feeding 90% of 
requirements increased expression at wk 1 postpartum (Supplemental Figure 1). 
Adipogenesis and lipid metabolism. Far-off management did not affect the expression of 
any of the genes in this category (FO, P > 0.05); however, close-up feeding affected the 
expression of FASN (CU, CU*T, P < 0.05), PPARG (CU, CU*T, P < 0.05), and ADIPOQ 
(CU*T, P = 0.05), as feeding cows 90% of ME requirements during this period increased (P < 
0.05) the expression of these genes prepartum (-1 wk) relative to feeding 60 or 120% of 
requirements (Table 6.2 and 6.3). A carry over-effect was also detected for PPARG and 
ADIPOQ, as their expression was still up-regulated 1 wk postpartum in Feed90 cows. 
Furthermore, parturition had a strong effect (T, P < 0.01), causing a significant down-regulation 
(P < 0.05) postpartum of all four genes (Table 6.3). 
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An interaction between FO and CU was detected for FASN and RXRA (FO*CU, P < 0.01). For 
both genes, the overall expression decreased (P < 0.05) when SlowBCS cows were overfeed (i.e. 
Feed120), while the same response (P < 0.05) was also detected for FASN when the FastBCS 
group were severely restricted (i.e. Feed65). 
MicroRNA expression 
Inflammation and lipolysis-related. Overfeeding cows during the far-off period 
(FastBCS) led to greater (P < 0.05) expression of miR-99a, mainly prepartum (FO*T, P < 0.05), 
while it decreased (P < 0.05) expression of miR-145 over the entire transition period (FO, P < 
0.05) (Table 6.4 and 6.5). miR-221 expression was affected by time (T, P < 0.05) and close-up 
feeding (CU, P < 0.05), with greater (P < 0.05) overall expression postpartum and a greater (P < 
0.05) expression in cows overfed close to parturition  (Feed120). 
All three miRNAs (miR-99a, miR-145, miR-221) had a significant two-way interaction between 
far-off management and close-up feeding (FO*CU, P < 0.05), with greater expression in either 
SlowBCS-Feed120 or FastBCS-Feed65 cows (Table 6.4). 
Adipose infiltration of Immune Cells. Time had an opposite effect on expression of miR-155 
and miR193b (T, P < 0.05), with an increase in expression (P < 0.05) postpartum for the former, 
and a decrease (P < 0.05) in expression after parturition with the latter (Table 6.5). 
Far-off management had an overall effect on miR-132 (FO, P < 0.05) and a prepartum effect on 
miR-126 and miR-155 (FO*T, P < 0.05) (Table 6.4 and 6.5). Similar to prepartal expression of 
miR-155, the expression of miR-132 was greater (P < 0.05) in SlowBCS cows, while, in the 
same group, expression was lower (P < 0.05) prepartum for miR-126. 
Close-up feeding had a significant effect on miRNA involved in immune cell infiltration (CU P 
< 0.05; miR-26b, miR-132, and miR-155; CU*T, P < 0.05; miR-126 and miR-193b). Feed120 
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cows had the greatest overall (P < 0.05) expression of miR-132 and miR155, with the lowest (P 
< 0.05) expression of miR-26b. miR-126 and miR-193b were only affected postpartum, with 
Feed90 cows having the greatest (P < 0.05) expression of miR-126 (wk 1) and the lowest (P < 
0.05) expression of miR-193b (wk 1 and 4). 
An interaction between far-off management and close-up feeding was detected for miR-126 and 
miR-155 (FO*CU, P < 0.05). In both cases, the greatest (P < 0.05) expression was detected in 
overfed (Feed120) SlowBCS and feed restricted (Feed65) FastBCS cows. 
Proadipogenic miRNA. Far-off management affected expression of miR-143 and miR-
378, with greater (P < 0.05) prepartal expression in FastBCS compared with SlowBCS cows 
(FO*T, P < 0.05). The same miRNA were also affected by close-up feeding (CU*T, P = 0.01) 
(Table 6.5). Expression of miR-143 was greater (P < 0.05) in Feed65 and Feed90 prepartum and 
early postpartum (wk 1), respectively. No differences (P > 0.05) were detected at 4 wk 
postpartum. Expression of miR-378 was greater (P < 0.05) in Feed90 cows prepartum and in 
Feed120 late postpartum (4 wk). No differences (P > 0.05) were detected early postpartum (wk 
1) for this miRNA. Expression of miR-103 also was affected by close-up feeding (CU, P < 0.05), 
with increased expression in Feed90 compared with the other groups (Table 6.4). This was 
mainly due to an interaction with far-off management, such that SlowBCS cows experienced no 
change when fed differently in the close-up period, while FastBCS cows had the highest 
expression of miR-103 when feed-restricted (Feed65), and lowest in the Feed90 group (FO*CU, 
P < 0.05). 
Blood metabolites 
Fatty acids were the only metabolite affected by far-off management (FO, P < 0.05), with 
greater concentrations in SlowBCS cows (Table 6.6). Close-up feeding level also affected their 
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concentration (CU, CU*T, P < 0.05), mainly due to prepartum concentrations being inversely 
correlated with feeding level (Feed65 > Feed90 >Feed120). Similarly, BHB and cholesterol 
concentrations were greater (CU*T, P < 0.05) prepartum in underfed than overfed cows (CU*T, 
P < 0.05). However, for cholesterol, its concentrations changed at wk 4 postpartum, with higher 
(P < 0.05) concentrations in Feed90 compared with other feeding groups.  
Time affected blood concentrations of fatty acids, BHB, and cholesterol (T, P < 0.05) (Table 
6.7). Fatty acid and BHB concentrations were greatest (P < 0.05) early postpartum (wk 1). 
Compared with prepartum concentrations, postpartum concentrations of cholesterol decreased (P 
< 0.05). 
 
DISCUSSION 
The combination of mRNA and miRNA profiling has been used previously to understand 
the molecular “self-regulatory” mechanism within the adipose depot during the transition period 
in dairy cows in the context of the relationship between dry period BCS and close-up feeding 
(Vailati Riboni et al., 2016). Our present work demonstrates that part of the variation caused by 
BCS could be attributed to the nutritional strategies utilized to allow cows to reach optimal 
adiposity at calving. Furthermore, the level of nutrition from close-up to calving could interact 
with far-off management. 
In our previous experiment (Vailati Riboni et al., 2016) we speculated that the infiltration 
of immune cells in the cow adipose tissue around parturition is part of the regulatory 
mechanisms in adipose tissue. Despite differences in cellularity, adipokine production and gene 
expression (e.g., abundance), and cell systems between omental and subcutaneous adipose tissue 
(Dodson et al., 2014), the latter  was used in the present study to allow for multiple sampling 
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across time on the same animal, which is central for the mechanistic understanding during the 
transition period.  
Recently Akter et al. (2012) concluded that the extent of fatness in early lactating dairy 
cows may not be high enough to stimulate significant infiltration of phagocytic cells and, 
therefore, these immune cells may have no major role in the immunologic and metabolic 
adaptations during early lactation. This was supported by the analysis of chemoattractant 
molecule CCL2 mRNA and protein distribution in the adipose tissue of the same animals 
(Haussler et al., 2015). However both studies, based on the experiment of von Soosten et al. 
(2011), used Holstein heifers rather than multiparous mature cows as a model. As heifers are still 
growing and developing during their first lactation, adipose mobilization is generally less 
prominent than mature cows (e.g., lower fatty acids and BHB). The authors justified the choice 
of heifers as a way to avoid the influence of previous lactations on adaptations within the adipose 
tissue. However, the first lactation might be of substantial importance to develop the adaptive 
mechanisms that will help the animal support the greater production performance of the 
subsequent lactations.  
When taking into consideration the work of Contreras et al. (2015) using multiparous 
cows with a displaced abomasum in early lactation compared to non-lactating healthy 
individuals, and flow cytometry rather than only immunostaining, a degree of immune 
infiltration was detected not only in both subcutaneous and omental fat, but also in healthy cows 
with no difference in cells markers (CD14, CD172a, CD11c, CD163, CD3) between depots. 
However, interpreting the immunostaining results, the authors described the macrophages count 
in subcutaneous adipose tissue of healthy cows as “sparse and randomly localized” in relation to 
the adipocytes number. Since those were multiparous non-lactating and non-gestating dairy cows 
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in an anabolic state, the possibilities that healthy cows might experience a “physiologically 
functional” degree of immune cell infiltration during the catabolic peripartal period is not to 
exclude. 
We recognize the importance of direct measurements of adipose tissue immune cell 
infiltration (i.e., flow cytometry and/or immunohistochemistry), but despite their lack in the 
present study, miRNA and mRNA results support its existence. Despite the fact that data on 
miRNA function and correlations with immunity and inflammation come mainly from human 
models, they are highly conserved among species. For instance, the high similarity between 
miRNA sequences between B. taurus and H. sapiens obtained using blastn (NCBI, Bethesda, 
USA) indicate a similar function in bovine (Supplemental Table D.8). Furthermore, the degree of 
similarity between CCL2 mRNA and protein between bovine and human is high (blastn and 
blastp, Supplemental Table D.9). This is valid also for MMP12 (which activates CCL2), and the 
receptors CCR2 and CCR4. Thus, because CCL2 was detectable in the present study, we 
speculate a similarity in function in bovine compared with human. Overall, the blastn and the 
blastp results (Supplemental Table D.8 and D.9) support the existence of similar function in 
human and bovine of the many players involved in the immune cell infiltration of adipose tissue. 
Far-off, non-lactating period nutrition 
Far-off nutrition in TMR-based herds is normally designed to meet basic nutrition 
requirements (e.g., maintenance and gestation), while avoiding excessive storage of reserves that 
could impair the animal adaptation to the next lactation. However, in grazing systems, cows are 
generally dried-off at a BCS too low to ensure a proper transition into lactation; thus, leading to 
the need for fattening cows prior to parturition (Roche et al., 2007). Judging by the up-regulation 
of pro-adipogenic miRNA, also observed in previous research [miR-143, miR-378 (Jin et al., 
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2009, Jin et al., 2010)], it can be surmised that overfeeding cows in the far-off period is a suitable 
management practice to meet adiposity requirements at calving, with FastBCS cows still 
exhibiting lipogenic traits at a wk prepartum (i.e., approximately 2 wk after they were switched 
to different close-up feeding management).  Despite this, the lack of change in expression of 
their common target gene, PPARG, was suggestive that the pro-adipogenic effect of these 
miRNA might have been achieved through the regulation of other target genes (i.e. MPAK1, 
ERK5).  
Although overfeeding thinner cows after dry-off (i.e., FastBCS) did not have long-term 
effects on expression of adipogenic genes, it seemed to prime the adipose tissue to retain rather 
than release fatty acid reserves in early lactation. This was surmised by the greater overall 
concentration of circulating fatty acids in SlowBCS cows compared with FastBCS cows (Roche 
et al., 2017, and Table 6.6). This hypothesis is also supported by the expression of miR-99a and 
miR-145 in FastBCS cow. In humans, miR-99a is negatively correlated with the concentrations 
of free FA within adipocytes (Kloting et al., 2009) and miR-145 regulates adipocyte lipolysis 
through different mechanisms (Lorente-Cebrian et al., 2014). Despite the lower BCS in FastBCS 
cows at 1 wk postpartum, the lower overall expression of miR-99a and the higher expression of 
miR-145 in SlowBCS cows support their greater lipolysis than in FastBCS cows.  
It is possible that the greater degree of mobilization in SlowBCS cows was partly 
regulated by infiltration of immune cells within the adipose tissue. Despite both chemokines 
(CCL2 and CCL5) not being affected by far-off management, signs of infiltration could be 
discerned in SlowBCS cows because of the greater expression of both miR-132 and miR-155, 
which are markers of macrophage infiltration in humans (Kloting et al., 2009) (i.e., an overall 
effect for the first and prepartum for the latter). In addition, the expression prepartum of miR-
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126, a CCL2 inhibitor that leads to reduced infiltration of immune cells (Arner et al., 2012), was 
lower in the same cows. 
In the present study, the expression of both TLRs (TLR4 and TLR9) was studied as a way 
to connect metabolism and inflammatory signals. Signaling through TLR4 in non-ruminants can 
induce insulin resistance and lipolysis in adipocytes (Shi et al., 2006, Song et al., 2006). Thus, 
the dual activation of TLR4 in adipocytes by lipopolysaccharide and fatty acids represents a 
molecular gate that connects innate immunity with metabolism (Schaffler and Scholmerich, 
2010). In the same fashion, TLR9, originally identified in non-ruminants as a sensor of 
exogenous DNA fragments (Scharfe-Nugent et al., 2012), can also be activated by fatty acids, 
leading to chronic adipose tissue inflammation and insulin resistance (Pallares et al., 2010, 
Nishimoto et al., 2016).  
Because cows in the present experiment were clinically healthy and free from pathogen-
related inflammatory events (e.g., cows passed a veterinary clinical examination), activation of 
TLR4 and TLR9 in SlowBCS cows likely was mediated by fatty acids; hence, they transmitted 
lipolytic signals to the tissue. The greater activation of both TLR could be surmised not only by 
their greater expression, but also by the greater expression of IL6 in the same cows. In fact, 
TLR4 activation is known to induce IL6 expression, both in adipocytes and macrophages (Shi et 
al., 2006). In non-ruminants, IL-6 is known to have lipolytic effects (Yang et al., 2008) at least, 
in part, due to its ability to enhance insulin resistance (Shoelson et al., 2007). Since miR-99a was 
negatively correlated with secretion of IL-6 (Kloting et al., 2009) in non-ruminants, we speculate 
that the greater overall expression of IL6 in SlowBCS cows might partly be attributed to 
infiltrating macrophages rather than adipocytes themselves. This scenario has been demonstrated 
in models of human obesity, as release of interleukins and other inflammatory cytokines from 
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human adipose depots is enhanced in obesity, primarily due to the nonfat cells (Fain, 2006). 
However, further research is needed to localize the origin (e.g. immune cells, or nonfat cells) of 
IL6 expression in the tissue. 
At least in cows that reach the end of lactation at a greater BCS, and were not overfed 
during the far-off period, these relationships underscored the importance of immunological 
control of lipolysis. We further speculate the existence of a “positive-feedback” loop between FA 
and immune cell infiltration. Whether the observed effects were due to nutrition management 
only or BCS at drying-off requires further research.  
Close-up feeding 
 A general outcome when overfeeding cows during the close-up period is a decrease in 
adipose mobilization and greater storage of surplus nutrients (Ji et al., 2012). The marked 
decrease in the overall concentration of circulating FA along the entire transition period, and 
BHB and cholesterol in the prepartum period, in cows fed 120% of ME requirements (Feed120) 
all indicate a decrease in lipid mobilization. This systemic effect was mirrored peripherally by 
the down-regulation of lipolytic and insulin resistance signaling genes (e.g., lower IL1B, IL6R, 
TLR9) (Lagathu et al., 2006, Yang et al., 2008, Pallares et al., 2010). Paradoxically, however, the 
down-regulation of FASN and the pro-adipogenic miR-378 and miR-143 (Jin et al., 2009, Jin et 
al., 2010), as well as ADIPOQ, in Feed120 cows were indicative of a reduction in the 
differentiation and proliferation of adipocytes in the overfeeding treatment.  
The response in ADIPOQ expression (e.g., lower in Feed120) was particularly interesting 
because, in non-ruminants, the increase in its expression improves insulin sensitivity and exerts 
some regulation over fatty acid metabolism (Brochu-Gaudreau et al., 2010). Expression of 
ADIPOQ also is markedly increased during ruminant adipocyte differentiation (Roh et al., 2006). 
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Thus, lower expression of ADIPOQ is a marker of reduced pre-adipocyte differentiation 
(Soliman et al., 2007). In vivo data also revealed a tendency for a reduction of circulating 
ADIPOQ during overconditioning (similar to our mRNA data) (Locher et al., 2015), but the 
cows, opposite to the present study, also gained weight and BCS over time. In light of these 
seemingly-paradoxical responses, questions arise on the adipose’s utilization of the excess 
energy. For example, because adipose did not seem to accrete additional triglycerides and BCS 
did not change in the wk before parturition, (Roche et al., 2017), the additional intake could have 
been entirely partitioned towards meeting the requirements for gestation. In fact, cows did not 
experience an increase in adiposity, but their BW increased before parturition (Roche et al., 
2017).  
Despite the apparent absence of new fat deposition, the adipose tissue of overfed cows 
seemed to respond similar to what is observed in fat depots from obese individuals in the sense 
that infiltration of immune cells appeared to be stimulated by the excess feeding. The overall 
upregulation of the chemokine gene, CCL2, coupled with upregulation of miR-132 and miR-155 
led us to speculate an increase in infiltration of immune cells (Kloting et al., 2009). Such a 
response normally increases insulin resistance and lipid mobilization to avoid excess storage in 
adipocytes and associated detrimental effects (Olefsky and Glass, 2010).  
As lipolytic and insulin resistance signals are suppressed (IL1B, IL6R, TLR9) in Feed120 
cows, the tentative onset of an inflammatory cascade could be a response to the need for 
mobilization to meet lactation requirements postpartum; however, it could also be related to the 
need to establish new reserves. This idea is supported by recent data demonstrating that 
adipocyte inflammation is an important component for a healthy expansion and remodeling of 
the adipose tissue (Asterholm et al., 2014). In either scenario, the apparent immune-related 
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tendency to kick start an inflammatory response to modulate metabolism could be a reaction to 
what has been previously described as a “lazy” phenotype in cows overfed prepartum (Vailati 
Riboni et al., 2016). This concept shares strong similarities with the well-known calcium 
metabolism and nutrition of the dry cow, as overfeeding calcium before parturition will increase 
the risk of metabolic failures (e.g. milk fever) by dampening the physiological mechanisms 
behind calcium homeostasis (Horst et al., 1997). 
Contrary to overfeeding, a strong feed restriction (Feed65) elicited a clear outcome. The 
phenotypic data from this study indicated that such severe restriction during the pre-calving 
period increases the risk of disease in early lactation and reduces milk production (Roche et al., 
2017). These cows experienced an excessive degree of mobilization of tissue reserves prepartum 
(Table 6.6), together with a reduction in BCS, but without a loss of BW (Roche et al., 2017).  
The presented transcriptome data point to a negative-feedback salvage mechanism (i.e. due to the 
excess mobilization prepartum, cows experience an even greater loss of reserves in the 
postpartum). Despite the contention that evolutionary programming of animal physiology is 
pointed towards the offspring rather than the mother (Bauman and Currie, 1980), the 
downregulation of a possible immune infiltration signal (CCL2) and lipolytic signal (IL6) 
postpartum, and the upregulation of the pro-adipogenic miR-143 (at least prepartum) in Feed65 
cows could represent an attempt by the fat depots of the cow to control and maintain its reserves, 
as under extreme circumstances (e.g. malnourishment) the physiological priority can come back 
to the mother (Bauman and Currie, 1980). 
Considering the entire set of mRNA and miRNA analyzed, and contrary to expectations, 
a slight restriction (Feed90) during the transition period was the main driver of changes in 
expression of most target genes. These changes, however, did not create an extreme phenotype, 
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and rather seemed to be part of the natural physiological adaptation to lactation. The overall up-
regulation of immune lipolytic signaling (e.g., IL1B, TLR4, TLR9), combined with the lowest 
expression of miR-155 and the absence of a clear change in chemokine expression (both CCL2 
and CCL5) underscored that the fat depots of these cows did not rely on the action of immune 
cells to regulate and induce changes in metabolism. Furthermore, the marked upregulation 
prepartum in Feed90 of pro-adipogenic gene (e.g. PPARG, FASN, and ADIPOQ) indicated an 
equilibrating mechanism to balance lipolytic and anti-lipolytic signals in order to prime the 
mobilization machinery in light of the imminent parturition. Once this balancing mechanism was 
complete (PPARG, FASN, and ADIPOQ expression decreased after parturition), the lipolytic 
signaling and insulin resistance mechanisms are already established and can fully act on 
adipocyte metabolism (i.e. IL6, IL6R, TLR4, TLR9, and TNF all had a higher expression 
postpartum in Feed90 cows).  
Together, these changes led to a numerically greater, but non-significant, level of 
circulating FA in early lactation (Table 6.6). As indicated by the higher expression postpartum of 
miR-126, a direct inhibitor of chemokine CCL2 (Arner et al., 2012), these changes did not seem 
to encompass an infiltration of immune cells. We speculate that the involvement of the innate 
immune system in regulating adipocyte metabolism may only occur in extreme nutritional 
situations (e.g. Feed65, Feed120), similar to the obesity scenario in humans, or in clinical 
scenarios [e.g. displaced abomasum, Contreras et al. (2015)], in which most of the relationships 
among immunity and metabolism have already been well-studied. 
Possible interaction of far-off and close-up nutritional strategies 
No interactions among far-off management and close-up feeding level were detected for 
production and health outcomes as presented in the main manuscript concerning this experiment 
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(Roche et al., 2017). However, at a molecular level (adipocyte transcriptome), distinct and 
similar changes were caused by their interaction in SlowBCS-Feed120 and FastBCS-Feed65 
cows. Both groups experienced a state of low lipolytic signaling and higher insulin sensitivity 
(low IL1B, TNF) during the entire transition period. Such a physiological state would have been 
supported by the higher expression of miR-99a, which in non-ruminants is inversely correlated 
with IL-6 secretion and FA acid concentration (Kloting et al., 2009), miR-221, which is inversely 
correlated with TNF-α secretion (Chou et al., 2013), and miR-126, which is a CCL2 inhibitor 
(Arner et al., 2012).  
Although adipose tissue of SlowBCS-Feed120 and FastBCS-Feed65 cows appears not to 
have been primed to mobilize its reserves, at least from the genes studied, it also did not seem to 
signal an increase in TAG storage because the expression of FASN and RXRA was markedly 
lower compared with the other experimental groups. To further complicate this scenario of an 
apparent metabolic “stasis”, contradictory responses were detected. Both miR-155 and miR-145 
were up-regulated in SlowBCS-Feed120 and FastBCS-Feed65, suggesting greater immune cell 
infiltration (Kloting et al., 2009) and lipolytic activity (Lorente-Cebrian et al., 2014), while miR-
103 was also up-regulated, possibly increasing insulin sensitivity (Trajkovski et al., 2011) and 
stimulating pro-adipogenic signaling (Romao et al., 2011, Romao et al., 2014). Thus, the 
metabolic effect of the interactions detected remains unclear and are further complicated by the 
lack of interaction at the phenotype level. Further research is needed to better characterize the 
physiology of the relationships among far-off and close-up nutrition. 
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CONCLUSIONS 
The current results support the hypothesis that bovine adipose tissue possesses a 
homeorhetic mechanism for the adaptation to lactation, driven, in part, by inflammatory changes 
and, we speculate, in a cross-talk with the innate immune system. This mechanism appears to be 
modulated by peripartal nutrition. Overfeeding animals in the far-off period to achieve optimal 
calving BCS (FastBCS) reduced the propensity to mobilize adipose depots after parturition; 
however, animals that were managed in late lactation to dried-off at optimal calving BCS 
(SlowBCS) seemed more primed to lose BCS in early lactation. Concerning close-up nutrition, 
what seems to be a natural progression of self-driven inflammatory events in slightly underfed 
cows (Feed90) can be modulated both by underfeeding (Feed65) or overfeeding (Feed120), 
which we speculate caused the recruitment of the innate immune system to help modulate 
adipocyte metabolism. In light of the present results, to obtain a favorable transition to lactation, 
at least in grazing systems, dairy cows should be managed to achieve an optimal calving BCS at 
close-up, either by overfeeding thinner cows or control-feeding those already dried-off at target 
BCS, as neither strategy (FastBCS, SlowBCS), despite their different outcomes, interfere in the 
physiological adaptation. Subsequently, in the close-up period, BCS should be managed by 
applying a slight feed restriction closer to calving.  
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TABLES 
 
Table 6.1. Details and functions of the miRNA targets analyzed in the current study, adapted from Vailati Riboni et al. (2016), Moisa 
et al. (2016), and Arner and Kulyte (2015) 
 
miRNA Function and/or expression pattern Model System1 Reference 
Infiltration of immune cells 
miR-26b Expression is associated with the number of macrophages infiltrating 
the fat depot 
Affected by levels of circulating TNF, leptin and resistin 
Hu (Kloting et al., 2009, Xu et al., 2013) 
miR-126 Directly inhibits CCL2 expression Hu (Kloting et al., 2009, Arner et al., 
2012) 
miR-132 Expression levels are associated with the number of macrophages 
infiltrating fat depots  
Activates NF‐κB signalling and the transcription of IL8 and CCL2  
Lower expression is associated with increased secretion of IL-6  
Hu (Kloting et al., 2009, Strum et al., 
2009, Estep et al., 2010) 
miR-155 Expression levels are associated with the number of macrophages 
infiltrating fat depots 
Hu (Kloting et al., 2009) 
miR-193 Indirectly inhibits CCL2 expression through a network of transcription 
factors  
Hu (Arner et al., 2012) 
Inflammation and lipolysis 
miR-99a Negative correlation with secretion of IL-6 and level of free fatty acids Hu (Kloting et al., 2009) 
miR-145 Affects secretion of TNFα, regulating lipolysis Hu (Lorente-Cebrian et al., 2014) 
miR-221 Lower expression is associated with high levels of TNFα Hu (Chou et al., 2013) 
Proadipogenic 
miR-103 Regulates expression of PPARG, PANK1, CAV1, FASN, ADIPOQ and 
FABP4 
Bo, Ma, Mo (Romao et al., 2011, Trajkovski et al., 
2011, John et al., 2012, Romao et al., 
2014) 
miR-143 Regulates expression of ERK5, SLC2A4, TFAP2A, LIPE, PPARG, 
CEBPA, and FABP4 
Bo, Hu, Ma, 
Mo 
(Esau et al., 2004, Kajimoto et al., 
2006, Xie et al., 2009, Jin et al., 2010, 
Li et al., 2011, Romao et al., 2011) 
miR-378 Targets PPARG expression through the MAPK1 pathway B, Mo (Gerin et al., 2010, Jin et al., 2010, 
John et al., 2012, Sacco and Adeli, 
2012, Liu et al., 2015) 
1Bo = Bovine (Bos taurus); Hu = Human; Ma = Mammalian; Mo = Mouse 
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Table 6.2. Effect of far-off and close-up feeding management on subcutaneous adipose tissue expression (back-transformed LSM and SEM) in 
grazing dairy cows during the transition period. 
   
 
 
 FO*CU         
 
FO1  CU2  SlowBCS  FastBCS   p-value 
Target 
Slow 
BCS 
Fast 
BCS 
 
Feed 
65 
Feed 
90 
Feed 
120 
 
Feed 
65 
Feed 
90 
Feed 
120 
 
Feed 
65 
Feed 
90 
Feed 
120 
SE
M3 
FO CU FO*CU 
Infiltration of immune cells 
CCL2 0.80 0.64  0.58a 0.64a 0.99b  0.76 0.56 1.18  0.44 0.73 0.82 0.24 0.18 0.01 0.09 
CCL5 0.89 0.86  1.00 0.87 0.78  1.03 1.05 0.66  0.97 0.72 0.93 0.22 0.86 0.52 0.22 
Inflammation and lipolysis 
HP 0.11 0.11  0.15 0.07 0.12  0.23 0.06 0.08  0.10 0.07 0.19 0.09 0.86 0.09 0.10 
IL1B 0.75 0.64  0.67a 0.99b 0.50c  1.09ac 1.20a 0.32b  0.41b 0.82ac 0.77c 0.18 0.21 < 0.01 < 0.01 
IL6 0.46a 0.26b  0.25 0.40 0.42  0.47 0.38 0.55  0.13 0.41 0.32 0.16 0.01 0.12 0.06 
IL6R 1.02 0.91  1a 1.09a 0.82b  1.13 1.23 0.78  0.89 0.97 0.87 0.12 0.15 0.02 0.13 
SAA3 0.26 0.24  0.35 0.18 0.25  0.27 0.18 0.37  0.45 0.18 0.17 0.13 0.66 0.07 0.07 
TLR4 1.03a 0.77b  0.74a 1.21b 0.79a  0.92 1.42 0.84  0.59 1.03 0.74 0.18 < 0.01 < 0.01 0.40 
TLR9 0.68a 0.54b  0.63a 0.71a 0.50b  0.78 0.80 0.51  0.50 0.63 0.50 0.08 < 0.01 < 0.01 0.07 
TNF 1.07 1.02  1.03 1.19 0.92  1.33a 1.21a 0.75b  0.80b 1.17a 1.12a 0.17 0.63 0.11 < 0.01 
Adipogenesis and lipid metabolism 
ADIPOQ 0.75 0.63  0.57 0.87 0.66  0.59 1.02 0.70  0.54 0.74 0.63 0.20 0.28 0.09 0.82 
FASN 0.13 0.14  0.09a 0.29b 0.09a  0.14ac 0.27ac 0.05b  0.05b 0.31a 0.16c 0.08 0.66 < 0.01 < 0.01 
PPARG 0.99 0.83  0.75a 1.21b 0.83a  0.87 1.31 0.84  0.64 1.12 0.81 0.21 0.21 < 0.01 0.73 
RXRA 0.96 1.01  1.02 1.02 0.92  1.05a 1.09a 0.77b  1.00a 0.95a 1.09a 0.09 0.37 0.28 < 0.01 
1 FO = Far-off feeding management. Cows that were dried off at a lower BCS than optimal (0.75-1.00 unit lower) were overfed to quickly reach 
optimal calving BCS at 5wk prepartum, hence FastBCS, While animals that were dried closer to optimal (<0.25 unit than optimal) were fed to 
maintenance to slowly reach calving BCS at 5wk prepartum, hence SlowBCS 
2 CU = close-up feeding management; Feed65, Feed90, and Feed120 were fed to reach 65, 90, and 120% of estimated ME requirements, respectively   
3 SEM = greatest standard error of the mean. 
a,b,c = significant difference among groups (P < 0.05) 
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Table 6.3. Effect of far-off and close-up feeding management, and time on subcutaneous adipose tissue expression (back-transformed LSM and 
SEM) in grazing dairy cows during the transition period.  
  
 
FO*T3 
 
CU*T4  p-values 
Target Wk1 T2 
 
SlowBCS FastBCS 
 
Feed65 Feed90 Feed120 SEM5 T FO*T CU*T FO*CU*T 
Infiltration of immune cells 
CCL2 -1 0.43x  0.52 0.36  0.36a,x 0.29a,x 0.78b 0.36 < 0.01 0.79 0.02 0.71 
1 0.77y  0.81 0.74  0.40a,x 0.91b,y 1.27b 
4 1.10y  1.20 1.00  1.34y 1.01y 0.97 
CCL5 -1 0.81  0.77 0.84  1.01 0.64 0.81 0.27 0.40 0.15 0.30 0.14 
1 1.00  1.23 0.82  1.20 0.94 0.90 
4 0.84  0.75 0.94  0.82 1.09 0.66 
Inflammation and lipolysis 
HP -1 0.07x  0.07 0.07  0.08 0.02 0.18 0.17 0.01 0.87 0.08 0.55 
1 0.22y  0.19 0.26  0.37 0.13 0.22 
4 0.08x  0.08 0.08  0.12 0.09 0.05 
IL1B -1 0.69  0.80 0.59  0.59 0.73 0.75 0.33 0.22 0.71 0.07 0.45 
1 0.83  0.81 0.84  0.77 1.34 0.55 
4 0.58  0.65 0.52  0.66 1.00 0.30 
IL6 -1 0.26x  0.42 0.16  0.18x 0.22x 0.42 0.22 0.02 0.21 0.01 0.15 
1 0.30x  0.33 0.28  0.12a,x 0.62b,y 0.36b 
4 0.53y  0.71 0.40  0.66y 0.46xy 0.50 
IL6R -1 0.84x  0.96 0.74  1.03a 0.73b,x 0.80ab 0.19 0.04 0.34 0.04 0.71 
1 1.10y  1.19 1.03  1.05ab 1.47a,y 0.87b 
4 0.97xy  0.95 0.99  0.93ab 1.21a,y 0.80b 
SAA3 -1 0.23xy  0.20 0.26  0.37 0.16 0.20 0.19 0.04 0.49 0.82 0.62 
1 0.37y  0.40 0.33  0.57 0.24 0.36 
4 0.18x  0.22 0.15  0.19 0.15 0.22 
TLR4 -1 0.76  1.03a 0.55b,x  0.73 0.72x 0.82 0.35 0.08 0.05 0.01 0.24 
1 0.96  0.96 0.96y  0.64a 1.89b,y 0.74a 
4 0.96  1.10 0.85y  0.85a 1.30b,y 0.80a 
TLR9 -1 0.51x  0.60 0.42  0.66a 0.41b,x 0.48b 0.14 < 0.01 0.38 < 0.01 0.77 
1 0.73y  0.79 0.67  0.61a 1.20b,y 0.54a 
4 0.61z  0.66 0.56  0.62ab 0.74a,z 0.50b 
TNF -1 0.85x  0.98 0.73  0.80 0.74x 1.02x 0.25 0.01 0.16 < 0.01 0.05 
1 1.28y  1.33 1.23  1.23 1.38y 1.22x 
4 1.05xy  0.94 1.16  1.13a 1.64b,y 0.62b,y 
Adipogenesis and lipid metabolism 
ADIPOQ -1 1.02x  1.07 0.98  0.95ab,x 1.60a,x 0.71b 0.38 < 0.01 0.32 0.05 0.48 
1 0.46y  0.58 0.36  0.29a,y 0.70b,y 0.47ab 
4 0.70z  0.68 0.72  0.67x 0.59y 0.87 
FASN -1 0.57x  0.05 0.04  0.17a,x 3.49b,x 0.30a,x 1.11 < 0.01 0.79 < 0.01 0.35 
1 0.05y  0.52 0.62  0.03y 0.08y 0.04y 
4 0.08z  0.08 0.09  0.11x 0.09y 0.06y 
PPARG -1 1.31x  1.52 1.13  1.14a,x 2.15b,x 0.92a 0.42 < 0.01 0.16 0.05 0.17 
1 0.62y  0.75 0.51  0.39a,y 0.91b,y 0.65b 
4 0.92z  0.84 1.01  0.92x 0.90y 0.93 
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Table 6.3 (cont) 
 
RXRA -1 1.40x  1.26 1.55  1.38 1.65 1.21 0.20 < 0.01 0.19 0.51 0.88 
1 0.84y  0.93 0.76  0.88 0.87 0.78 
4 0.81y  0.75 0.88  0.88 0.75 0.81 
1 Wk = week relative to parturition 
2 T = time 
3 FO = Far-off feeding management. Cows that were dried off at a lower BCS than optimal (0.75-1.00 unit lower) were overfed to quickly reach optimal 
calving BCS at 5wk prepartum, hence FastBCS, While animals that were dried closer to optimal (<0.25 unit than optimal) were fed to maintenance to 
slowly reach calving BCS at 5wk prepartum, hence SlowBCS 
4 CU = close-up feeding management; Feed65, Feed90, and Feed120 were fed to reach 65, 90, and 120% of estimated ME requirements, respectively   
5 SEM = greatest standard error of the mean. 
a,b,c =  significant difference among groups within the same week relative to parturition (P < 0.05) 
x,y,z =  significant difference among time points, within group (P < 0.05) 
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Table 6.4. Effect of far-off and close-up feeding management on subcutaneous adipose tissue microRNA expression (back-
transformed LSM and SEM) in grazing dairy cows during the transition period. 
 
   
 
 
 FO*CU         
  FO
1  CU2  SlowBCS  FastBCS   p-value 
Target 
Slow 
BCS 
Fast 
BCS 
 Feed 
65 
Feed 
90 
Feed 
120 
 Feed 
65 
Feed 
90 
Feed 
120 
 Feed 
65 
Feed 
90 
Feed 
120 SEM3 FO CU FO*CU 
Infiltration of immune cells 
miR-26b 0.92 1.00  1.00a 1.05a 0.84b  1.08 0.94 0.77  0.93 1.16 0.92 0.10 0.24 0.03 0.07 
miR-126 0.81 0.92  0.85 0.92 0.82  0.67a 0.87ab 0.90ab  1.09b 0.97bc 0.74ac 0.14 0.22 0.70 0.04 
miR-132 1.09a 0.91b  0.94a 0.95a 1.12b  1.02 1.08 1.19  0.86 0.84 1.06 0.08 < 0.01 0.02 0.67 
miR-155 1.18 1.05  1.11a 0.88b 1.42c  1.02ab 0.91bd 1.76c  1.20a 0.84b 1.14ad 0.14 0.08 < 0.01 < 0.01 
miR-193b 0.88 0.86  1.00 0.77 0.86  0.94 0.82 0.90  1.07 0.72 0.82 0.13 0.78 0.11 0.52 
Inflammation and lipolysis 
miR-99a 0.78a 0.94b  0.87 0.84 0.85  0.67a 0.75ab 0.92bc  1.14c 0.94bc 0.78ab 0.13 0.04 0.94 0.01 
miR-145 1.28a 0.99b  1.17 0.95 1.28  1.07ac 1.09ac 1.81b  1.28c 0.83a 0.91a 0.23 0.02 0.07 0.01 
miR-221 0.94 0.92  0.93ab 0.84a 1.04b  0.81a 0.88ac 1.17b  1.06cb 0.80a 0.92ac 0.09 0.72 0.03 0.01 
Proadipogenic 
miR-103 0.99 0.95  1.05a 0.89b 0.98a  1.00abc 0.95ac 1.02abc  1.10b 0.83d 0.95c 0.05 0.29 < 0.01 0.03 
miR-143 0.93 0.89  0.91 1.07 0.79  0.85 1.04 0.92  0.97 1.09 0.68 0.15 0.72 0.09 0.23 
miR-378 0.79 0.86  0.88 0.78 0.81  0.76 0.77 0.83  1.02 0.78 0.80 0.11 0.33 0.55 0.28 
1 FO = Far-off feeding management. Cows that were dried off at a lower BCS than optimal (0.75-1.00 unit lower) were overfed to quickly reach 
optimal calving BCS at 5wk prepartum, hence FastBCS, While animals that were dried closer to optimal (<0.25 unit than optimal) were fed to 
maintenance to slowly reach calving BCS at 5wk prepartum, hence SlowBCS 
2 CU = close-up feeding management; Feed65, Feed90, and Feed120 were fed to reach 65, 90, and 120% of estimated ME requirements, respectively   
3 SEM = greatest standard error of the mean. 
a,b,c = significant difference among groups (P < 0.05) 
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Table 6.5. Effect of far-off and close-up feeding management, and time on subcutaneous adipose tissue microRNA expression (back-
transformed LSM and SEM) in grazing dairy cows during the transition period. 
  
  
FO*T3  CU*T4 
 
p-value 
 Target Wk1 T2 SlowBCS FastBCS  Feed65 Feed90 Feed120 SEM5 T FO*T CU*T FO*CU*T 
Infiltration of immune cells 
miR-26b -1 0.94 0.84 1.06  0.97 0.89 0.97 0.13 0.68 0.25 0.16 0.33 
1 1.00 0.98 1.03  1.12 1.16 0.78 
4 0.93 0.96 0.91  0.93 1.11 0.79 
miR-126 -1 0.76 0.57a,x 1.01b  0.97 0.67x 0.67 0.24 0.22 0.02 0.04 0.62 
1 0.96 0.97y 0.96  0.78a 1.39b,y 0.82a 
4 0.88 0.96y 0.81  0.82 0.82x 1.01 
miR-132 -1 1.04 1.21 0.89  0.97 1.09 1.07 0.12 0.50 0.13 0.65 0.26 
1 0.94 1.05 0.85  0.90 0.86 1.10 
4 1.02 1.02 1.01  0.95 0.93 1.21 
miR-155 -1 0.97x 1.18a 0.79b,x  0.93 0.83 1.18 0.16 0.01 0.01 0.19 0.41 
1 1.14xy 1.19 1.09y  1.15 0.77 1.67 
4 1.24y 1.17 1.33y  1.27 1.05 1.44 
miR-193b -1 1.20x 1.03 1.38  1.21 1.51x 0.93 0.28 < 0.01 0.22 0.02 0.63 
1 0.82y 0.96 0.70  1.11a 0.66b,y 0.75ab 
4 0.68y 0.70 0.66  0.75ab 0.46a,y 0.91b 
Inflammation and lipolysis            
miR-99a -1 0.86 0.63a 1.17b,x  1.01 0.83 0.76 0.17 0.19 < 0.01 0.06 0.94 
1 0.95 0.87 1.04x  0.93 1.12 0.82 
4 0.76 0.85 0.69y  0.71 0.64 0.98 
miR-145 -1 1.10 1.21 1.00  1.25 0.99 1.08 0.22 0.14 0.28 0.56 0.68 
1 1.29 1.64 1.01  1.40 1.01 1.51 
4 1.01 1.07 0.95  0.92 0.86 1.30 
miR-221 -1 0.81x 0.86 0.77  0.84 0.73 0.88 0.12 0.02 0.64 0.84 0.60 
1 0.98y 0.95 1.00  0.96 0.83 1.16 
4 1.02y 1.02 1.01  0.98 0.97 1.10 
Proadipogenic             
miR-103 -1 0.88 0.83 0.94  0.94 0.78 0.94 0.09 0.07 0.14 0.51 0.14 
1 1.07 1.12 1.02  1.22 0.93 1.08 
4 0.97 1.04 0.90  1.02 0.96 0.94 
miR-143 -1 0.80 0.66a,x 0.97b  1.12a 0.67b,x 0.69b 0.32 0.08 0.04 0.01 0.83 
1 1.11 1.22y 1.01  0.97a 1.77b,y 0.79a 
4 0.86 1.00y 0.73  0.69 1.02x 0.90 
miR-378 -1 1.10x 0.86a 1.40b,x  1.19ab,x 1.36b,x 0.82a 0.20 < 0.01 0.02 0.01 0.42 
1 0.72y 0.76 0.68y  0.78y 0.69y 0.71 
4 0.70y 0.74 0.66y  0.73ab,y 0.50a,y 0.93b 
1 Wk = week relative to parturition 
2 T = time 
3 FO = Far-off feeding management. Cows that were dried off at a lower BCS than optimal (0.75-1.00 unit lower) were overfed to quickly reach optimal 
calving BCS at 5wk prepartum, hence FastBCS, While animals that were dried closer to optimal (<0.25 unit than optimal) were fed to maintenance to slowly 
reach calving BCS at 5wk prepartum, hence SlowBCS 
4 CU = close-up feeding management; Feed65, Feed90, and Feed120 were fed to reach 65, 90, and 120% of estimated ME requirements, respectively   
5 SEM = greatest standard error of the mean. 
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Table 6.5 (cont) 
 
a,b,c =  significant difference among groups within the same week relative to parturition (P < 0.05) 
x,y,z =  significant difference among time points, within group (P < 0.05) 
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Table 6.6. Effect of far-off and close-up feeding management on plasma concentrations of fatty acids (FA), β-hydroxybutyrate 
(BHB), and cholesterol in grazing dairy cows during the transition period. 
 
 
 
 
 
 FO*CU 
    
 
FO1  CU2  SlowBCS  FastBCS 
 
p-value 
 
Slow 
BCS 
Fast 
BCS 
 
Feed 
65 
Feed 
90 
Feed 
120 
 
Feed 
65 
Feed 
90 
Feed 
120 
 
Feed 
65 
Feed 
90 
Feed 
120 
SEM3 FO CU 
FO*C
U 
FA 
(mmol/L) 
0.761a 0.671b  0.780a 0.747a 0.621b  0.840 0.771 0.673  0.720 0.723 0.568 0.054 0.04 0.01 0.77 
BHB 
(mmol/L) 
0.558 0.520  0.552 0.536 0.529  0.580 0.563 0.531  0.523 0.510 0.527 0.031 0.13 0.75 0.62 
Cholestero
l (mM) 
2378 2285  2440 2377 2178  2467 2437 2230  2413 2316 2127 264 0.62 0.46 0.99 
1 FO = Far-off feeding management. Cows that were dried off at a lower BCS than optimal (0.75-1.00 unit lower) were overfed to quickly reach 
optimal calving BCS at 5wk prepartum, hence FastBCS, While animals that were dried closer to optimal (<0.25 unit than optimal) were fed to 
maintenance to slowly reach calving BCS at 5wk prepartum, hence SlowBCS 
2 CU = close-up feeding management; Feed65, Feed90, and Feed120 were fed to reach 65, 90, and 120% of estimated ME requirements, 
respectively   
3 SEM = greatest standard error of the mean. 
a,b,c = significant difference among groups (P < 0.05) 
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Table 6.7. Effect of far-off and close-up feeding management, and time on plasma concentrations of fatty acids (FA), β-
hydroxybutyrate (BHB), and cholesterol in grazing dairy cows during the transition period. 
 
  
  
FO*T3  CU*T4 
 
p-value 
  Wk1 T2 SlowBCS FastBCS  Feed65 Feed90 Feed120 SEM5 T FO*T CU*T FO*CU*T 
FA 
(mmol/L) 
-1 0.653x 0.705 0.602  0.893a,x 0.690b,x 0.377c,x 0.064 < 0.01 0.89 < 0.01 0.55 
1 1.001y 1.034 0.969  0.989x 1.018y 0.997y 
4 0.493z 0.546 0.440  0.458y 0.534z 0.488x 
BHB 
(mmol/L) 
-1 0.455x 0.494 0.416  0.557a,x 0.459b,x 0.350c,x 0.036 < 0.01 0.23 < 0.01 0.41 
1 0.646y 0.665 0.626  0.626x 0.634y 0.677y 
4 0.516z 0.514 0.517  0.472y 0.516x 0.560z 
Cholesterol 
(mM) 
-1 2860x 2992 2728  3286a,x 2831ab,x 2463b 287 < 0.01 0.38 0.04 0.60 
1 2039y 2172 1907  2351y 1808y 1959 
4 2095y 1969 2221  1682a,z 2490b,xy 2113ab 
1 Wk = week relative to parturition 
2 T = time 
3 FO = Far-off feeding management. Cows that were dried off at a lower BCS than optimal (0.75-1.00 unit lower) were overfed to quickly reach optimal 
calving BCS at 5wk prepartum, hence FastBCS, While animals that were dried closer to optimal (<0.25 unit than optimal) were fed to maintenance to slowly 
reach calving BCS at 5wk prepartum, hence SlowBCS 
4 CU = close-up feeding management; Feed65, Feed90, and Feed120 were fed to reach 65, 90, and 120% of estimated ME requirements, respectively   
5 SEM = greatest standard error of the mean. 
a,b,c =  significant difference among groups within the same week relative to parturition (P < 0.05) 
x,y,z =  significant difference among time points, within group (P < 0.05) 
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CHAPTER 7: HEPATIC ONE-CARBON METABOLISM AND TRANSSULFURATION 
PATHWAY ENZYME ACTIVITY AND INTERMEDIATE METABOLITES ARE 
ALTERED TO DIFFERENT EXTENTS BY PREPARTUM BODY CONDITION SCORE 
AND PLANE OF NUTRITION IN GRAZING DAIRY COWS 
 
ABSTRACT 
Alterations in activity and intermediates of the hepatic one-carbon metabolism pathways 
were evaluated in 28 pregnant and non-lactating grazing dairy cows of mixed age and breed. 
They were randomly allocated to 1 of 4 treatment groups in a 2 × 2 factorial design: 2 prepartum 
body condition score (BCS) categories [4.0 (thin) and 5.0 (optimal); 10-point scale], and 2 levels 
of energy intake during the 3 wk preceding calving (75% or 125% of estimated requirements). 
Liver tissue was collected by biopsy at −7, 7, and 28 d relative to calving. Tissue samples were 
used for 14C radio-labeling assays to measure betaine-homocysteine S-methyltransferase 
(BHMT), 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR), and cystathionine-
β-synthase (CBS) activity. Liver metabolomics was undertaken using a targeted GC/MS-based 
profiling approach. Enzyme activity and metabolite area under the curve (AUC) were normalized 
with the homogenate protein concentration, and subjected to repeated measures ANOVA via 
PROC MIXED in SAS, with BCS, Feeding, and Time as fixed effects, and cow as random 
effect. All enzymes were affected by time, with BHMT activity peaking at 7 d, while CBS and 
MTR activity decreased post-partum. Overall, thin cows had greater MTR activity, while cows 
fed 125% requirements had greater CBS activity. An interaction was detected between BCS and 
feeding for CBS activity, as thin cows fed 125% of requirements had greater overall activity. 
Compared with liver from BCS 4 cows, BCS 5 cows had overall greater betaine, glycine, 
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butyrobetaine/acetylcholine, serine, and taurine concentrations. The same metabolites, plus 
choline, and N-N-dimethyl glycine, were overall greater in liver of cows fed 75% compared with 
those fed 125% of requirements. An interaction of BCS and feeding level was detected for the 
aforementioned metabolites plus methionine, cystathionine, cysteinesulfinate, and hypotaurine, 
due to greater overall concentrations in BCS 5 cows feed 75% of requirements compared with 
other groups. Overall, the present data highlight a potentially greater capacity in grazing cows to 
regenerate methionine from folate compared with cows in confinement systems, based on 
published data. The lower MTR and CBS activity postpartum could be associated with the 
greater abundance of antioxidant precursors in pasture. However, the differences in MTR and 
CBS activity and intermediate metabolites suggest that both BCS and feeding level can alter the 
internal antioxidant system (e.g., glutathione and taurine) throughout the periparturient period. 
The data support the need for differential management prepartum based on adiposity: feed 
restricting optimally conditioned cows while allowing a higher overall nutrient intake for thin 
cows via stocking rate manipulation. 
 
INTRODUCTION 
 The advantage of a pasture-based dairy system is centered around the low cost of pasture 
compared with more controlled total mixed ration (TMR) systems, based on conserved forages 
and concentrates. For their profitability, however, grazing systems depend on high levels of 
pasture production, and on the efficiency with which cows are able to harvest it (Kolver, 2003). 
This is achieved by managing stocking rate (e.g., number of cows per pasture area), calving 
times in seasonal systems, and conservation and supplementation of feeds (Holmes et al., 1987, 
Roche et al., 2017). 
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Regarding periparturient or “transition” dairy cows, the research focus has been on 
energy nutrition (Roche et al., 2017), as intake of energy in pasture systems is a major limiting 
factor for milk production (Kolver, 2003). On the other hand, protein supply in pasture-based 
diets, both in terms of quantity and quality, has always been considered adequate. More than 30 
years ago, Beever and Siddons (1986) suggested that milk production in grazing systems might 
also be limited by duodenal protein supply; however, when tested, this hypothesis yielded mixed 
results. Researchers looking at New Zealand pasture-based systems suggested that MP supply 
was adequate in grazing dairy cows, as their milk production did not respond to supplementation 
with undegraded dietary protein (Brookes, 1984, Penno and Carruthers, 1995). Similar earlier 
studies by Rogers et al. (1980) and Minson (1981) reported enhanced milk yield under a similar 
type of protein supplementation scheme, suggesting that MP supply from ryegrass pastures 
might be insufficient to maximize milk production.  
Regarding specific amino acid supply, lysine and methionine supply is a well-known 
limiting factor for milk production in high-producing confinement systems, while in pasture-
based systems, their supplementation has not proven effective (Pacheco-Rios et al., 1997, Rusdi 
and van Houtert, 1997). These amino acid limitations will, in fact, only affect production if there 
are no other first-limiting nutrients. Since energy intake is the first-limiting nutrient in milk 
production in grazing systems, supplementation of high-quality pasture would first need to 
correct the deficiency in energy rather than amino acid supply (Roche, 2017). This can also 
explain the inconsistent results from rumen undegradable protein supplementation studies. 
In our recent work (Vailati-Riboni et al., 2016) we identified hepatic transcriptomic 
changes related to the methionine cycle (e.g., folate biosynthesis, one-carbon pool by folate, and 
vitamin B6 metabolism) when underconditioned cows were allowed a higher pasture area 
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prepartum, thus, increasing their overall energy supply. The changes detected in these three 
pathways seemed to indicate a greater flux through the one-carbon metabolism and the 
methionine cycle, with a potential increase in the availability of methionine and antioxidants. 
Together with the increase in activation of ‘taurine and hypotaurine metabolism’ during early 
lactation in those animals, these results suggested a link between amino acid metabolism and 
energy intake, together with a beneficial alteration of methionine metabolism via prepartal 
energy intake manipulation. 
To better understand the activity and flux through the one-carbon metabolism, 
methionine cycle, and transsulfuration pathway in response to prepartum feed allowance and its 
interaction with body condition score (BCS), we measured the activity of 3 key enzymes: (i) 
betaine homocysteine methyltransferase (BHMT), which regulates the use of choline in the re-
methylation of homocysteine, thus, regenerating methionine; (ii) 5-methyltetrahydrofolate-
homocysteine methyltransferase (MTR), responsible for the methylation of homocysteine to 
regenerate methionine via the folate pathway; and (iii) cystathionine β-synthase (CBS), which 
channels homocysteine out of the cycle to generate glutathionine or taurine as important 
antioxidants. Furthermore, we also measured abundance of genes and concentration of 
metabolites involved in these pathways. 
 
MATERIAL AND METHODS 
Animal Management 
Complete details of the experimental design are published elsewhere (Roche et al., 2015). 
Briefly, a group of 150 mid-lactation grazing dairy cows of mixed age and breed were enrolled 
in the experiment on 21st January 2013. Animals were allocated randomly to one of six treatment 
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groups (25 cows per group) in a 2 × 3 factorial arrangement: two pre-calving BCS categories 
(4.0 and 5.0, BCS4 and BCS5; based on a 10-point scale, where 1 is emaciated and 10 obese; 
Roche et al. 2004)  and three levels of energy intake during the three wk preceding calving (75, 
100, and 125% of estimated requirements; (Roche et al., 2004)(Roche et al., 2004)(Roche et al., 
2004)(Roche et al., 2004)(Roche et al., 2004)(Roche et al., 2004). The different levels of energy 
intake were obtained by daily manipulation of pasture allowance, adjusting area allocation 
(m2/cow) in each group. Cows were randomly assigned to the six groups, balanced for age, breed 
(Holstein and Holstein  Jersey), BCS at the time of enrolment, and expected calving date. For 
the current study, only four groups, with a subset of 24 animals (6 cows per group), were 
considered. These were cows with prepartum BCS4 fed to meet 75 (B4F75) or 125 (B4F125) % 
of requirements, and cows with prepartum BCS5 fed to meet 75 (B5F75) or 125 (B5F125) % of 
requirements. The subset groups were still balanced for breed, age, and calving date. Average 
age and days in gestation ± SD at enrolment was 6.20 ± 2.18 years, and 259.32 ± 1.86 d, 
respectively. 
The intermediate groups in both BCS classes (B4F100 and B5F100) were omitted from 
the present analysis as feeding to the exact requirements is rarely achievable in field conditions. 
In practice, multiple factors (e.g., pasture management and allocation, animal competition, and 
social interaction) result in cows being mostly overfed or underfed. 
Sample Collection 
Liver tissue was collected via percutaneous biopsy under local anesthesia at -7, 7, and 28 
d relative to parturition. Tissue samples were immediately snap frozen in liquid nitrogen and 
stored at -80°C until further analysis. 
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Enzyme Activity Assays 
Enzyme activity assays were performed as previously described (Zhou et al., 2017). 
Briefly, BHMT activity was measured as described by Garrow (1996). MTR activity was 
determined on the basis of Banerjee et al. (1997). CBS activity was determined on the basis of 
Lambert et al. (2002), except that the separation of 14C-cystathionine from 14C-Ser was done 
according to Taoka et al. (1998). Enzyme assay details are reported in Supplemental Methods. 
Metabolomics 
About 100 mg of frozen tissue was extracted by the two-step protocol described by Wu et 
al. (2008). Targeted metabolomics (LC-MS) was performed to quantify metabolites related to the 
one carbon metabolism and the transsulfuration pathway (Table 7.1). Samples were analyzed 
with the 5500 QTRAP LC/MS/MS system (Sciex, Framingham, MA). Software Analyst 1.6.2 
was used for data acquisition and analysis. The 1200 series HPLC system (Agilent Technologies, 
Santa Clara, CA) includes a degasser, an autosampler, and a binary pump. The LC separation 
was performed on a Phenomenex C18 (2) column (4.6  150mm, 5 μm. Torrance, CA) with 
mobile phase A (10 mM ammonia formate) and mobile phase B (methanol). The flow rate was 
0.4 mL/min. The linear gradient was as follows: 0-1min, 95% A; 8min, 50% A; 15-18min, 0% 
A; 18.1-26min, 95% A. The autosampler was set at 10°C. The injection volume was 10 μL. Mass 
spectra were acquired under both positive (ion spray voltage was +5500 V) and negative (ion 
spray voltage was -4500 V) electrospray ionization (ESI). The source temperature was 500°C. 
The curtain gas, ion source gas 1, and ion source gas 2 were 35, 65, and 55, respectively. 
Multiple reaction monitoring (MRM) was used for quantitation. Before statistical analysis, the 
area under the curve (AUC) was normalized by the protein concentration of the samples. 
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RNA isolation, cDNA Synthesis, and Quantitative PCR 
Total RNA was isolated from 100 mg of tissue using the miRNeasy kit (Qiagen) 
following the manufacturer’s protocols. Samples were treated on-column with DNaseI (Qiagen); 
quantification was accessed using the NanoDrop ND-1000 (NanoDrop Technologies), and RNA 
quality was measured using an Agilent 2100 Bioanalyzer (Agilent). The qPCR was performed as 
described previously (Vailati Riboni et al., 2016). Before statistical analysis, normalized (against 
internal control genes) gene relative abundance was log2 transformed to ensure a normal 
distribution. 
Statistical Analysis 
Enzyme activity (U · mg protein-1, or nmol product · h-1 · mg protein-1), mRNA 
abundance (log2 relative abundance), and metabolite relative concentrations (AUC · mg protein
-
1) were subjected to repeated measures ANOVA in SAS using the PROC MIXED procedure. 
BCS (B, 4 or 5), feeding (F, 75 or 125%), time (T, -1, +1, +4 wk from parturition), and their 
interactions (B*F, B*T, F*T, B*F*T) were used as fixed effects. Cow nested in group (B*F) was 
the random effect. The Kenward Roger statement was used to compute the degrees of freedom, 
and spatial power was used as covariance structure for the repeated measurement. Normality of 
the residuals was checked via PROC UNIVARIATE. Data for fumarate, NAD+, NADH, 
NAD+:NADH, adenosine, and cysteinesulfinate were log2 transformed to obtain normality. All 
other data were normally distributed. Metabolite data reported in tables and graphs were properly 
back-transformed to aid in their interpretation. mRNA abundance data were back-transformed 
only in tables, and kept as log2 relative mRNA abundance for figures. Statistical significance was 
determine at P ≤ 0.05, while tendencies were considered at P ≤ 0.10. 
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RESULTS 
One-Carbon Metabolism 
Enzyme activity. There was no statistical effect of BCS, feeding, or their interaction on 
BHMT activity (P > 0.05), which was, however, affected by time, with greater activity (1 vs -1 
wk, P = 0.02; 4 vs -1, P = 0.07) postpartum compared with prepartum (Table 7.2, Figure 7.1). 
The significant interaction (F*T, P = 0.05) between feeding level and time indicated that cows 
fed to 75% of requirements had stable BHMT enzyme activity throughout the transition period, 
while  cows overfed to 125% of requirements experienced an increase in activity postpartum. 
Furthermore, compared with overfed, restricted cows tended (P = 0.07) to have greater activity 
prepartum. MTR activity was influence by time (P < 0.0001), but with an opposite trend. 
Activity was, in fact, highest prepartum and then decreased over time (-1 vs 1 wk, P = 0.06; -1 vs 
4 wk, P < 0.0001). Feeding strategy did not statistically alter its activity, but thin animals (BCS 
4) had a lower (P = 0.001) activity of MTR compared with optimally conditioned cows (BCS 5). 
mRNA abundance. Abundance of MAT2A and MTR was stable over time (T, P > 0.05; 
Table 7.3), while BHMT1 followed the enzyme activity trend, with greater (P < 0.05) abundance 
postpartum compared with prepartum (Table 7.3, Figure 7.2). Abundance of MAT2A was greater 
in optimally conditioned cows (B, P = 0.004), while no statistical effects of BCS (P > 0.05) were 
identified for BHMT1 and MTR. Overfeeding animals prepartum induced an overall lower 
abundance of both MAT2A and MTR (F, P < 0.05), but not BHMT1 (P > 0.05). No statistical 
interaction of BCS and feeding (B*F, P > 0.05) was recorded for these genes related to the one-
carbon metabolism. Three-way interactions were detected for all three genes (B*F*T, P < 0.05). 
Metabolomics.  A time effect existed for all metabolites (T, P < 0.05; Table 7.4). Except 
for adenosine and S-5’-adenosyl-homocysteine, whose concentrations decreased (P < 0.05) 
188 
 
postpartum, all metabolites in this pathway increased (P < 0.05) in concentration postpartum 
compared with prepartum (Table 7.4, Figure 7.3). Compared with thin cows, optimally-
conditioned cows had greater (B, P < 0.05) concentrations of betaine, carnitine, choline, glycine, 
and butyrobetaine/acetylcholine in liver tissue. Compared with feed restriction, overfeeding 
decreased (F, P < 0.05) the concentration of these metabolites, overall, including that of N,N-
dimethylglycine (N,N-DG). Interactions of BCS and feeding (B*F, P < 0.05) were detected for 
betaine, choline, glycine, methionine, N,N-DG, and butyrobetaine/acetylcholine. Compared with 
all other groups, betaine, choline, carnitine, glycine, and N,N-DG concentrations were greatest 
(B*F, P < 0.05) in feed restricted, optimally-conditioned cows. The peak concentration of 
methionine was, instead, detected for B5F75 and B4F125 cows, while 
butyrobetaine/acetylcholine was greatest in B5F75 cows, followed by B5F125, and then both 
BCS 4 groups.   
Interactions of BCS and feeding with time were detected for carnitine, glycine and 
butyrobetaine/acetylcholine (B*T, F*T, P < 0.05; Table 7.4, Figure 7.3). Overall, BCS5 
compared with BCS4 or feed restricted compared with overfed cows had greater postpartal 
carnitine concentrations at 4 wk. Feed restricted cows also had greater (P < 0.05) levels of 
carnitine prepartum (-1 wk). Concentrations of glycine in BCS4 and BCS5 cows were similar at -
1, and 1 wk relative to calving, but differed at 4 wk postpartum, with greater values in BCS5 
cows. Similarly, cows feed-restricted and overfed had similar concentrations of glycine at -1 and 
1 wk relative to parturition, but feed restricted animals had higher glycine 4 wk from calving. 
Regarding butyrobetaine/acetylcholine, compared with BCS4, concentration was greater in 
BCS5 cows both prepartum and at 4wk postpartum. Similar concentrations were detected at 1wk 
postpartum between the two BCS groups. Feeding level had no statistical effect at -1 and 1 wk 
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from parturition, but affected butyrobetaine/acetylcholine concentrations at 4 wk from calving, 
with restricted cows having greater concentrations compared with overfed cows. A three way 
interaction (B*F*T, P < 0.05) was identified for butyrobetaine/acetylcholine, carnitine, glycine, 
and N,N-DG. 
Transsulfuration pathway 
Enzyme activity. Similar to MTR, CBS activity was lower postpartum (T, P < 0.05) 
compared with prepartum levels (Table 7.2, Figure 7.1). BCS did not statistically affect its 
activity overall (B, P = 0.23), but compared with feed restricted cows, overfed cows had greater 
overall CBS activity (F, P < 0.0001). The significant interaction between BCS and feeding (B*F, 
P = 0.004) indicated that overfeeding led to greater CBS activity, mostly in thin cows (BCS 4) 
and not in optimally conditioned cows (BCS 5).  
mRNA abundance. Compared with prepartum levels, abundance of CSB, GCLC, and 
GSS was lower (T, P < 0.05) early postpartum (1 wk) (Table 7.3, Figure 7.2). Abundance for 
these 3 genes remained lower later postpartum (4 wk), but GSS returned to its prepartum level of 
abundance. No overall statistical effect of BCS, feeding, or their interaction was evident for 
genes involved in the transsulfuration pathway.  Interaction of feeding and time was significant 
for CSAD and GSS abundance (F*T, P < 0.05).  Compared with overfed cows, CSAD abundance 
was greater (P = 0.04) prepartum in feed restricted cows. Early postpartum its abundance was 
similar, but late postpartum feed restricted had lower (P = 0.01) CSAD abundance compared with 
overfed cows. An opposite trend was detected for GSS abundance, with feed restricted cows 
having greater abundance prepartum, followed by lower abundance late postpartum when 
compared with overfed cows. A three way interaction (B*F*T, P < 0.05) was identified for CBS 
and GSS expression. 
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Metabolites. Time affected (T, P < 0.05) concentrations of cystathionine, hypotaurine, 
and serine, with higher levels 4 wk postpartum compared with earlier times (Table 7.4, Figure 
7.4). Overall effects of BCS and feeding were detected only for serine, whose concentration was 
greater in BCS5 (B, P = 0.02) or feed restricted (F, P = 0.001) cows. The interaction of BCS and 
feeding was significant for all metabolites measured (B*F, P < 0.05). Overall, compared with 
other groups, feed restricted optimally-conditioned cows had the greatest (P < 0.05) 
concentrations of cystathionine and serine. Concentration of cysteine sulfonate was greatest (P < 
0.05) in overfed thin and feed restricted optimally-conditioned cows, while hypotaurine was 
greatest (P < 0.05) for B5F75 compared with B4F75 and B5F125 cows. Cows in B4F125 had an 
intermediate concentration of hypotaurine. An interaction of BCS and time was detected for 
cystathionine (B*T, P = 0.05), but no difference between BCS groups were detected at any time 
point. Only a tendency (P = 0.07) for greater concentration of cystathionine in BCS5 compared 
with BCS4 cows at 4 wk postpartum was detected. The interaction of feeding and time was 
significant for all metabolites measured in the transsulfuration pathway (F*T, P < 0.05). For all 
metabolites, there were no statistical differences between feeding levels at 1 wk postpartum (P > 
0.05). In contrast, prepartum, overfeeding compared with feed restriction tended (P < 0.10) to 
increase concentrations of cystathionine, cysteinesulfinate, and hypotaurine, but not serine (P > 
0.10). It is noteworthy that late postpartum (4 wk) overfeeding compared with feed restriction led 
to lower (P < 0.05) concentrations of all metabolites.  A three way interaction (B*F*T, P < 0.05) 
was detected for serine. 
Energy Metabolism 
Differences due to time were detected for the concentrations of FAD, fumarate, 
glutamate, NAD+, and NADH, and NAD+:NADH ratio (T, P <0.05; Table 7.4, Figure 7.5). 
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Concentrations of FAD increased linearly over the transition period, while fumarate 
concentrations increased to a stable level postpartum. Compared with prepartal concentrations, 
glutamate tended (P = 0.09) to be higher around parturition, and increased later in the transition 
period. In contrast, concentrations of NAD+ and NADH decreased (P = 0.001) during the 
transition period, with the first being stable around calving and declining at 4 wk postpartum, 
and the latter decreasing after calving to stable levels throughout the postpartal period. In 
contrast, their ratio increased postpartum, with peak levels right after parturition. Overall, 
optimally conditioned cows had a greater concentration (B, P <0.05) of FAD, and glutamate, and 
lower (B, P = 0.002) concentration of -ketoglutarate compared with thin cows. Feed restriction 
caused an increase (F, P < 0.05) in concentrations of FAD, and glutamate. A BCS and feeding 
interaction was detected (B*F, P < 0.05) for FAD, glutamate, and glutamine, as feed restricted, 
optimally conditioned cows had greater concentrations of these metabolites compared with other 
cows. 
Interactions between BCS and time were detected for FAD and glutamine (B*T, P < 
0.05), with BCS5 cows having greater postpartal concentrations of these metabolites at 1 and 4 
wk compared with BCS4 cows, and also at 1 wk prepartum (Table 7.4, Figure 7.5). FAD, 
glutamine, glutamine, and NAD+:NADH ratio also had a significant interaction between feeding 
and time (F*T, P < 0.05). Compared with overfed cows, feed restricted cows had greater (P < 
0.05) concentrations of glutamine and FAD postpartum (1 and 4 wk), and greater (P < 0.05) 
concentrations of glutamate late postpartum (4 wk). The NAD+:NADH ratio was greater 
prepartum in feed restricted animals, but greater at 1 wk postpartum in overfed cows. A similar 
ratio between feeding groups was evident at the end of the transition period. A three way 
interaction was detected for FAD, and NAD+:NADH ratio (B*F*T, P < 0.05). 
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DISCUSSION 
The Transition Period 
The one-carbon metabolism pathway comprises a network involving interactions between 
several B vitamins, homocysteine, and methionine. Its function is not limited to the regeneration 
of methionine via remethylation of homocysteine (e.g., BHMT, and MTR), as methionine is 
further converted to S-adenosyl-methionine (SAM). This step increases the functions of the one-
carbon metabolism, as methyl groups in SAM can be donated to form a wide-range of vitally 
important methylated compounds including creatine, epinephrine, and sarcosine, as well as 
methylated DNA, RNA, and proteins (Ducker and Rabinowitz, 2017). The one-carbon 
metabolism further connects to the animal’s antioxidant system via the transsulfuration pathway. 
Homocysteine together with serine are, in fact, used as substrates by CBS to generate 
cystathionine and then cysteine, leading to the synthesis of both glutathione and taurine, 
powerful cellular antioxidants. 
The onset of lactation in dairy cows is characterized by high output of methylated 
compounds in milk when sources of methyl group are in short supply, even at the cost of 
depleting reserves of these compounds in liver tissue (Pinotti et al., 2002). Together with the 
well-known challenges of the transition period (e.g., negative energy and metabolizable protein 
balance), a negative methyl-donor balance could be an additional nutritional challenge of the 
peripartal dairy cow. At the same time, the overproduction of reactive oxygen species (ROS) 
leads to oxidative stress, which has been identified as an underlying factor of dysfunctional 
inflammatory responses (Abuelo et al., 2015), underlying the importance of the transsulfuration 
pathway in keeping an adequate supply of antioxidants. The work of Zhou et al. (2017) 
highlighted the importance of one-carbon metabolism in transition dairy cows reared in intense 
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TMR-based confinement systems. They reported a 130% and 26% increase of the hepatic 
activity of BHMT and MTR, respectively, around parturition, and a similar response (+72%) in 
BHMT hepatic abundance, but no changes in MTR abundance. Similarly, they reported a 20 and 
13% increase in hepatic CBS activity and abundance, respectively, postpartum, when compared 
with prepartum. 
Compared with their counterparts in confinement feeding systems, pasture-based systems 
utilize cows genetically selected with more emphasis on fertility and body condition score, and 
less on milk production. However, despite the lower milk production, the physiological and 
immunological dysfunction during the transition period in grazing dairy cows appears to be of 
similar magnitude to the higher producing TMR-fed counterparts (Kay et al., 2015). This said, 
our data appear to underscore fundamental differences in the one-carbon and transsulfuration 
pathway activity between the two systems. For instance, BHMT activity and mRNA abundance 
were the only parameters in pasture cows that resembled the trends reported in confinement 
systems. However, activity values, despite being similar prepartum, were half of those identified 
previously in TMR-fed cows (Zhou et al., 2017). The identified increase in BHMT activity was 
accompanied by an increase in concentrations of N,N-DG and choline, the products of the 
reaction, suggesting an increase in flux through the enzyme. The increase in concentrations of 
choline and butyrobetaine/acetylcholine, which feed betaine to BHMT, suggests they might have 
driven the increase in enzymatic activity. Despite the increase in concentrations of metabolites 
supplying substrates to MTR (e.g., folate, glycine, serine), its activity decreased postpartum; this 
is contrary to what was reported in TMR-fed cows (Zhou et al., 2017). Furthermore, the 2 to 3-
fold greater activity prepartum and early postpartum in pasture fed cows suggested a more 
important role of this enzyme in grazing animals probably due to the high concentration of folate 
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in their diet, a precursor of 5-methyl-tetrahydrofolate and substrate of MTR, which is abundant 
in green leafy forage (Dong and Oace, 1975). 
Concerning the transsulfuration pathway, the fact that homocysteine was undetectable, 
and that we detected a greater concentration of its metabolites (e.g., cystathionine, hypotaurine, 
serine) led us to speculate an increased flux postpartum. However, contrary to what was reported 
in TMR-based systems (Zhou et al., 2017), the activity and abundance of CBS decreased 
postpartum. Furthermore, in grazing cows activity values were close to half of those in higher-
producing TMR-fed cows. Despite an extensive review of the literature concluding that grazing 
cows undergo a similar degree of peripartal physiological dysfunction than high-producing 
animals in TMR-systems (Roche et al., 2013), the substantial differences in BHMT, MTR, and 
CBS activity suggest a different load on the metabolic activity of the one-carbon metabolism and 
transsulfuration pathways. The unique trends during the transition period between systems might 
be explained by the difference in demand for lactation (e.g., lower milk production) and in 
nutrient intake. 
Regarding energy status, the decrease in NAD+ and NADH detected after calving was of 
particular interest. Our previous transcriptomic data indicated an increase in the activity of the 
“Nicotinate and nicotinamide metabolism” postpartum (responsible for the nicotinamide adenine 
dinucleotides family synthesis) in thin animals when overfed prepartum (Vailati-Riboni et al., 
2016). The NAD+ molecule plays a most-important role, as it is necessary to maintain hepatic 
fatty acid oxidative capacity, which is crucial after parturition when fat depot mobilization 
increases markedly (Schulz, 1991). The general decrease in concentrations of both NAD+ and 
NADH postpartum suggested a lower energy status and possibly an impaired capacity to handle 
the flux of fatty acids arising from mobilization of fat depots. The fact that NAD+:NADH ratio 
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increased postpartum, peaking right after calving, indicated that cows were able to maintain a 
higher level of reduced substrate to handle the increased demand for fatty acid β-oxidation. The 
rapid decrease of these molecules postpartum could be connected to the increased output of their 
precursors in milk. In fact, bovine milk is among the richest dietary sources of nicotinamide, 
tryptophan, and nicotinamide riboside (Trammell et al., 2016).  
Prepartal Management 
 Manipulation of both prepartum cow adiposity and overall energy intake via pasture 
allocation (i.e., cow/m2) had a large impact on activity and expression of enzymes involved in 
the one-carbon metabolism, transsulfuration pathway, and TCA cycle, including their 
metabolism. Overall, data support the idea of greater flux of nutrients through these pathways in 
optimally conditioned cows and in cows that were feed restricted prepartum. Few exceptions 
have to be noted: MTR activity and α-ketoglutarate concentration were greater in thin cows, and 
CBS activity was greater in overfed cows, despite all its downstream metabolites having greater 
concentrations in feed restricted cows. The latter suggested a negative feed-back effect. Since 
these metabolic pathways are integrated with energy status, and countless studies have 
demonstrated that BCS, DMI, and energy balance around parturition can be altered by 
management (reviewed elsewhere, (Roche et al., 2009, Drackley and Cardoso, 2014)), we 
speculate that the differences highlight a better energy and overall nutritional status in BCS5 or 
prepartum feed restricted cows. As the major inputs of the one-carbon metabolism (e.g., folate, 
methionine, choline) are naturally present in significant quantities in green pasture (NRC, 2001), 
it is logical that a better energy status (e.g., through greater DMI) may have led to greater 
concentrations of intermediates of this cycle and its related pathways. 
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Concerning the BCS effects detected in the present study, a direct relationship with 
calving adiposity and postpartum DMI and negative energy balance (NEB) has been observed in 
grazing conditions. Thinner cows often have greater DMI and more positive NEB postpartum 
compared with fat cows (Roche et al., 2009). However, compared with optimally conditioned 
cows, thin cows have similar energy balance, but slightly lower DMI and greater muscle mass 
mobilization after calving (Pires et al., 2013). Furthermore, thinner cows are at a greater risk of 
being afflicted by diseases and often demonstrate signs of poorer welfare compared with 
optimally conditioned cows (Roche et al., 2009). Thus, we speculate that the greater 
concentrations of metabolites in the one-carbon, transsulfuration, and TCA cycle pathways in 
BCS5 compared with BCS4 cows indicate a better metabolic and health status. 
Despite lack of interactions of BCS and prepartal feeding regime for BHMT and MTR 
activity, and for mRNA abundance of all detected genes, the metabolites measured highlight a 
consistently greater flux throughout the one-carbon metabolism, methionine cycle and their 
related pathways in feed-restricted, optimally conditioned cows. These results confirm our 
previous hypothesis and recommendations regarding the use of separate prepartal nutritional 
strategies based on BCS at dry off.  Not many interactions were detected for thin animals, who 
compared with optimally conditioned cows, displayed the greatest response at a transcription 
level (Vailati-Riboni et al., 2016). However, the greater CBS enzyme activity in overfed BCS4 
cows, together with methionine, cysteinesulfinate, and hypotaurine concentrations comparable to 
those of feed restricted BCS5 cows, suggested a greater flux through the transsulfuration 
pathway. As such, optimally conditioned-feed restricted cows and thin-overfed cows were 
geared to better withstand the oxidative stress and inflammatory environment that characterizes 
the postpartum period. Furthermore, these results fit with our previous recommendation for 
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lower stocking density at pasture (e.g., increased feeding level) when managing thin cows 
prepartum (Vailati-Riboni et al., 2016). 
CONCLUSIONS 
The activity patterns over time of hepatic enzymes controlling one-carbon metabolism 
and transsulfuration pathway in grazing dairy cows highlight fundamental differences in the 
metabolic progression of these animals when compared with their counterparts reared in TMR-
based, higher yield, confinement systems. Grazing cows, in fact, seem to have a greater capacity 
to regenerate methionine from folate. The lower CBS activity, and its decrease over time, 
indicate that grazing cows have a lower grade of oxidative stress or a lesser need to support the 
internal antioxidant system (e.g., glutathione and taurine), possibly thanks to the abundance of 
vitamin A and E precursors in pasture. Furthermore, metabolic data support our previous 
hypothesis that cows with different levels of adiposity at dry off need to be managed differently 
in the prepartum; this can be achieved by feed restricting optimally conditioned cows, while 
allowing a higher overall nutrient intake for thin cows by increasing feed allowance by either 
decreasing stocking density or providing supplementary feeds. 
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TABLES AND FIGURES 
 
Table 7.1. List of metabolites analyzed via targeted metabolomics in liver tissue of cows with 
different prepartum body condition score (BCS 4 or 5, on a 10-point scale), and different feed 
allowance prepartum (75 or 125% of estimated energy requirements). 
 
Metabolites Detected 
Folic acid and methionine cycle  
5-methyltetradydrofolic acid No 
Adenosine Yes 
Betaine Yes 
Betaine aldehyde No 
Butyrobetaine/acetylcholine Yes 
Choline Yes 
Carnitine Yes 
Folic acid Yes 
Glycine Yes 
Homocysteine  
Methionine Yes 
N,N-dimethylglycine (N,N-DG) Yes 
N-methylglycine No 
S-5'-adenosyl-homocysteine (S-5-AH) Yes 
S-5'-adenosyl-methionine No 
Tetrahydrofolic acid No 
Transsulfuration pathway  
Cystathionine Yes 
Cysteine No 
Cysteinesulfinic acid Yes 
Glutathione No 
Hypotaurine Yes 
Serine Yes 
Taurine No 
Vitamin B12 No 
Vitamin B6 No 
γ-Glutamylcysteine No 
TCA cycle  
Acetyl-CoA No 
Adenosine monophosphate (AMP) No 
Adenosine triphosphate (ATP) No 
α-ketoglutaric acid (α-KG) Yes 
Cyclic adenosine monophosphate (cAMP) No 
Citrate No 
Flavin adenine dinucleotide (FAD) Yes 
Fumarate Yes 
Glutamate Yes 
Glutamine Yes 
Guanosine-5'-triphosphate (GTP) No 
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Table 7.1 (cont)  
  
Isocitric acid No 
Malate Yes 
NAD+:NADH Yes 
Nicotinamide adenine dinucleotide – oxidized form (NAD+) Yes 
Nicotinamide adenine dinucleotide – reduced form (NADH) Yes 
Nicotinamide adenine dinucleotide phosphate – oxidized form (NADP+) No 
Nicotinamide adenine dinucleotide phosphate – reduced form (NADPH) No 
Nicotinic acid No 
Pyruvate No 
Succinyl-CoA No 
Tri-methyl-lysine No 
Uridine diphosphate (UDP) No 
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Table 7.2. Activity (nmol product/h/mg protein) of betaine-homocysteine S-methyltransferase (BHMT), 5-methyltetrahydrofolate-
homocysteine methyltransferase (MTR), and cystathionine-β-synthase (CBS) at -1, 1, and 4 weeks around parturition (T) in liver 
tissue of cows with different prepartum body condition score (BCS 4 or 5, on a 10-point scale), and different feed allowance 
prepartum (F 75 or 125% of estimated energy requirements). 
 
       BCS*F  
           
 BCS  F  4 5  Time (T) 
 
P-value 
 4 5  75 125  75 125 75 125  -1 1 4 SEM1 BCS F BCS*F T BCS*T F*T BCS*F*T 
Folic acid and methionine cycle 
BHMT 15.83 14.76  15.10 15.49  15.37 16.30 14.84 14.68  13.69a 16.47b 15.73ab 1.13 0.33 0.72 0.62 0.06 0.99 0.05 0.69 
MTR 72.75a 39.15b  51.60 60.30  64.11 81.38 39.09 39.22  78.46a 57.14a 32.25b 9.30 <0.01 0.34 0.35 <0.0001 0.44 0.16 0.22 
Transsulfuration pathway 
CBS 22.61 20.27  16.02b 26.86a  14.15a 31.08c 17.89ab 22.65b  27.63a 20.52b 16.17b 2.01 0.23 <0.0001 <0.01 <0.0001 0.46 0.22 0.16 
1Largest standard error of the mean 
a,b,c Different superscripts indicate that means differ (P ≤ 0.05) 
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Table 7.3. Relative mRNA abundance of genes associated with the folic acid cycle, methionine cycle, and transsulfuration pathway at 
-1, 1, and 4 weeks around parturition (T) in liver tissue of cows with different prepartum body condition score (BCS 4 or 5, on a 10-
point scale), and different feed allowance prepartum (F 75 or 125% of estimated energy requirements). 
 
       BCS*F  
           
 BCS  F  4 5  Time (T) 
 
P-value1 
 4 5  75 125  75 125 75 125  -1 1 4 SEM1 BCS F BCS*F T BCS*T F*T BCS*F*T 
Folic acid and methionine cycle 
BHMT1 0.95 0.98  1.01 0.92  1.01 0.89 1.01 0.95  0.77a 1.10b 1.05b 0.09 0.72 0.26 0.72 0.003 0.43 0.93 0.02 
MAT2A 0.78a 0.92b  0.91a 0.79b  0.86 0.70 0.96 0.88  0.84 0.92 0.79 0.07 0.004 0.01 0.31 0.22 0.91 0.12 0.04 
MTR 1.16 1.12  1.26a 1.03b  1.29 1.04 1.23 1.02  1.12 1.13 1.16 0.05 0.37 <0.0001 0.59 0.78 0.96 0.16 0.02 
Transsulfuration pathway 
CBS 0.95 0.91  0.93 0.93  0.98 0.92 0.88 0.94  1.07a 0.86b 0.88b 0.06 0.39 0.93 0.23 0.02 0.99 0.17 0.02 
CDO1 0.75 0.72  0.74 0.72  0.76 0.74 0.72 0.71  0.75 0.74 0.71 0.04 0.45 0.69 0.86 0.53 0.73 0.09 0.45 
CSAD 0.97 0.88  0.99 0.87  1.16 0.81 0.84 0.93  0.82 0.96 1.02 0.18 0.55 0.41 0.15 0.24 0.90 0.002 0.23 
GCLC 0.80 0.66  0.78 0.68  0.91 0.70 0.66 0.66  1.06a 0.64b 0.56b 0.13 0.20 0.35 0.40 <0.0001 0.85 0.14 0.12 
GSS 0.94 0.98  0.93 0.98  0.97 0.91 0.90 1.06  1.00a 0.88b 1.01a 0.06 0.47 0.36 0.06 0.07 0.87 0.004 0.05 
1Largest standard error of the mean 
a,b,c Different superscripts indicate that means differ (P ≤ 0.05)  
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Table 7.4. Relative concentration [area under the curve (AUC) · mg protein-1] of metabolites in the folic acid and methionine cycle, 
transsulfuration, and energy metabolism pathways at -1, 1, and 4 weeks around parturition (T) in liver tissue of cows with different 
prepartum body condition score (BCS 4 or 5, on a 10-point scale), and different feed allowance prepartum (F 75 or 125% of estimated 
energy requirements). 
 
       BCS*F  
           
 BCS  F  4 5  Time (T) 
 
P-value 
Metabolite 4 5  75 125  75 125 75 125  -1 1 4 SEM1 BCS F BCS*F T BCS*T F*T BCS*F*T 
Folic acid and methionine cycle 
Butyrobetaine/acetylcholine 1528
a 2231b  2099a 1659b  1523a 1532a 2676c 1785b  1460a 1758a 2419b 149 <.0001 <.0001 <.0001 <.0001 0.01 0.02 0.005 
Adenosine 676 690  695 671  713 642 678 703  1521
a 671b 313c 307 0.93 0.89 0.78 <.0001 0.06 0.63 0.09 
Betaine 3082
a 3973b  4089a 2966b  3305a 2859a 4873b 3072a  2815a 3612ab 4155a 340 0.01 0.003 0.05 0.01 0.46 0.72 0.59 
Carnitine 967a 1307b  1351a 923b  1020a 913a 1682b 933a  884c 1081b 1446a 73 <.0001 <.0001 0.0001 <.0001 <.0001 0.04 0.0002 
Choline 574482
a 702855b  723915a 553422b  535837a 613128a 911993b 493716a  371518a 575745a 968742b 80123 0.10 0.03 0.003 <.0001 0.24 0.13 0.54 
Folate 344 381  376 350  318 370 433 329  178
a 386b 524b 62 0.53 0.66 0.19 0.0003 0.99 0.92 0.83 
Glycine 35897
a 45147b  47554a 33490b  34568a 37226a 60540b 29755a  20166a 35470b 65930c 3057 0.003 <.0001 <.0001 <.0001 0.002 <.0001 <.0001 
Methionine 41842 48255  48015 42082  30645
a 53039b 65385b 31125a  26103a 38237a 70804b 7124 0.36 0.39 0.0003 <.0001 0.50 0.17 0.09 
N,N-dimethylglycine 6407 7287  7574
a 6120b  6592a 6221a 8556b 6019a  5369a 6941b 8231b 568 0.11 0.01 0.05 0.0004 0.08 0.14 0.0003 
S-5'-adenosyl-homocysteine 21567 22993  24973 19587  23133 20001 26813 19173  29572
a 21988ab 15281b 4998 0.77 0.26 0.64 0.06 0.61 0.41 0.70 
Transsulfuration pathway 
Cystathionine 9122 11161  11226 9057  8653
a 9592a 13799b 8522a  6491a 7156a 16778b 1455 0.16 0.13 0.04 <.0001 0.09 0.001 0.15 
Cysteinesulfinate 265 310  275 298  161
a 436b 471b 204a  305 255 302 102 0.50 0.73 0.001 0.67 0.05 0.001 0.17 
Hypotaurine 2260 2570  2624 2206  1800
a 2720ab 3448b 1692a  1855a 1830a 3561b 457 0.47 0.34 0.01 0.001 0.96 0.002 0.70 
Serine 20965
a 24872b  25793a 20044b  20205a 21726a 31382b 18363a  16165a 20043a 32548b 1913 0.02 0.001 <.0001 <.0001 0.12 0.01 0.01 
TCA cycle                       
α-ketoglutarate 3859a 2572b  3451 2979  4100 3617 2802 2341  2695 3185 3765 398 0.002 0.21 0.98 0.08 0.39 0.07 0.08 
FAD 1234a 1510b  1604a 1140b  1300a 1169a 1908b 1111a  1131c 1317b 1668a 83 0.002 <.0001 0.0004 <.0001 0.04 <.0001 0.01 
Fumarate 5948 5300  5992 5261  5838 6060 6151 4566  4553b 6188a 6282a 684 0.30 0.24 0.14 0.04 0.70 0.58 0.40 
Glutamate 474799a 564473b  600389a 438883b  449666bc 499933b 751113a 377833c  369451b 463805b 725651a 39531 0.03 0.0002 <.0001 <.0001 0.13 0.004 0.15 
Glutamine 238 313  319 232  231a 245a 407b 220a  258 256 313 52 0.12 0.08 0.05 0.07 0.02 0.0004 0.06 
Malate 587237 472793  577446 482584  583124 591351 571769 373818  435528 562923 591595 61258 0.06 0.11 0.09 0.09 0.76 0.78 0.64 
NAD 1234 1465  1453 1244  1215 1253 1738 1235  2557a 1429a 665b 540 0.53 0.57 0.49 0.001 0.12 0.10 0.25 
NADH 679 1048  956 744  700 658 1305 842  1883a 754b 422b 440 0.15 0.41 0.53 0.001 0.10 0.32 0.77 
NAD:NADH 1.68 1.45  1.57 1.55  1.71 1.66 1.44 1.45  1.28c 1.93a 1.54b 0.31 0.27 0.94 0.91 0.004 0.44 0.002 0.01 
1Largest standard error of the mean 
a,b,c Different superscripts indicate that means differ (P ≤ 0.05) 
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Figure 7.1. Activity (nmol product/h/mg protein) of betaine-homocysteine S-methyltransferase 
(BHMT), 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR), and cystathionine-
β-synthase (CBS) at -1, 1, and 4 weeks around parturition (T) in liver tissue of cows with 
different prepartum body condition score (BCS 4 or 5, on a 10-point scale), and different feed 
allowance prepartum (F 75 or 125% of estimated energy requirements). 
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Figure 7.2. mRNA abundance of genes in the folic acid cycle, methionine cycle, and 
transsulfuration pathway at -1, 1, and 4 weeks around parturition (T) in liver tissue of cows with 
different prepartum body condition score (BCS 4 or 5, on a 10-point scale), and different feed 
allowance prepartum (F 75 or 125% of estimated energy requirements). a-dDifferent letters 
indicate that means differ (P ≤ 0.05). 
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Figure 7.3. Concentration [area under the curve (AUC)/mg protein] of metabolites in the folic 
acid and methionine cycle at -1, 1, and 4 weeks around parturition (T) in liver tissue of cows 
with different prepartum body condition score (BCS 4 or 5, on a 10-point scale), and different 
feed allowance prepartum (F 75 or 125% of estimated energy requirements). a-gMeans differ (P ≤ 
0.05). 
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Figure 7.4. Relative concentration [area under the curve (AUC)/mg protein] of metabolites in 
the hepatic transsulfuration pathway at -1, 1, and 4 weeks around parturition (T) in liver tissue of 
cows with different prepartum body condition score (BCS 4 or 5, on a 10-point scale), and 
different feed allowance prepartum (F 75 or 125% of estimated energy requirements). a-dMeans 
differ (P ≤ 0.05). 
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Figure 7.5. Relative concentration [area under the curve (AUC)/mg protein] of metabolites 
associated with hepatic energy metabolism at -1, 1, and 4 weeks around parturition (T) in liver 
tissue of cows with different prepartum body condition score (BCS 4 or 5, on a 10-point scale), 
and different feed allowance prepartum (F 75 or 125% of estimated energy requirements). a-
dMeans differ (P ≤ 0.05). 
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CHAPTER 8: CONCLUSIONS AND FUTURE PERSPECTIVES 
 
  
Proper management of the dairy cows during its peripartal period is of paramount 
importance for the productivity of the dairy industry and the welfare of the operating herds. This 
transitional period from the non-lactating to the lactating status, together with its own neonatal 
days, is in fact the highest risk stages in a dairy cow life cycle, capable of determining the 
outcome of its future lactation, reproduction potential, and health. The use of nonsteroidal anti-
inflammatory drugs (e.g., carprofen) injection postcalving to alleviate the well-documented 
underlying inflammatory status post calving did not produced positive effect on the animal 
health, fertility, and production. The possibility that the cows in our study (grazing 
Holstein*Jersey mix on a seasonal calving system) did not undergo a pronounced inflammatory 
state in early lactation (e.g., due to differences in production system and genetics) could have 
masked any positive effects of the treatment. 
Focus was then moved from pharmacological intervention postpartum to nutritional 
intervention prepartum tailored to the animal adiposity level measured through the assessment of 
body conditioned score (BCS), a procedure commonly practice in commercial herds. Feed 
restriction or increased feed allowance (75 vs 125 % of calculated metabolizable energy, 
respectively) managed through animal density (cow/m2 of pasture) was tested in thin or 
optimally conditioned animals. As hypothesized, the effect of prepartum plane of nutrition on 
hepatic function and adipose tissue metabolism was dependent on the BCS of the cow, 
underscoring how these management tools need to be evaluated together to optimize the 
biological adaptations of the cow during the peripartum period. Omics analysis of the liver 
transcriptome highlighted how thin animals were more susceptible to prepartal nutritional 
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management. Furthermore, pathways expression patterns, and metabolomics analysis suggested 
how overfeeding in late-pregnancy should be limited to thin cows, while cows with optimal 
adiposity should be maintained on an energy-restricted diet. Adipose tissue mRNA and 
microRNA expression further confirmed this hypothesis, and indicated a relationship between 
the immune and metabolic response of the adipose tissue underscoring the existence of a “self-
regulatory” mechanism, which can be modulated via nutritional strategies. Further supported by 
performance and blood profile data, New Zealand farmers, thought DairyNZ (the industry 
organization that represents all New Zealand dairy producers), are now instructed that optimally 
conditioned cows will benefit from a short-term (2–3 wk) controlled feed restriction (75–90% of 
requirements), whereas cows in less than optimal condition should be fed to requirements before 
calving. This is an easily implementable strategy based on pasture allocation capable of 
benefitting the farmer with a minimum cost. 
In a seasonal pasture based system, due to season fluctuation of pasture mass availability, 
cows are at greater risk to reach the end of lactation at a suboptimal level of adiposity; 
overfeeding thin animal at the end of their lactation is thus standard practice of the New Zealand 
production system. Our results suggested that to obtain a favorable transition to lactation, at least 
in grazing systems, dairy cows should be managed to achieve an optimal calving adiposity at 
close-up, providing confidence that over-feeding in the far-off nonlactating cow, as is customary 
in grazing systems, is not detrimental to the subsequent health of the cow. Afterwards animals 
should be maintained on a slight feed restriction until calving, following on the previously 
determined strategy of feed-restricting optimally condition animals. 
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Future perspective 
Across all three experiment undertaken to understand the effect of different peripartal 
strategies in grazing dairy cows one results was consistently observed: the existence of a 
mechanism linking the animal immune system to the metabolic homeorhetic adaptation during 
the cow transition to the new lactation. This is an arising concept observed in recent literature, 
with the recognition that a certain degree of inflammation is likely necessary to support the 
intricate adaptation in the transition period. Most notably, its role in the facilitation of parturition, 
through (i) influx of innate immune cells into the uterus lining which promotes its contraction, 
cervix dilation, rupture of the fetal membranes, and expulsion of the placenta. Similarly, our 
results support the role of innate cells (e.g., macrophages) infiltration in the cow adipose tissue 
around parturition to induce a localize inflammatory status aiming at the impairment of the tissue 
insulin sensitivity, allowing for the release of stored energy with the goal of covering the animal 
energy deficit typical of the postpartal period. This resembles mechanisms already observed in 
nature, including human adipose response in obese patient. 
The interface of immunity and tissue/organ metabolism is an emerging field of study. 
Relatively recent immunity and metabolism were considered separate entity, with the only link 
being metabolism as the simple source of energy for the immune system cellular components and 
function. Nowadays instead, the field of immunometabolism considers the role of immune cells 
in metabolism of organs and their effect on the whole organism metabolism, and the effect of 
specific metabolic pathways on immune cells functionality and the broader organism immunity. 
These concepts will have to be applied also to livestock physiological sciences, and specifically 
to dairy science to (i) better understand the immune system role during the transition period, and 
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(ii) redefine the maintenance requirements for a more complete nutritional management of the 
dairy cow. To the end future research goal will have to aim at: 
1. The understanding of the molecular mechanism that ignite the inflammatory processes 
around calving, and the identification of the cellular players involved in the signaling 
cascade. After either blocking (e.g., NSAID) or enhancing (e.g., pro-inflammatory 
molecules) the inflammatory scenario, scientist could combine targeted traditional 
approaches with more holistic technologies, such as transcriptomic, proteomic, and 
metabolomics to identify molecules, mediators, and targets involved in the immunometabolic 
adaptation to lactation. 
2. The effect that immune cells and inflammatory mediators have on specific organs at the 
center of peripartal metabolic adaptation. Response to similar immunological stimuli is 
different depending on the receiving system; if influx of immune cells in the uterus is aimed 
at the facilitating parturition and subsequent expulsion of placental and fetal lining tissues, 
influx in the adipose tissue appears to be linked to the organism energy metabolism. 
Furthermore, the role of liver residing immune cells (e.g., Kupffer cells) in the hepatic 
adaptation to lactation is still to be explored. Similarly, the role of immune cells (e.g., brain 
microglia) in the central nervous system regulation of feed intake in dairy animals is a 
potential aspect to consider in the complexity of ruminant physiology. As important part of 
animal protein metabolism, the involvement of muscle tissue and its possible link with 
immunity has also to be further investigated. 
3. The system network that link organ/tissue crosstalk as part of the physiological changes 
throughout the peripartal period. As organ/tissues secreted molecules (e.g., myokines, 
adipokines, hepatokines) are involved in the fundamental molecular mechanism that allows 
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communication amongst metabolic organs in the endocrine and metabolic system, immune 
cells can act as mediators of organs crosstalk.  
The pursuit of these lines of research will yield a greater understanding of the complex 
network of adaptation during the transition period, allowing future scientist to design 
nutritional and non-nutritional strategies to target specific node of this network aiming at the 
optimization of the dairy cow transition. As consumer scrutiny of the goods and feeds 
marketed by the dairy industry, including the strategies applied to produce such foods, has 
increased in today’s society, I believe that nutritional intervention (e.g., macro and 
micronutrients, bioactive compounds, pre and probiotics, phytonutrients) will become the 
norm as future preventative and prophylactic strategies to ensure food safety and security, 
while supporting animal productivity, health, and welfare.  
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APPENDIX A 
 
CHAPTER 3 - SUPPLEMENTAL MATERIAL 
 
RNA extraction and Real-Time Quantitative PCR (qPCR) 
 Liver RNA extraction. Liver tissue (30-50 mg) was homogenized in a TissueLyser II 
(Qiagen GmbH) for 2 x 2 min bursts at 30 Htz. Total RNA and DNA were extracted using a 
Qiagen AllPrep DNA/RNA mini kit (Qiagen GmbH) as per manufacturer’s instructions and 
RNA was treated with DNase (Ambion DNA-free kit; Ambion Inc., Austin, TX).  
 Adipose RNA extraction. Total RNA was extracted using Trizol® reagent (Life 
Technologies, New Zealand). Adipose tissue (30-80 mg) was placed in 1 mL of Trizol reagent 
and tissue was homogenized with a PRO200 homogeniser (Pro Scientific, CT, USA) using two 
20 sec bursts of the homogeniser at full speed (30,000 RPM) and placed on ice after any 
homogenisation. The homogeniser tool was rinsed between each sample twice with 75% 
molecular grade ethanol (Merk, Millipore, Darmstadt, Germany), and UltraPure™ 
RNAse/DNase-free distilled water (Life Technologies, CA, USA) and once with RNAseZap® 
(Life Technologies, USA). Choloroform was added to homogenised sample, centrifuged, and 
aqueous phase carefully removed. Precipitation of RNA was achieved with the addition of 
ispopropanol (Merk Millipore, Germany), and the subsequent RNA pellet was washed (with 75% 
ethanol), dried, resuspended in UltraPure™ RNAse/DNase-free distilled water and DNAse 
treated (Ambion DNA-free kit; Ambion Inc., Austin, TX).  
RNA quality evaluation. The RNA quantity, purity, and integrity were determined using a 
NanoDrop ND-1000 (NanoDrop Technologies Inc., Wilmington, DE) and the Agilent 2100 
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Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA). RNA samples were stored at -80 °C 
awaiting analysis. From the original set of samples, a subset of 10 animals per treatment was 
chosen based on RIN scores >7 for liver tissue and >6 for adipose tissue. After screening, 
average RIN scores for liver and adipose tissues were 7.50  0.39 and 6.59  0.58 respectively. 
 cDNA synthesis and qPCR performance. Genes selected for transcript profiling in liver 
tissue are associated with fatty acid oxidation (PPARA, CPT1A, ACOX1), growth hormone/IGF-
1 axis (GHR, IGF1, IGFALS, IGFBP1), liver-secreted hepatokines (FGF21, ANGPTL4), 
ketogenesis (HMGCS2), lipoprotein metabolism (MTTP, APOB), gluconeogenesis (PC, PCK1, 
PDK4), inflammation mediators (NFKB1, STAT3, XBP1), and acute-phase proteins (ALB, HP, 
SAA2, SAA3). In adipose tissue, the selected genes are associated with fatty acid metabolism 
(ADIPOQ, FASN, LEP, PPARA, PPARG, RXRA), acute-phase proteins (HP, SAA3), and 
inflammation (CCL2, CCL5, TLR4, IL6R, IL1B, IL6, TNFA). Complete information about primer 
sequences and qPCR performance are reported in Suppl. Table A.1-4. 
A portion of the RNA was diluted to 100 ng/μL with DNase/RNase-free water for cDNA 
synthesis through RT-PCR. To accommodate the analysis of all genes, per each sample cDNA 
was synthesized using 6 μL of diluted RNA, 6 μL of Random Primers (3 μg/μL; 
cat#11034731001, Roche) and 54 μL of DNase/RNase-free water. The mixture was incubated at 
65°C for 5 min and kept on ice for 3 min. A total of 54 μL of master mix, composed of 24 μL of 
5X First-Strand Buffer (cat#EP0441, Thermo Scientific), 6 μL of Oligo dT18 (Custom DNA 
Oligo Tubes, Integrated DNA Technologies), 12 μL of 10mM dNTP mix (cat#18427-088, 
Invitrogen), 1.5 μL of Reverse Transcriptase (200 U/μL as final concentration, cat#EP0441, 
Thermo Scientific), 0.75 μL of Rnase inhibitor (200 U/μL as final concentration, cat#EO0381, 
Thermo Scientific), and 9.75 μL of  DNase/RNase-free water, was added. The reaction was 
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performed in an Eppendorf Mastercycler Gradient following the appropriate temperature 
program: 25°C for 5 min, 42°C for 60 min, and 70°C for 5 min. The cDNA was then diluted 1:4 
(to a final volume of 480 μL) with DNase/RNase-free water, prior to Quantitative Polymerase 
Chain Reaction Analysis. 
Quantitative PCR was performed using 4 μL diluted cDNA combined with 6 μL of a mixture 
composed of 5 μL SYBR Green master mix (cat#95073-05K, Quanta BioSciences), 0.4 μL each 
of 10 μM forward and reverse primers, and 0.2 μL DNase/RNase free water in a MicroAmp™ 
Optical 384-Well Reaction Plate (Applied Biosystems). Each sample was run in triplicate and a 7 
point relative standard curve plus the non-template control were used. The reactions were 
performed in an ABI Prism 7900 HT SDS instrument using the following conditions: 2 min at 50 
°C, 10 min at 95 °C, 40 cycles of 15 s at 95 °C (denaturation), and 1 min at 60 °C (annealing + 
extension). The presence of a single PCR product was verified by the dissociation protocol using 
incremental temperatures to 95 °C for 15 s plus 65 °C for 15 s.  Data were calculated with the 
7900 HT Sequence Detection Systems Software. The final data were normalized using the 
geometric mean of three internal control genes (ICG): ACTB, GAPDH and RPS9 for adipose 
tissue (Ji et al., 2012; Khan et al., 2013), and GAPDH, RPS9 and UXT for liver tissue (Khan et 
al., 2014). 
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Suppl. Table A.1.  Accession number, gene symbol, and forward and reverse primer sequences 
of genes analyzed in liver tissue.  
 
 
 
Accession # Symbol Forward sequence Reverse sequence 
NM_001035289.3 ACOX1 ACCCAGACTTCCAGCATGAGA TTCCTCATCTTCTGCACCATGA 
BC151546.1 ALB AGTGCTGCACAGAGTCATTGGT GGCTTTGGGTACATATGTTTCATCA 
DQ355521.1 ANGPTL4 AGGAAGAGGCTGCCCAAGAT CCCTCTCTCCCTCTTCAAACAG 
XM_005895759.1 APOB CAAGGCTTTGTACTGGGTTAACG ACCATGTCCTGCTCATGTTTATCA 
FJ415874.1 CPT1A TCGCGATGGACTTGCTGTATA CGGTCCAGTTTGCGTCTGTA 
XM_001789587.2 FGF21 CAGAGCCCCGAAAGTCTCTTG AAAGTGCAGCGATCCGTACAG 
NM_001034034.2 GAPDH TGGAAAGGCCATCACCATCT CCCACTTGATGTTGGCAG 
JQ711177.1 GHR TCCAGCCTCTGTTTCAGGAG GCTGCCAGAGATCCATACCT 
NM_001045883.1 HMGCS2 TTACGGGCCCTGGACAAAT GCACATCATCGAGAGTGAAAGG 
NM_001040470.2 HP GGTTCGGAAAACCATCGCTA CACTCGTGTCCCCTCCCTC 
HQ324241.1 IGF1 CCAATTCATTTCCAGACTTTGCA CACCTGCTTCAAGAAATCACAAAA 
NM_001075963.1 IGFALS GCTGGTCCTGGCAGGTAACA TAGAGTTTCTGGAGCTTGGGCA 
NM_174554.3 IGFBP1 CCTGCCAGCGAGAACTCTACA TTGTTGCAGTTTGGCAGATAAAA 
NM_001101834.1 MTTP ACCAGGCTCATCAAGACAAAGTG GTGACACCCAAGACCTGATGTG 
BC153232.1 NFKB1 TTCAACCGGAGATGCCACTAC ACACACGTAACGGAAACGAAATC 
NM_177946.4 PC GCAAGGTCCACGTGACTAAGG GGCAGCACAGTGTCCTGAAG 
JQ733516.1 PCK1 AAGATTGGCATCGAGCTGACA GTGGAGGCACTTGACGAACTC 
NM_001101883.1 PDK4 CAGGTGGACAGGGCAGTCTAG TCCTCCTTTTCCATCTTTCTTCTTT 
NM_001034036.1 PPARA CATAACGCGATTCGTTTTGGA CGCGGTTTCGGAATCTTCT 
NM_001101152.2 RPS9 CCTCGACCAAGAGCTGAAG CCTCCAGACCTCACGTTTGTTC 
NM_001075260.2 SAA2 GACCAGTGCTCTCCTCCACTG CCCCTTCATAAGCCTCACCAA 
DQ298246.1 SAA3 GGGCATCATTTTCTGCTTCCT TTGGTAAGCTCTCCACATGTCTTTAG 
NM_001012671.2 STAT3 GGTAGCATGTGGGATGGTCTCT GCATCCCTAGAAACTCTGGTCAA 
BC108205.1 UXT TGTGGCCCTTGGATATGGTT GGTTGTCGCTGAGCTCTGTG 
NM_001271737.1 XBP1 GAGAGCGAAGCCAATGTGGTA ACTGTGAATTCAGGGTGATCTTTCT 
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Suppl. Table A.2.  Accession number, gene symbol, and forward and reverse primer sequences 
of genes analyzed in adipose tissue.  
Accession# Symbol Forward sequence Reverse sequence 
XM_005225005.1 ACTB ACCAACTGGGACGACATGGA GTCTCGAACATGATCTGGGTCAT 
BC140488.1 ADIPOQ GATCCAGGTCTTGTTGGTCCTAA GAGCGGTATACATAGGCACTTTCTC 
BC142093.1 CCL2 TCAACAGTAAGAAGATCTCCATGCA CAGGACGGTCTTGAAAATCACA 
BC102064.1 CCL5 CCCTGCTGCTTTGCCTATATCT ATAAAGACAACTGCTGCCATGGA 
AF285607.2 FASN ACCTCGTGAAGGCTGTGACTCA TGAGTCGAGGCCAAGGTCTGAA 
NM_001040470.2 HP GGTTCGGAAAACCATCGCTA CACTCGTGTCCCCTCCCTC 
EU276067.1 IL1B TCCACCTCCTCTCACAGGAAA TACCCAAGGCCACAGGAATCT 
EU276071.1 IL6 CCAGAGAAAACCGAAGCTCTCAT CCTTGCTGCTTTCACACTCATC 
NM_001110785.1 IL6R GCTCTTTCTACGTATTGTCCCTGTGT GGGTCGGGCTGTAGGAGTTT 
NM_173928.2 LEP GGCTTTGGCCCTATCTGTCTTA GAGACGGACTGCGTGTGTGA 
NM_001034036.1 PPARA CATAACGCGATTCGTTTTGGA CGCGGTTTCGGAATCTTCT 
NM_181024.2 PPARG CCAAATATCGGTGGGAGTCG ACAGCGAAGGGCTCACTCTC 
XM_005213506.1 RXRA ACGTCCTTGCTGTGTTTGAAAA TGAACCAGATTGGTCTACTGAAGGT 
DQ298246.1 SAA3 GGGCATCATTTTCTGCTTCCT TTGGTAAGCTCTCCACATGTCTTTAG 
DQ839567.1 TLR4 GCTGTTTGACCAGTCTGATTGC GGGCTGAAGTAACAACAAGAGGAA 
NM_173966.3 TNF CCAGAGGGAAGAGCAGTCCC TCGGCTACAACGTGGGCTAC 
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Suppl. Table A.3.  qPCR performance of genes measured in adipose tissue. 
 
Gene Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 
ADIPOQ 19.041 -2.884 -3.158 0.996 2.073 
CCL2 24.127 2.202 -2.950 0.990 2.183 
CCL5 28.851 6.926 -3.258 0.988 2.027 
FASN 25.073 3.148 -3.246 0.998 2.033 
HP 23.851 1.922 -3.248 0.993 2.032 
IL1B 26.699 4.774 -2.960 0.984 2.176 
IL6 28.168 6.245 -2.975 0.980 2.168 
IL6R 23.240 1.316 -3.256 0.991 2.028 
LEP 29.284 7.360 -3.383 0.980 1.975 
PPARA 26.544 4.619 -2.980 0.974 2.165 
PPARG 22.121 0.189 -2.980 0.994 2.165 
RXRA 21.610 -0.315 -2.942 0.990 2.187 
SAA3 26.765 4.840 -2.982 0.992 2.164 
TLR4 24.466 2.543 -3.057 0.991 2.124 
TNF 29.777 7.861 -2.953 0.982 2.180 
 
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal controls] for each 
time point and each cow. 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
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Suppl. Table A.4.  qPCR performance of genes measured in liver. 
Gene Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 
ACOX1 19.392 -1.593 -3.407 0.996 1.966 
ALB 13.056 -7.929 -3.330 0.997 1.997 
ANGPTL4 25.280 4.295 -3.286 0.991 2.015 
APOB 20.215 -0.770 -3.731 0.990 1.854 
CPT1A 22.335 1.350 -3.388 0.993 1.973 
FGF21 23.763 2.778 -3.173 0.992 2.066 
GHR 21.726 0.741 -3.509 0.993 1.927 
HMGSC2 19.260 -1.725 -3.549 0.992 1.913 
HP 21.985 1.000 -3.700 0.991 1.863 
IGF1 24.938 3.953 -2.911 0.920 2.206 
IGFALS 23.302 2.317 -3.695 0.991 1.865 
IGFBP1 18.343 -2.642 -3.695 0.984 1.865 
MTTP 21.590 0.605 -3.197 0.991 2.055 
NFKB1 24.243 3.258 -3.240 0.994 2.035 
PC 22.532 1.547 -3.452 0.981 1.948 
PCK1 19.177 -1.808 -3.663 0.992 1.875 
PDK4 24.765 3.780 -3.474 0.987 1.940 
PPARA 23.943 2.958 -3.073 0.986 2.116 
SAA2 19.921 -1.064 -3.422 0.993 1.960 
SAA3 23.894 2.909 -3.148 0.994 2.078 
STAT3 23.087 2.102 -3.412 0.991 1.964 
XBP1 19.422 -1.563 -3.616 0.992 1.890 
 
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal controls] for each 
time point and each cow. 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
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APPENDIX B 
 
CHAPTER 4 - SUPPLEMENTAL MATERIAL 
 
RNA Extraction. Adipose tissue was weighted (~0.2 g), immediately placed in 1.2 mL of 
QIAzol Lysis Reagent (cat#79306, Qiagen) and homogenized using a Mini-Beadbeater-24 
(cat#112011, Biospec Products Inc.) with two 30 s cycles, and a 1 min incubation on ice in 
between the cycles. Samples were then centrifuged for 10 min at 12,000 g and 4 °C, and the 
supernatant was transfer in a separate tube and mix with 240 μL of Chloroform (cat#C298, 
Fisher Chemical). After centrifugation for 15 min at 12,000 g and 4 °C, the aqueous phase was 
transferred to a new tube, mixed with 900 μL of 100% Ethanol (cat#2701, Decon Labs), and total 
RNA was cleaned using miRNeasy mini kit columns (cat# 217004, Qiagen) following 
manufacture protocol. During purification, genomic DNA was removed using the RNase-Free 
DNase Set (cat# 79254, Qiagen).  
RNA Quality Evaluation. The RNA quantity, purity, and integrity were determined using a 
NanoDrop ND-1000 (cat#E112352, NanoDrop Technologies Inc.) and the Agilent 2100 
Bioanalyzer (cat#G2939AA, Agilent Technologies Inc.). Samples had an average RIN score of 
6.5 ± 0.8. RNA samples were stored at -80 °C until analysis.  
mRNA cDNA Synthesis and qPCR Performance. Genes selected for transcript profiling are 
associated with fatty acid metabolism: fatty acid synthase (FASN), peroxisome proliferator-
activated receptor gamma (PPARG); adipokines: adiponectin (ADIPOQ), leptin (LEP); and 
inflammation: chemokine (C-C motif) ligand 2 (CCL2), chemokine (C-C motif) ligand 5 
(CCL5), haptoglobin (HP), interleukin-1β (IL1B), inteleukin-6 (IL6), inteleukin-6 receptor 
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(IL6R), retinoid X receptor alpha (RXRA), serum amyloid A3 (SAA3), toll-like receptor 4 
(TLR4), and tumor necrosis factor α (TNF). Complete information about primer sequences and 
qPCR performance are reported in the supplemental file (Suppl. Tab. B.1 and 3). A portion of the 
RNA was diluted to 100 ng/μL with DNase/RNase-free water for cDNA synthesis through RT-
PCR. Per each sample, 4 μL of diluted RNA, 5 μL of Random Primers (3 μg/μL; 
cat#11034731001, Roche) and 45 μL of DNase/RNase-free water. The mixture was incubated at 
65°C for 5 min and kept on ice for 3 min. A total of 36 μL of master mix, composed of 20 μL of 
5X First-Strand Buffer (cat#EP0441, Thermo Scientific), 5 μL of Oligo dT18 (Custom DNA 
Oligo Tubes, Integrated DNA Technologies), 10 μL of 10mM dNTP mix (cat#18427-088, 
Invitrogen), 1.25 μL of Reverse Transcriptase (200 U/μL as final concentration, cat#EP0441, 
Thermo Scientific), 0.625 μL of Rnase inhibitor (200 U/μL as final concentration, cat#EO0381, 
Thermo Scientific), and 8.125 μL of  DNase/RNase-free water, was added. The reaction was 
performed in an Eppendorf Mastercycler Gradient following the appropriate temperature 
program: 25°C for 5 min, 42°C for 60 min, and 70°C for 5 min. The cDNA was then diluted 1:4 
with DNase/RNase-free water, prior to quantitative PCR analysis. 
Quantitative PCR was performed using 4 μL diluted cDNA combined with 6 μL of a mixture 
composed of 5 μL SYBR Green master mix (cat#95073-05K, Quanta BioSciences), 0.4 μL each 
of 10 μM forward and reverse primers, and 0.2 μL DNase/RNase free water in a MicroAmp™ 
Optical 384-Well Reaction Plate (Applied Biosystems). Each sample was run in triplicate and a 7 
point relative standard curve plus the non-template control were used. The reactions were 
performed in an ABI Prism 7900 HT SDS instrument using the following conditions: 2 min at 50 
°C, 10 min at 95 °C, 40 cycles of 15 s at 95 °C (denaturation), and 1 min at 60 °C (annealing + 
extension). The presence of a single PCR product was verified by the dissociation protocol using 
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incremental temperatures to 95 °C for 15 s plus 65 °C for 15 s.  Data were calculated with the 
7900 HT Sequence Detection Systems Software. The final data were normalized using the 
geometric mean of three internal control genes (ICG): ACTB, GAPDH and RPS9 (Khan et al., 
2014, Vailati Riboni et al., 2015). 
microRNA cDNA Synthesis and qPCR Performance. miRNA selected for expression profiling 
are associated with immune cell infiltration (miR-26b, miR-126, miR-132, miR-155, miR-193), 
inflammation and lipolysis (miR-99a, miR-145, miR-221), and positive regulation of 
adipogenesis (miR-103, miR-143, miR-378). Complete information about primer sequences and 
qPCR performance are reported in the supplemental file (Suppl. Tab. 2 and 4). microRNA-
specific cDNA synthesis was performed starting from 5 μL of 100 ng/ μL diluted RNA, using the 
Quanta qScript microRNA cDNA Synthesis Kit (cat# 95107, Quanta BioSciences, Inc.), 
following the manufacturer’s protocols. The cDNA was diluted 1:4 with DNase/RNase-free 
water, and quantitative PCR analysis was performed according to the Quanta qScript kit protocol 
using SybrGreen, the specific primers and a universal primer provided with the kit. Each sample 
was run in triplicate and a 7 point relative standard curve plus the non-template control were 
used. The reactions were performed in an ABI Prism 7900 HT SDS instrument. Data were 
calculated with the 7900 HT Sequence Detection Systems Software. The final data were 
normalized using the geometric mean of, miR-let-7b, miR-16b and miR-181a, which served as 
the internal controls. 
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Suppl. Table B.1.  Accession number, gene symbol, and forward and reverse primer sequences 
of genes analyzed in adipose tissue.  
Accession# Symbol Forward sequence Reverse sequence 
BC140488.1 ADIPOQ GATCCAGGTCTTGTTGGTCCTAA GAGCGGTATACATAGGCACTTTCTC 
NM_174006.2 CCL2 TCAACAGTAAGAAGATCTCCATGCA CAGGACGGTCTTGAAAATCACA 
NM_175827.2 CCL5 CCCTGCTGCTTTGCCTATATCT ATAAAGACAACTGCTGCCATGGA 
NM_001012669.1 FASN ACCTCGTGAAGGCTGTGACTCA TGAGTCGAGGCCAAGGTCTGAA 
NM_001040470.2 HP GGTTCGGAAAACCATCGCTA CACTCGTGTCCCCTCCCTC 
NM_174093.1 IL1B TCCACCTCCTCTCACAGGAAA TACCCAAGGCCACAGGAATCT 
NM_173923 IL6 CCAGAGAAAACCGAAGCTCTCAT CCTTGCTGCTTTCACACTCATC 
NM_001110785.1 IL6R GCTCTTTCTACGTATTGTCCCTGTGT GGGTCGGGCTGTAGGAGTTT 
NM_173928.2 LEP GGCTTTGGCCCTATCTGTCTTA GAGACGGACTGCGTGTGTGA 
NM_181024.2 PPARG CCAAATATCGGTGGGAGTCG ACAGCGAAGGGCTCACTCTC 
NM_001304343.1 RXRA ACGTCCTTGCTGTGTTTGAAAA TGAACCAGATTGGTCTACTGAAGGT 
NM_181016.3 SAA3 GGGCATCATTTTCTGCTTCCT TTGGTAAGCTCTCCACATGTCTTTAG 
NM_174198.6 TLR4 GCTGTTTGACCAGTCTGATTGC GGGCTGAAGTAACAACAAGAGGAA 
NM_173966.3 TNF CCAGAGGGAAGAGCAGTCCC TCGGCTACAACGTGGGCTAC 
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Suppl. Table B.2. Measured microRNA assay primer sequence information. A PerfeCTa 
Universal PCR Primer (Quanta BioSciences, Inc.) was coupled to the assay primer for 
expression analysis via qPCR. 
miRNAs Sequence 
miR-26b TTCAAGTAATTCAGGATAGGTT 
miR-99a AACCCGTAGATCCGATCTTGT 
miR-103 AGCAGCATTGTACAGGGCTATGA 
miR-126 CGTACCGTGAGTAATAATGCG 
miR-132 TAACAGTCTACAGCCATGGTCG 
miR-143 TGAGATGAAGCACTGTAGCTCG 
miR-145 GTCCAGTTTTCCCAGGAATCCCT 
miR-155 TTAATGCTAATCGTGATAGGGGT 
miR-193 AACTGGCCCACAAAGTCCCGCTTT 
miR-221 AGCTACATTGTCTGCTGGGTTT 
miR-378 ACTGGACTTGGAGTCAGAAGGC 
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Suppl. Table B.3.  qPCR performance of measured genes. 
Gene Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 
ADIPOQ 18.11 -0.75 -3.404 0.997 1.967 
CCL2 24.27 5.44 -3.127 0.997 2.088 
CCL5 26.76 8.10 -3.321 0.995 2.001 
FASN 21.31 2.26 -3.334 0.994 1.995 
HP 23.87 4.69 -3.398 0.996 1.969 
IL1B 27.07 8.28 -3.297 0.988 2.011 
IL6 28.64 9.86 -3.330 0.964 1.997 
IL6R 22.40 3.66 -3.490 0.993 1.934 
LEP 24.44 5.47 -3.027 0.996 2.140 
PPARG 21.48 2.55 -3.489 0.993 1.935 
RXRA 21.58 2.73 -3.402 0.996 1.968 
SAA3 26.37 7.76 -3.080 0.992 2.112 
TLR4 24.88 5.86 -3.168 0.994 2.069 
TNF 29.42 10.62 -3.293 0.974 2.012 
 
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal controls] for 
each time point and each cow. 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
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Suppl. Table B.4.  qPCR performance of measured miRNAs. 
Gene Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 
miR-26b 18.37 1.37 -3.08 0.992 2.113 
miR-99a 14.34 -2.43 -3.28 0.998 2.019 
miR-103 21.19 4.43 -3.31 0.994 2.007 
miR-126 18.37 1.92 -3.29 0.996 2.015 
miR-132 17.47 1.17 -3.17 0.998 2.069 
miR-143 16.92 0.22 -3.26 0.998 2.028 
miR-145 19.16 2.45 -3.20 0.998 2.053 
miR-155 21.61 4.82 -3.22 0.995 2.044 
miR-193 18.14 1.62 -3.39 0.999 1.972 
miR-221 17.86 1.13 -3.28 0.996 2.018 
miR-378 21.25 4.34 -3.25 0.999 2.030 
 
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal controls] for 
each time point and each cow. 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
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APPENDIX C 
 
CHAPTER 5 – SUPPLEMENTAL MATERIAL 
 
 
Supplemental file 1. Provides detailed and complete information about the protocol used 
during the microarray and qPCR procedures, and blood collection and analysis. Moreover, it 
provides additional discussion points, omitted from the main body of the manuscript. 
SUPPLEMENTAL MATERIAL AND METHODS 
RNA extraction 
Liver tissue (30-50 mg) was homogenized in a TissueLyser II (Qiagen GmbH) for 2  2 min 
bursts at 30 Htz. Total RNA and DNA were extracted using a Qiagen AllPrep DNA/RNA mini 
kit (Qiagen GmbH) as per manufacturer’s instructions and RNA was treated with DNase 
(Ambion DNA-free kit; Ambion Inc., Austin, TX). The RNA quantity, purity, and integrity 
were determined using a NanoDrop ND-1000 (NanoDrop Technologies Inc., Wilmington, DE) 
and the Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA). Average RNA 
Integrity Number (RIN) for samples at -7, 7, and 28 d relative to parturition were 8.18 (± 
0.39), 7.77 (± 0.43), and 8.17 (± 0.45), respectively. RNA samples were stored at -80 °C until 
analysis. 
Microarrays 
cRNA Synthesis, Labeling, and Purification. The Agilent platform was chosen to 
conduct the microarray experiment, using the 44K Bovine (V2) gene expression microarray 
chip (Agilent Technologies Inc.), following the manufacturer’s protocols. Briefly, a total of 
200 ng of RNA per sample were used to generate first-strand cDNA, which was reverse 
transcribed to cRNA using the low-input quick amp labeling kit (Agilent Technologies Inc). 
The resulting cRNA was labeled with either Cy3 or Cy5 fluorescent dye, purified using 
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RNeasy mini spin columns (Qiagen), and subsequently eluted in 30 μL of DNase-RNase-free 
water. The NanoDrop ND-1000 (Thermo Fisher Scientific Inc., Waltham, MA) was used to 
confirm the manufacturer’s recommended criteria for yield and specific activity of at least 
0.825 μg and ≥6.  
Hybridization and Scanning. The labeled cRNA was fragmented and then hybridized 
to the microarray slide according to manufacturer’s protocol. Briefly, 825 ng of Cy3 and Cy5 
labeled cRNA sample were combined, mixed with 11 μL of 10× Blocking Agent (Agilent 
Technologies Inc.), 2.2 μL of 25× Fragmentation Buffer (Agilent Technologies Inc.), and 
nuclease-free water (to a final volume of 55 μL); and then fragmented at 60°C for 30 s. The 
reaction was then stopped by adding 55 μL of 2× GEx Hybridization Buffer (Agilent 
Technologies Inc.), and the samples were loaded onto the slide. These were hybridized in a 
rotating hybridization oven (Agilent Technologies Inc.) at 65°C for 17 h. The slides were 
washed according to the manufacturer’s recommended procedures and scanned using a 
GenePix 4000B scanner (Axon Instruments Inc., Sunnyvale, CA) and GenePix Pro v.6.1 
software. Resulting spots where features were substandard were flagged as bad and excluded 
from subsequent analysis. 
qPCR Validation 
cDNA synthesis. A portion of the RNA was diluted to 100 ng/μL with DNase/RNase-
free water for cDNA synthesis through RT-PCR. Per each sample, 4 μL of diluted RNA, 5 μL 
of Random Primers (3 μg/μL; cat#11034731001, Roche) and 45 μL of DNase/RNase-free 
water. The mixture was incubated at 65°C for 5 min and kept on ice for 3 min. A total of 36 μL 
of master mix, composed of 20 μL of 5X First-Strand Buffer (cat#EP0441, Thermo Scientific), 
5 μL of Oligo dT18 (Custom DNA Oligo Tubes, Integrated DNA Technologies), 10 μL of 
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10mM dNTP mix (cat#18427-088, Invitrogen), 1.25 μL of Reverse Transcriptase (200 U/μL as 
final concentration, cat#EP0441, Thermo Scientific), 0.625 μL of Rnase inhibitor (200 U/μL as 
final concentration, cat#EO0381, Thermo Scientific), and 8.125 μL of  DNase/RNase-free 
water, was added. The reaction was performed in an Eppendorf Mastercycler Gradient 
following the appropriate temperature program: 25°C for 5 min, 42°C for 60 min, and 70°C for 
5 min. The cDNA was then diluted 1:4 with DNase/RNase-free water, prior to quantitative 
PCR analysis. 
Real Time qPCR. Primer couples were designed using NCBI Primer-BLAST toll, and 
tested through normal PCR, using the same thermo cycle as the final qPCR analysis, and gel 
electrophoresis to certify the presence of a single PCR product of the expected size. The 
product was then purified and send for sequencing at the UIUC Core Sequencing Facility, to 
asses amplification of the correct target. Complete details on primer couples and amplification 
products sequences can be found in Supplemental Table C.8. Quantitative PCR was performed 
using 4 μL diluted cDNA combined with 6 μL of a mixture composed of 5 μL SYBR Green 
master mix (cat#95073-05K, Quanta BioSciences), 0.4 μL each of 10 μM forward and reverse 
primers, and 0.2 μL DNase/RNase free water in a MicroAmp™ Optical 384-Well Reaction 
Plate (Applied Biosystems). Each sample was run in triplicate and a 7 point relative standard 
curve plus the non-template control were used. The reactions were performed in an ABI Prism 
7900 HT SDS instrument using the following conditions: 2 min at 50 °C, 10 min at 95 °C, 40 
cycles of 15 s at 95 °C (denaturation), and 1 min at 60 °C (annealing + extension). The 
presence of a single PCR product was verified by the dissociation protocol using incremental 
temperatures to 95 °C for 15 s plus 65 °C for 15 s.  Data were calculated with the 7900 HT 
Sequence Detection Systems Software. The final data were normalized using the geometric 
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mean of three internal control genes (ICG): GAPDH, RPS9, and UXT. Details on qPCR 
performances can be found in Supplemental Table C.9. 
 
Blood Collection and analysis 
Blood was sampled by coccygeal venipuncture using evacuated blood tubes containing 
a lithium heparin anticoagulant. Samples were placed immediately on ice and centrifuged 
within 30 min at 1,500 × g for 12 min at 4°C. Following centrifugation, aspirated plasma was 
stored at −20°C until assayed. 
Blood NEFA and BHBA analysis was performed by Gribbles Veterinary Pathology 
Ltd. Blood metabolites were assayed using colorimetric techniques at 37°C with a Hitachi 
Modular P800 analyzer (Roche Diagnostics, Indianapolis, IN). Plasma NEFA concentration 
(mmol/L) was measured using Wako Chemicals (Osaka, Japan) kit NEFA HR2 measuring 
oxidative condensation of 3-methyl-N-ethyl-N-β hydroxyethyl aniline with 4-aminoantipyrine, 
while plasma BHBA (mmol/L) concentrations was assessed using Roche reagent kits 
measuring the reduction of NAD to NADH during oxidation of d-3-hydroxybutyrate to 
acetoacetate. 
 
SUPPLEMENTAL DISCUSSION 
B4F125 vs B4F75 
Lipid metabolism. Lipid metabolism in thinner cows was much more impacted by 
prepartum feeding management, with a distinct postpartum activation of every pathway among 
the top 25 impacted when animals were fed 125% compared with 75% of requirements. 
Biosynthetic pathways rather than catabolic ones were impacted around parturition. In fact, out 
of the five most-impacted pathways in this category, three are concerned with the biosynthesis 
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of fatty acids, unsaturated fatty acids, and their elongation in the mitochondria. Despite the lack 
of change in blood NEFA (Table 5.2), this response could be taken as an indication of lower 
postpartum mobilization of body reserves in BCS4 animals fed 125% than 75%. This idea 
agrees with the fact that overfeeding energy during the dry period also increases the 
concentration of plasma insulin, hence, preventing excessive adipose tissue lipolysis (Ji et al., 
2012). We further speculate that a possible greater postpartum mobilization in B4F75 cows 
could increase the hepatic uptake of fatty acids, consequently inhibiting the biosynthetic 
pathways, which is a well-established effect in non-ruminant liver. Additionally, NEFA values 
are often quite variable, especially as a function of meal patterns (Allen et al., 2005, Nakamura 
et al., 2014). Hepatic transcriptome alterations, in comparison, reflect longer-term regulatory 
responses to changes in BCS and nutrition.  
Among the non-biosynthetic pathways, ‘Glycerolipid metabolism’ was impacted and 
activated at 7 d postpartum in cows fed 125% of requirements. Because this pathway is 
involved in the synthesis of triacylglycerol (TAG) from free fatty acids, its activation could be 
a consequence of an increased flux of NEFA or could suggest a better ‘handling’ of the hepatic 
NEFA flux. Among the top DEG, the expression of DGAT1 (diacylglycerol O-acyltransferase 
1) had a fold change of + 4.5 in B4F125 cows. As the protein product of this gene catalyzes the 
final step of TAG synthesis, and the fact that BCS4 cows had an overall lower plasma 
concentration of NEFA (Table 5.2), the greater DGAT1 expression indicates a faster handling 
of mobilized fatty acids, avoiding accumulation in the liver that could lead to partial oxidation 
and ketogenesis. 
Also of great interest, is the activation of the ‘α-Linolenic acid metabolism’ in the first 
week after parturition combined with activation of the ‘Biosynthesis of unsaturated fatty acids’ 
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in lean animals fed 125%. The α-linolenic fatty acid (C18:3) is part of both pathways, being 
partially oxidized for energy in the first or converted to eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) in the second. These two ω-3 fatty acids elicit numerous effects 
on functional responses of cells involved in inflammation and immunity (Calder, 2013), all of 
which have been interpreted in the context of reducing inflammation, i.e. they are beneficial 
during inflammatory conditions (Calder, 2006). The concurrent increase in activity of the two 
pathways leads us to hypothesize a greater availability of C18:3 at the hepatic level (because its 
metabolism was increased), for synthesis of EPA or DHA and, hence, an improvement of the 
immunological status of the cow. This scenario would be beneficial as cows always experience 
an inflammatory state after parturition that can impair production and reproduction, and 
predispose to disease (Bertoni et al., 2008). 
B5F125 vs B5F75 
Lipid metabolism. The pathways of ‘Lipid metabolism’ impacted in optimally-
conditioned cows (BCS5) mainly concerned pathways of utilization rather than synthesis (as 
detected in the BCS4 group), and they were mostly impacted in early lactation (7 d). 
‘Sphingolipid metabolism’ and ‘Arachidonic acid metabolism’ were both impacted, being 
activated in B5F125 compared with B5F75 cows. However, because flux in ‘sphingolipid 
metabolism’ was close to zero (-0.58), we considered the pathway impacted and induced in 
both groups (B5F75 and B5F125). This pathway is associated with the production of 
ceramides, a lipid species that exerts biological effects through cellular proliferation, 
differentiation, and cell death, and interacts with several pathways involved in insulin 
resistance, oxidative stress, inflammation, and apoptosis, all of which are linked to non-
alcoholic fatty liver (Pagadala et al., 2012).  
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The fact that ‘sphingolipid metabolism’ was unequivocally activated early postpartum 
in BCS5 cows compared with BCS4 cows, regardless of feeding management, highlights how 
underconditioned animals should be less susceptible to liver TAG accumulation. In a recent 
study, it was reported that plasma concentrations of total ceramide and monohexosylceramide 
increase as lactation approaches, with greater concentrations in cows exhibiting higher 
adiposity a month prior to parturition relative to those with a lean phenotype (Rico et al., 
2015). Furthermore, changes in plasma ceramide concentration occurred concomitantly with 
changes in plasma NEFA, insulin, and insulin sensitivity, leading the authors to speculate that 
circulating ceramides may be fundamentally involved in the homeorhetic adaptation to early 
lactation (Rico et al., 2015). 
The activation of ‘Arachidonic acid metabolism’ in BCS5 animals fed 75% compared 
with 125% of requirements indicated some degree of inflammation in the former. Arachidonic 
acid metabolites can have both pro- and anti-inflammatory effects (Samuelsson, 1991). 
However, among the top DEG at 7 d postpartum with FC ≥ |3| (Supplemental Table C.5), the 
pro-inflammatory pathways seem to prevail, e.g. ALOX12 was upregulated in B5F75 cows. 
This enzyme catalyzes the conversion of arachidonic acid to 12-hydroxyeicosatetraenoic acid 
(12-HETE), a chemotactic compound in human neutrophils (Goetzl and Pickett, 1980). If 
biologically-active, this compound could initiate a local inflammatory response that might 
impair liver function. Activation of inflammatory-related hepatic functions also have been 
detected in feed-restricted compared with overfed cows (Shahzad et al., 2014); however, 
despite blood biomarkers revealing greater distress in liver and a low-grade inflammatory 
response in feed-restricted cows prepartum, overfed cows postpartum had greater bilirubinemia 
and hepatic lipid accumulation leading authors to conclude that feed restriction served to 
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“prime” the liver to better handle the postpartal metabolic and inflammatory challenges 
(Shahzad et al., 2014). 
The ‘Glycerophospholipid metabolism’ pathway was impacted and activated prepartum 
in B5F125 compared with B5F75. One of the central metabolites of the pathway is 
phosphatidylcholine, the main building block of cellular membranes that are components of 
lipoproteins. Lecithin also is secreted in bile to increase emulsification of micelles during 
intestinal lipid absorption. Even if in low amounts, the greater pasture allowance prepartum in 
B5F125 could have led to a greater amount of lipid ingestion and the induction of 
phosphatidylcholine production through the ‘glycerophospholipid metabolism’ to aid in 
absorption and repackaging of fatty acids in the liver (Bauchart, 1993). 
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Suppl. Table C.1. Differentially expressed genes at -7 days from parturition with fold change 
(FC) ≤ −3 or ≥ +3 in liver of animals with BCS 4 fed either 125 (B4F125) compared with 75 
(B4F75) % of requirement for the last 3 weeks before parturition. 
 
Gene Description FC at -7 d 
Upregulated 
LOC788413 olfactory receptor, family 10, subfamily C, member 1-like 11,16 
PTPRU protein tyrosine phosphatase, receptor type, U 4,81 
KIAA1045 KIAA1045 ortholog 4,66 
OBSCN obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF  4,45 
ARHGAP21 Rho GTPase activating protein 21 4,35 
AGR2 anterior gradient homolog 2 4,25 
ZNF445 zinc finger protein 445 4,21 
LOC100137795 uncharacterized LOC100137795 4,20 
SPATA2 spermatogenesis associated 2 4,00 
KIAA0319L KIAA0319-like ortholog 3,87 
DCP1A DCP1 decapping enzyme homolog A 3,84 
GTF2A1 general transcription factor IIA, 1, 19/37kDa 3,81 
ANKRD34B ankyrin repeat domain 34B 3,78 
PTPN4 protein tyrosine phosphatase, non-receptor type 4 3,77 
RNPEP arginyl aminopeptidase 3,39 
PLCL2 phospholipase C-like 2 3,34 
BDA20 major allergen BDA20 3,25 
C25H16orf45 chromosome 25 open reading frame, human C16orf45 3,08 
MBD1 methyl-CpG binding domain protein 1 3,02 
Downregulated 
MAU2 MAU2 chromatid cohesion factor homolog -7,61 
ZNF236 zinc finger protein 236 -7,49 
LRRC49 leucine rich repeat containing 49 -5,34 
AQP6 aquaporin 6 -4,85 
CACNB2 calcium channel, voltage-dependent, beta 2 subunit -4,56 
LOC789904 ribosomal protein L7a-like -4,30 
FGF11 fibroblast growth factor 11 -3,97 
SSPO SCO-spondin homolog -3,95 
LRRTM3 leucine rich repeat transmembrane neuronal 3 -3,59 
CDH7 cadherin 7, type 2 -3,59 
LOC524560 olfactory receptor, family 10, subfamily H, member 1-like -3,50 
SASH3 SAM and SH3 domain containing 3 -3,49 
EZH2 enhancer of zeste homolog 2 -3,39 
C2CD4D C2 calcium-dependent domain containing 4D -3,36 
KCNG3 potassium voltage-gated channel, subfamily G, member 3 -3,31 
PTH2R parathyroid hormone 2 receptor -3,19 
KCTD1 potassium channel tetramerization domain containing 1 -3,11 
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Suppl. Table C.1 (cont) 
   
HIATL1 hippocampus abundant transcript-like 1 -3,11 
RHOF ras homolog gene family, member F -3,05 
PDLIM7 PDZ and LIM domain 7 -3,03 
MS4A18 membrane-spanning 4-domains, subfamily A, member 18 -3,03 
WDR87 WD repeat domain 87 -3,01 
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Suppl. Table C.2. Differentially expressed genes at +7 days from parturition with fold change 
(FC) ≤ −3 or ≥ +3 in liver of animals with BCS 4 fed either 125 (B4F125) compared with 75 
(B4F75) % of requirement for the three weeks before parturition. 
 
Gene Description FC at +7 d 
Upregulated 
SOSTDC1 sclerostin domain containing 1 12,07 
MYOC myocilin, trabecular meshwork inducible glucocorticoid response 7,45 
MBOAT2 membrane bound O-acyltransferase domain containing 2 6,94 
SYT15 synaptotagmin XV 6,71 
HSFY2 heat shock transcription factor, Y linked 2 6,23 
GABRA6 gamma-aminobutyric acid (GABA) A receptor, alpha 6 5,69 
GAD2 glutamate decarboxylase 2 5,69 
LOC530773 germinal histone H4-like 5,54 
GALNT2 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 2 (GalNAc-T2) 
5,41 
FSCN3 fascin homolog 3, actin-bundling protein, testicular 5,16 
SLC24A6 solute carrier family 24 (sodium/potassium/calcium exchanger), member 6 4,86 
ANAPC15 anaphase promoting complex subunit 15  4,83 
SLC16A14 solute carrier family 16, member 14 (monocarboxylic acid transporter 14) 4,61 
DGAT1 diacylglycerol O-acyltransferase 1 4,50 
HS3ST2 heparan sulfate (glucosamine) 3-O-sulfotransferase 2 4,26 
EIF5A eukaryotic translation initiation factor 5A 4,24 
AARS alanyl-tRNA synthetase 4,19 
GRM1 glutamate receptor, metabotropic 1 4,06 
CRLF2 cytokine receptor-like factor 2 4,04 
GOLGA1 golgin A1 3,98 
PALM2 paralemmin 2 3,94 
TRIM63 tripartite motif containing 63 3,89 
TCRA T cell receptor, alpha 3,88 
GJD4 gap junction protein, delta 4, 40.1kDa 3,87 
HRH4 histamine receptor H4 3,84 
MGAT5 mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase 3,84 
MUC13 mucin 13, cell surface associated  3,83 
NFE2L1 nuclear factor (erythroid-derived 2)-like 1 3,79 
MAK male germ cell-associated kinase 3,74 
LOC783998 olfactory receptor, family 11, subfamily G, member 2-like 3,69 
TTLL6 tubulin tyrosine ligase-like family, member 6 3,69 
HERC2 hect domain and RLD 2 3,68 
ATG16L1 ATG16 autophagy related 16-like 1 3,64 
CACNA1A calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 3,62 
TMEM160 transmembrane protein 160 3,57 
FAM84B family with sequence similarity 84, member B 3,48 
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Suppl. Table C.2. (cont) 
   
ASXL3 additional sex combs like 3 3,48 
CELF4 CUGBP, Elav-like family member 4 3,46 
LRRC73 leucine rich repeat containing 73 3,43 
LBH limb bud and heart development 3,42 
OR52W1 olfactory receptor, family 52, subfamily W, member 1 3,42 
TLR7 toll-like receptor 7 3,41 
RPRD2 regulation of nuclear pre-mRNA domain containing 2 3,41 
KCNIP1 Kv channel interacting protein 1 3,39 
SP4 Sp4 transcription factor 3,35 
LOC615782 PWWP domain-containing protein MUM1L1 3,34 
TTLL8 tubulin tyrosine ligase-like family, member 8 3,32 
MAST1 microtubule associated serine/threonine kinase 1 3,32 
NKIRAS2 NFKB inhibitor interacting Ras-like 2 3,31 
MARCH10 membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase 3,31 
SLC14A1 solute carrier family 14 (urea transporter), member 1 3,31 
THBS2 thrombospondin 2 3,29 
ZFYVE20 zinc finger, FYVE domain containing 20 3,29 
PPP1R9A protein phosphatase 1, regulatory subunit 9A 3,29 
ENTPD6 ectonucleoside triphosphate diphosphohydrolase 6  3,27 
LOC614895 olfactory receptor, family 2, subfamily T, member 27-like 3,26 
DDX4 DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 3,22 
SLC8A1 solute carrier family 8 (sodium/calcium exchanger), member 1 3,21 
SLC18A2 solute carrier family 18 (vesicular monoamine), member 2 3,20 
WDR16 WD repeat domain 16 3,19 
SLC6A9 solute carrier family 6 (neurotransmitter transporter, glycine), member 9 3,16 
IPO4 importin 4 3,15 
SLC22A17 solute carrier family 22, member 17 3,15 
KLK4 kallikrein-related peptidase 4 3,14 
VWA2 von Willebrand factor A domain containing 2 3,14 
KCNT1 potassium channel, subfamily T, member 1 3,13 
ABCA13 ATP-binding cassette, sub-family A (ABC1), member 13  3,13 
ACTR3B ARP3 actin-related protein 3 homolog B 3,12 
SSTR2 somatostatin receptor 2 3,10 
COL4A6 collagen, type IV, alpha 6 3,09 
TXNDC8 thioredoxin domain containing 8 3,09 
MARCH4 membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase 3,08 
WC1.3 WC1.3 molecule 3,07 
MYH9 myosin, heavy chain 9, non-muscle 3,06 
NLN neurolysin (metallopeptidase M3 family) 3,06 
APLP2 amyloid beta (A4) precursor-like protein 2 3,05 
LOC100847827 transcription elongation regulator 1-like protein-like 3,05 
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Suppl. Table C.2. (cont) 
   
DOPEY1 dopey family member 1 3,02 
ATP5SL ATP5S-like 3,02 
NDP Norrie disease 3,01 
BTN1A1 butyrophilin, subfamily 1, member A1 3,01 
CALM calmodulin-like 3,01 
TNR tenascin R 3,00 
LOC100125776 olfactory receptor 3,00 
Downregulated 
ASPM asp (abnormal spindle) homolog, microcephaly associated -9,75 
BUB1 budding uninhibited by benzimidazoles 1 homolog -8,29 
O3FAR1 omega-3 fatty acid receptor 1 -7,98 
HIP1 huntingtin interacting protein 1 -6,12 
GLRA4 glycine receptor, alpha 4 -5,88 
LGSN lengsin, lens protein with glutamine synthetase domain -5,60 
TMEM169 transmembrane protein 169 -5,50 
CCK cholecystokinin -5,36 
GPX3 glutathione peroxidase 3 -5,25 
INS insulin -5,24 
CAMKK1 calcium/calmodulin-dependent protein kinase kinase 1, alpha -5,18 
LOC787081 UPF0632 protein A -5,13 
KIF4A kinesin family member 4A -4,88 
DAB2IP DAB2 interacting protein -4,69 
CKAP2 cytoskeleton associated protein 2 -4,69 
CHRDL1 chordin-like 1 -4,61 
RNASEH2A ribonuclease H2, subunit A -4,34 
RRM2 ribonucleotide reductase M2 -4,34 
GRASP GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein -4,22 
LOC526064 histone cluster 1, H2bl-like -4,13 
PLIN4 perilipin 4 -4,07 
RNF168 ring finger protein 168, E3 ubiquitin protein ligase -4,01 
LOC539789 stathmin-like pseudogene -4,01 
MC4R melanocortin 4 receptor -3,75 
LOC524985 olfactory receptor 1038-like -3,71 
ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9 -3,71 
OVOL2 ovo-like 2 (Drosophila) -3,66 
AGR2 anterior gradient homolog 2 -3,56 
MEIS2 Meis homeobox 2 -3,53 
E2F1 E2F transcription factor 1 -3,52 
NKG2C NKG2C protein -3,49 
UBE2C ubiquitin-conjugating enzyme E2C -3,48 
MYBL2 v-myb avian myeloblastosis viral oncogene homolog-like 2 -3,47 
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Suppl. Table C.2. (cont) 
   
ME1 malic enzyme 1, NADP(+)-dependent, cytosolic -3,45 
GPNMB glycoprotein (transmembrane) nmb -3,34 
BAALC brain and acute leukemia, cytoplasmic -3,33 
MEF2C myocyte enhancer factor 2C -3,33 
LOC787642 Olfactory receptor-like protein OLF2-like -3,28 
LOC510902 olfactory receptor, family 4, subfamily B, member 1-like -3,27 
CCDC162P coiled-coil domain containing 162, pseudogene -3,26 
VLDLR very low density lipoprotein receptor -3,26 
MED13L mediator complex subunit 13-like -3,25 
MAPRE3 microtubule-associated protein, RP/EB family, member 3 -3,25 
COL8A1 collagen, type VIII, alpha 1 -3,21 
LRRC16A leucine rich repeat containing 16A -3,20 
WDR93 WD repeat domain 93 -3,18 
VILL villin-like -3,17 
TMEM38A transmembrane protein 38A -3,16 
IKZF1 IKAROS family zinc finger 1 (Ikaros) -3,15 
C2H1orf64 chromosome 2 open reading frame, human C1orf64 -3,12 
METTL19 methyltransferase like 19 -3,09 
FAM13C family with sequence similarity 13, member C -3,08 
RFX5 regulatory factor X, 5 (influences HLA class II expression) -3,08 
RGS17 regulator of G-protein signaling 17 -3,07 
KCNMB1 potassium large conductance calcium-activated channel, subfamily M, beta 
member 1 
-3,07 
MARS methionyl-tRNA synthetase -3,05 
SPC24 SPC24, NDC80 kinetochore complex component, homolog -3,05 
WT1 Wilms tumor 1 -3,04 
LOC789904 ribosomal protein L7a-like -3,04 
BOLA-DMB major histocompatibility complex, class II, DMB -3,02 
LOC618591 killer cell lectin-like receptor-like -3,02 
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Suppl. Table C.3. Differentially expressed genes at +28 days from parturition with fold 
change (FC) ≤ −3 or ≥ +3 in liver of animals with BCS 4 fed either 125 (B4F125) compared 
with 75 (B4F75) % of requirement for the three weeks before parturition. 
 
Gene Description FC at +28 d 
Upregulated 
HSPA1A heat shock 70kDa protein 1A  4,27 
MYO7B myosin VIIB 3,82 
MMP9 matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV 
collagenase) 
3,69 
PPP1R21 protein phosphatase 1, regulatory subunit 21 3,41 
CDHR1 cadherin-related family member 1 3,31 
ALPK1 alpha-kinase 1 3,26 
APOA4 apolipoprotein A-IV 3,25 
FGF6 fibroblast growth factor 6 3,19 
Downregulated    
CD46 CD46 molecule, complement regulatory protein -9,87 
KRT9 keratin 9 -9,84 
PPP1R14C protein phosphatase 1, regulatory (inhibitor) subunit 14C -8,70 
AKAP6 A kinase (PRKA) anchor protein 6 -8,29 
KIR2DL5A killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 
5A 
-7,86 
FGF8 fibroblast growth factor 8 (androgen-induced) -7,40 
LOC100139191 uncharacterized LOC100139191 -7,36 
FGD3 FYVE, RhoGEF and PH domain containing 3 -7,33 
C7H5orf46 chromosome 7 open reading frame, human C5orf46 -7,22 
SGIP1 SH3-domain GRB2-like (endophilin) interacting protein 1 -7,21 
TCHHL1 trichohyalin-like 1 -6,97 
PLEKHG7 pleckstrin homology domain containing, family G (with RhoGef domain) 
member 7 
-6,85 
MYPN myopalladin -6,18 
OPN1SW opsin 1 (cone pigments), short-wave-sensitive -6,05 
LOC789829 sorting nexin-5-like -6,01 
RYR1 ryanodine receptor 1 -5,84 
KIAA1456 putative methyltransferase KIAA1456 homolog -5,79 
OVCH2 ovochymase 2 -5,78 
AGR2 anterior gradient homolog 2 -5,34 
LALBA lactalbumin, alpha- -5,14 
SLC35D3 solute carrier family 35, member D3 -5,10 
C26H10orf90 chromosome 26 open reading frame, human C10orf90 -5,08 
ALPK3 alpha-kinase 3 -5,06 
KRT6B keratin 6B -5,04 
CCDC178 coiled-coil domain containing 178 -5,01 
METTL24 methyltransferase like 24 -4,95 
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Suppl. Table C.3. (cont) 
   
LOC786089 establishment of cohesion 1 homolog 2-like -4,93 
TGM7 transglutaminase 7 -4,91 
PPP1R3A protein phosphatase 1, regulatory subunit 3A -4,90 
NEUROD6 neurogenic differentiation 6 -4,87 
SVOP SV2 related protein homolog (rat) -4,85 
CHRDL1 chordin-like 1 -4,78 
NIM1 serine/threonine-protein kinase NIM1 -4,73 
MMP13 matrix metallopeptidase 13 (collagenase 3) -4,64 
LOC532848 centrosomal protein KIAA1731-like -4,61 
RYR2 ryanodine receptor 2 (cardiac) -4,58 
HDAC9 histone deacetylase 9 -4,53 
ACHE acetylcholinesterase -4,52 
LAT2 linker for activation of T cells family, member 2 -4,47 
CTLA4 cytotoxic T-lymphocyte-associated protein 4 -4,45 
GABRA1 gamma-aminobutyric acid (GABA) A receptor, alpha 1 -4,44 
TAF1C TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 
110kDa 
-4,35 
MCF2 MCF.2 cell line derived transforming sequence -4,34 
GLYCAM1 glycosylation-dependent cell adhesion molecule 1 -4,33 
GHRL ghrelin/obestatin prepropeptide -4,33 
MTMR12 myotubularin related protein 12 -4,29 
CD4 CD4 molecule -4,28 
TEX13B testis expressed 13B -4,27 
DLGAP5 discs, large (Drosophila) homolog-associated protein 5 -4,24 
LOC618010 olfactory receptor, family 51, subfamily F, member 2-like -4,22 
GPR77 G protein-coupled receptor 77 -4,20 
LOC508589 olfactory receptor, family 8, subfamily A, member 1-like -4,20 
PI3 peptidase inhibitor 3, skin-derived (SKALP) -4,19 
IKZF1 IKAROS family zinc finger 1 (Ikaros) -4,11 
ATP2B3 ATPase, Ca++ transporting, plasma membrane 3 -4,09 
ITGA4 integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) -4,08 
UNC5B unc-5 homolog B -4,07 
NKX3-1 NK3 homeobox 1 -4,04 
DNAI2 dynein, axonemal, intermediate chain 2 -4,02 
PLAU plasminogen activator, urokinase -4,02 
KRT20 keratin 20 -4,02 
ATP8A2 ATPase, aminophospholipid transporter, class I, type 8A, member 2 -4,02 
DYNLRB1 dynein, light chain, roadblock-type 1 -4,02 
GPR88 G protein-coupled receptor 88 -4,00 
SLX4 SLX4 structure-specific endonuclease subunit homolog -3,98 
GALNT13 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 13 (GalNAc-T13) 
-3,97 
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Suppl. Table C.3. (cont) 
   
SUV39H1 suppressor of variegation 3-9 homolog 1 -3,96 
TUBB1 tubulin, beta 1 class VI -3,95 
VTCN1 V-set domain containing T cell activation inhibitor 1 -3,92 
C1H3orf52 chromosome 1 open reading frame, human C3orf52 -3,91 
PSMF1 proteasome (prosome, macropain) inhibitor subunit 1 (PI31) -3,90 
SMIM24 small integral membrane protein 24 -3,87 
GPNMB glycoprotein (transmembrane) nmb -3,85 
PCDH10 protocadherin 10 -3,82 
SYMPK symplekin -3,77 
LOC785406 olfactory receptor 5AL1 -3,74 
KIF5C kinesin family member 5C -3,74 
RNF183 ring finger protein 183 -3,72 
LOC508124 homer protein homolog 3-like -3,71 
LOC506891 olfactory receptor, family 9, subfamily G, member 4-like -3,71 
PTPN22 protein tyrosine phosphatase, non-receptor type 22 (lymphoid) -3,67 
NR4A2 nuclear receptor subfamily 4, group A, member 2 -3,67 
CNNM1 cyclin M1 -3,66 
GINS2 GINS complex subunit 2 (Psf2 homolog) -3,65 
RAX2 retina and anterior neural fold homeobox 2 -3,64 
NXF3 nuclear RNA export factor 3  -3,64 
IQGAP3 IQ motif containing GTPase activating protein 3 -3,62 
SPATS1 spermatogenesis associated, serine-rich 1 -3,61 
FGF18 fibroblast growth factor 18 -3,60 
PTX3 pentraxin 3, long -3,58 
SCN1A sodium channel, voltage-gated, type I, alpha subunit -3,55 
RBM28 RNA binding motif protein 28 -3,54 
CDH8 cadherin 8, type 2 -3,54 
SCRN1 secernin 1 -3,51 
LOC523060 olfactory receptor, family 4, subfamily A, member 15-like -3,49 
FAM70A family with sequence similarity 70, member A -3,46 
PRKCD protein kinase C, delta -3,45 
PREX1 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 -3,44 
SLC46A2 solute carrier family 46, member 2 -3,44 
SAA3 serum amyloid A 3 -3,42 
DPYSL4 dihydropyrimidinase-like 4 -3,40 
LOC618422 huntingtin-associated protein 1-like -3,38 
RPS29 ribosomal protein S29 -3,38 
OLFM4 olfactomedin 4 -3,36 
F2RL1 coagulation factor II (thrombin) receptor-like 1 -3,35 
PADI4 peptidyl arginine deiminase, type IV -3,32 
CHRAC1 chromatin accessibility complex 1 -3,31 
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Suppl. Table C.3. (cont) 
   
CLEC4E C-type lectin domain family 4, member E -3,30 
SHH sonic hedgehog -3,29 
TNFRSF9 tumor necrosis factor receptor superfamily, member 9 -3,26 
TAP tracheal antimicrobial peptide -3,25 
RPRD2 regulation of nuclear pre-mRNA domain containing 2 -3,24 
CCDC60 coiled-coil domain containing 60 -3,23 
ARMC3 armadillo repeat containing 3 -3,23 
ARF1 ADP-ribosylation factor 1 -3,23 
FLOT2 flotillin 2 -3,22 
TKDP2 trophoblast Kunitz domain protein 2 -3,22 
LOC510902 olfactory receptor, family 4, subfamily B, member 1-like -3,21 
CLSPN claspin -3,18 
LYZ1 ysozyme 1 -3,17 
GDPD3 glycerophosphodiester phosphodiesterase domain containing 3 -3,15 
DLX4 distal-less homeobox 4 -3,15 
C14H8orf34 chromosome 14 open reading frame, human C8orf34 -3,15 
PTPRU protein tyrosine phosphatase, receptor type, U -3,14 
FRY furry homolog -3,14 
BOSTAUV1R404 vomeronasal 1 receptor bosTauV1R404 -3,13 
CCDC136 coiled-coil domain containing 136 -3,12 
INTU inturned planar cell polarity effector homolog -3,12 
SNRPC small nuclear ribonucleoprotein polypeptide C -3,11 
ZZEF1 zinc finger, ZZ-type with EF-hand domain 1 -3,10 
VAV1 vav 1 guanine nucleotide exchange factor -3,10 
YBX2 Y box binding protein 2 -3,09 
CLOCK clock circadian regulator -3,09 
OR6C75 olfactory receptor, family 6, subfamily C, member 75 -3,08 
ZNF383 zinc finger protein 383 -3,06 
TK1 thymidine kinase 1, soluble -3,06 
LOC532330 insulin receptor substrate 3-like -3,04 
RCOR1 REST corepressor 1 -3,04 
RASAL2 RAS protein activator like 2 -3,03 
SNX29 sorting nexin 29 -3,03 
DYTN dystrotelin -3,01 
NTS neurotensin -3,00 
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Suppl. Table C.4. Differentially expressed genes at -7 days from parturition with fold change 
(FC) ≤ −3 or ≥ +3 in liver of animals with BCS 5 fed either 125 (B5F125) compared with 75 
(B5F75) % of requirement for the three weeks before parturition. 
 
Gene Description FC at -7 d 
Upregulated 
ESYT2 extended synaptotagmin-like protein 2 5,17 
CRYGD crystallin, gamma D 4,98 
RSPH1 radial spoke head 1 homolog 4,54 
ANGPTL7 angiopoietin-like 7 4,39 
PLD5 phospholipase D family, member 5 3,64 
RHBDL2 rhomboid, veinlet-like 2 3,54 
OBSCN obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF 3,18 
LOC787878 putative olfactory receptor 56B2-like 3,10 
Downregulated 
C1QL3 complement component 1, q subcomponent-like 3 -6,66 
CADPS Ca++-dependent secretion activator -6,15 
TRIM36 tripartite motif containing 36 -5,52 
MAEL maelstrom homolog -5,45 
NRCAM neuronal cell adhesion molecule -4,13 
FEZF1 FEZ family zinc finger 1 -4,03 
SLC26A8 solute carrier family 26, member 8 -3,80 
CKMT1B creatine kinase, mitochondrial 1B -3,71 
LOC782400 uncharacterized LOC782400 -3,71 
ELN elastin -3,25 
RPRD2 regulation of nuclear pre-mRNA domain containing 2 -3,11 
FLNA filamin A, alpha -3,09 
RPS28 ribosomal protein S28 -3,08 
FGFR2 fibroblast growth factor receptor 2 -3,03 
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Suppl. Table C.5. Differentially expressed genes at +7 days from parturition with fold change 
(FC) ≤ −3 or ≥ +3 in liver of animals with BCS 5 fed either 125 (B5F125) compared with 75 
(B5F75) % of requirement for the three weeks before parturition. 
 
Gene Description FC at +7 d 
Upregulated 
CRB1 crumbs homolog 1 7,77 
ALPK1 alpha-kinase 1 5,87 
TMEM163 transmembrane protein 163 5,18 
ARL14 ADP-ribosylation factor-like 14 4,76 
DAB2IP DAB2 interacting protein 4,66 
IPPK inositol 1,3,4,5,6-pentakisphosphate 2-kinase 4,65 
CALML5 calmodulin-like 5 4,41 
LOC616722 immunity-related GTPase family, cinema-like 4,30 
LOC618985 interferon, omega 1-like 4,16 
XPO4 exportin 4 4,15 
PGPEP1L pyroglutamyl-peptidase I-like 4,00 
LOC539818 ribophorin I-like 3,97 
MCART6 mitochondrial carrier triple repeat 6 3,93 
RASD2 RASD family, member 2 3,79 
MAN2C1 mannosidase, alpha, class 2C, member 1 3,73 
LOC788761 uncharacterized LOC788761 3,72 
C10H14orf39 chromosome 10 open reading frame, human C14orf39 3,69 
CCK cholecystokinin 3,66 
MAP3K12 mitogen-activated protein kinase kinase kinase 12 3,66 
NEIL3 nei endonuclease VIII-like 3 3,57 
LOC509124 olfactory receptor, family 9, subfamily G, member 4-like 3,51 
BMP7 bone morphogenetic protein 7 3,49 
CCDC113 coiled-coil domain containing 113 3,47 
LOC100140382 olfactory receptor, family 4, subfamily F, member 21-like 3,46 
DBIL5 endozepine-like peptide 2 3,41 
LOC618124 olfactory receptor, family 1, subfamily E, member 2-like 3,40 
CCBP2 chemokine binding protein 2 3,39 
LOC785309 T-cell receptor alpha chain V region PY14-like 3,31 
TRPC4 transient receptor potential cation channel, subfamily C, member 4 3,31 
DNAL4 dynein, axonemal, light chain 4 3,30 
KCNMB2 potassium large conductance calcium-activated channel, subfamily M, beta 
member 2 
3,30 
CRY1 cryptochrome 1 (photolyase-like) 3,29 
CLDN22 claudin 22 3,25 
LYG2 lysozyme G-like 2 3,23 
STAT5A signal transducer and activator of transcription 5A 3,15 
PDE10A phosphodiesterase 10A 3,13 
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Suppl. Table C.5. (cont) 
   
LOC532330 insulin receptor substrate 3-like 3,13 
FCGBP Fc fragment of IgG binding protein 3,11 
SLC6A6 solute carrier family 6 (neurotransmitter transporter, taurine), member 6 3,09 
LOC506670 solute carrier family 7 (anionic amino acid transporter), member 13-like 3,09 
LOC510100 olfactory receptor, family 10, subfamily A, member 5-like 3,08 
NKD1 naked cuticle homolog 1 3,04 
Downregulated    
FIGLA folliculogenesis specific basic helix-loop-helix -7,19 
KCNH6 potassium voltage-gated channel, subfamily H (eag-related), member 6 -6,74 
NDNF neuron-derived neurotrophic factor -6,71 
ELOVL7 ELOVL fatty acid elongase 7 -6,39 
TTF2 transcription termination factor, RNA polymerase II -5,68 
RTP3 receptor (chemosensory) transporter protein 3 -5,42 
PLEKHB2 pleckstrin homology domain containing, family B (evectins) member 2 -5,20 
PLD5 phospholipase D family, member 5 -4,79 
IRG1 immunoresponsive 1 homolog -4,70 
SLIT3 slit homolog 3 -4,50 
CAPN3 calpain 3, (p94) -4,49 
SUN3 Sad1 and UNC84 domain containing 3 -4,49 
FGF8 fibroblast growth factor 8 (androgen-induced) -4,29 
RS1 retinoschisin 1 -4,28 
OR10K1 olfactory receptor, family 10, subfamily K, member 1 -4,18 
GTPBP4 GTP binding protein 4 -4,10 
ANXA8L1 annexin A8-like 1 -4,09 
TRAF5 TNF receptor-associated factor 5 -4,02 
IFI47 interferon gamma inducible protein 47 -3,91 
UHRF1 ubiquitin-like with PHD and ring finger domains 1 -3,79 
KRT73 keratin 73 -3,71 
MTMR12 myotubularin related protein 12 -3,69 
NXPH3 neurexophilin 3 -3,63 
EFHB EF-hand domain family, member B -3,61 
AGAP2 ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 -3,51 
IFNA16 interferon, alpha 16 -3,47 
TAP1 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) -3,46 
KCNS1 potassium voltage-gated channel, delayed-rectifier, subfamily S, member 1 -3,32 
AMOTL2 angiomotin like 2 -3,30 
TRPA1 transient receptor potential cation channel, subfamily A, member 1 -3,29 
ALOX12 arachidonate 12-lipoxygenase -3,26 
FLT1 fms-related tyrosine kinase 1 -3,24 
KCTD6 potassium channel tetramerisation domain containing 6 -3,21 
RNF168 ring finger protein 168, E3 ubiquitin protein ligase -3,21 
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Suppl. Table C.5. (cont) 
   
MIS18BP1 MIS18 binding protein 1 -3,19 
NEU4 sialidase 4 -3,13 
ADAMTS4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 -3,13 
DAB2 disabled homolog 2, mitogen-responsive phosphoprotein -3,12 
RNF145 ring finger protein 145 -3,11 
LRRC3B leucine rich repeat containing 3B -3,10 
ICOS inducible T-cell co-stimulator -3,08 
ME1 malic enzyme 1, NADP(+)-dependent, cytosolic -3,04 
TMEM196 transmembrane protein 196 -3,01 
BCAT1 branched chain amino-acid transaminase 1, cytosolic -3,01 
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Suppl. Table C.6. Differentially expressed genes at +28 days from parturition with fold 
change (FC) ≤ −3 or ≥ +3 in liver of animals with BCS 5 fed either 125 (B5F125) compared 
with 75 (B5F75) % of requirement for the three weeks before parturition. 
 
Gene Description FC at +28 d 
Upregulated 
OPA3 optic atrophy 3 6,18 
LRRC49 leucine rich repeat containing 49 5,45 
FOXJ1 forkhead box J1 3,63 
ZNF19 zinc finger protein 19 3,61 
OTOL1 otolin 1 3,59 
CXCL11 chemokine (C-X-C motif) ligand 11 3,49 
UCN urocortin 3,39 
ZBTB46 zinc finger and BTB domain containing 46 3,03 
TNFAIP8L3 tumor necrosis factor, alpha-induced protein 8-like 3 3,01 
Downregulated 
LOC785406 olfactory receptor 5AL1 -6,05 
TMEM196 transmembrane protein 196 -4,22 
IFIT1 interferon-induced protein with tetratricopeptide repeats 1 -4,12 
TMEM54 transmembrane protein 54 -3,70 
SAA3 serum amyloid A 3 -3,43 
APOBEC3A apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A -3,42 
M-SAA3.2 mammary serum amyloid A3.2 -3,34 
MVK mevalonate kinase -3,07 
ATAD1 ATPase family, AAA domain containing 1 -3,03 
Suppl. Table C.7. Complete result datasets generated by the DIA analysis. The KEGG 
pathways are sorted by category and subcategory. Blue bars represent the Impact along the 
transition period, while red and green bars show the Direction of the Impact (red = 
upregulation, green = downregulation). [available for download from publisher at  
https://doi.org/10.1186/s12864-016-3191-3]
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Suppl. Table C.8. Accession number, gene symbol and EntrezID, forward and reverse primer sequences and product length of target 
genes for microarray validation. 
 
Accession # EntrezID Symbol Forward sequence Reverse Sequence Lenght 
NM_001081581.1 280969 ABAT TCATGTGGTACCGGAGCAAG GAATGGCTTTGGAGTGCGTG 174 
NM_001205333.1 515338 ACACB CACCCGCACCGGATGAC CCTCGAATCTCTGGAAGGCG 139 
NM_001192336.1 407169 ALOX12 AGGGCCAGCTGGACTGGTAT CGGACATCAGGTAGTGAGCC 121 
NM_001075321.1 507559 B4GALT7 GCCCTTTCGAGAACGCTTTG TGCCCGGTTGAACCTGAAAT 130 
NM_001083644.1 505926 BCAT1 GGCCCCACGATGAAGGATT TAAAACGGTGGCTCGTGTGA 123 
NM_001113232.2 514028 DSE TGGAGTACCTCCCTCCTTGG TCACCAACCAACTAGGCTGAG 177 
NM_001100337.1 511060 EXTL1 GCACAGGAAGGCCAGTGAC TGTGAGAAAGCCGACCATCC 157 
NM_174077.4 281210 GPX3 CCCTGCAACCAATTTGGAAA ACATACTTGAGGGTGGCTAGGATCT 78 
NM_001076814.1 507817 ME2 GCTCGAGTCCAGCAGAGC TTTCTCACCCCGCTTCTTGC 179 
NM_001206826.1 535975 UST AGAACAAACGTTCCCACAGGT TGTACCTGGGAAGGACCCAA 113 
NM_001008667.1 493989 XYLT2 GGCCGAGTCCTTCTTTCACA CAGCTTGCGGTTCCAGTTG 145 
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Suppl. Table C.9. qPCR performance of measured genes for microarray validation. 
Gene Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 
ABAT 21.81 0.69 -3.183 0.996 2.061 
ACACB 32.28 11.37 -3.194 0.975 2.056 
ALOX12 30.47 9.41 -3.014 0.998 2.147 
B4GALT7 25.72 4.72 -3.089 0.998 2.108 
BCAT1 29.53 8.58 -3.453 0.976 1.948 
DSE 28.15 7.20 -3.043 0.994 2.131 
EXTL1 27.25 6.20 -3.036 0.994 2.135 
GPX3 20.506 -0.521 -3.225 0.999 2.042 
ME2 26.935 5.995 -3.280 0.992 2.018 
UST 24.763 3.700 -3.183 0.990 2.061 
XYLT2 25.935 4.936 -3.380 0.994 1.976 
1 The median is calculated considering all cows 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal controls] 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
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Suppl. Figure C.1. Ingenuity pathway analysis legend for network analysis. 
 
 
 
258 
 
REFERENCES 
Allen, M. S., B. J. Bradford, and K. J. Harvatine. 2005. The cow as a model to study food intake 
regulation. Annual review of nutrition 25:523-547. 
Bauchart, D. 1993. Lipid absorption and transport in ruminants. Journal of dairy science 
76(12):3864-3881. 
Bertoni, G., E. Trevisi, X. Han, and M. Bionaz. 2008. Effects of inflammatory conditions on 
liver activity in puerperium period and consequences for performance in dairy cows. Journal of 
dairy science 91(9):3300-3310. 
Calder, P. C. 2006. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. 
American journal of clinical nutrition 83(6 Suppl):1505S-1519S. 
Calder, P. C. 2013. N-3 fatty acids, inflammation and immunity: New mechanisms to explain old 
actions. Proceedings of the Nutrition Society 72(3):326-336. 
Goetzl, E. J. and W. C. Pickett. 1980. The human PMN leukocyte chemotactic activity of 
complex hydroxy-eicosatetraenoic acids (HETEs). Journal of immunology 125(4):1789-1791. 
Ji, P., J. S. Osorio, J. K. Drackley, and J. J. Loor. 2012. Overfeeding a moderate energy diet 
prepartum does not impair bovine subcutaneous adipose tissue insulin signal transduction and 
induces marked changes in peripartal gene network expression. Journal of dairy science 
95(8):4333-4351. 
Nakamura, M. T., B. E. Yudell, and J. J. Loor. 2014. Regulation of energy metabolism by long-
chain fatty acids. Progress in lipid research 53:124-144. 
Pagadala, M., T. Kasumov, A. J. McCullough, N. N. Zein, and J. P. Kirwan. 2012. Role of 
ceramides in nonalcoholic fatty liver disease. Trends in endocrinology and metabolism 
23(8):365-371. 
Rico, J. E., V. V. Bandaru, J. M. Dorskind, N. J. Haughey, and J. W. McFadden. 2015. Plasma 
ceramides are elevated in overweight Holstein dairy cows experiencing greater lipolysis and 
insulin resistance during the transition from late pregnancy to early lactation. Journal of dairy 
science. 
Samuelsson, B. 1991. Arachidonic acid metabolism: Role in inflammation. Zeitschrift fur 
rheumatologie 50 Suppl 1:3-6. 
Shahzad, K., M. Bionaz, E. Trevisi, G. Bertoni, S. L. Rodriguez-Zas, and J. J. Loor. 2014. 
Integrative analyses of hepatic differentially expressed genes and blood biomarkers during the 
peripartal period between dairy cows overfed or restricted-fed energy prepartum. Plos one 
9(6):e99757. 
259 
 
APPENDIX D 
 
CHAPTER 6 - SUPPLEMENTAL MATERIAL 
 
RNA Extraction. Adipose tissue was weighted (~0.2 g), immediately placed in 1.2 mL of 
QIAzol Lysis Reagent (cat#79306, Qiagen) and homogenized using a Mini-Beadbeater-24 
(cat#112011, Biospec Products Inc.) with two 30 s cycles, and 1 min incubation on ice in 
between the cycles. Samples were then centrifuged for 10 min at 12,000 g and 4 °C, and the 
supernatant was transfer in a separate tube and mix with 240 μL of Chloroform (cat#C298, 
Fisher Chemical). After centrifugation for 15 min at 12,000 g and 4 °C, the aqueous phase was 
transferred to a new tube, mixed with 900 μL of 100% Ethanol (cat#2701, Decon Labs), and total 
RNA was cleaned using miRNeasy mini kit columns (cat# 217004, Qiagen) following 
manufacture protocol. During purification, genomic DNA was removed using the RNase-Free 
DNase Set (cat# 79254, Qiagen).  
RNA Quality Evaluation. The RNA quantity, purity, and integrity were determined using a 
NanoDrop ND-1000 (cat#E112352, NanoDrop Technologies Inc.) and the Agilent 2100 
Bioanalyzer (cat#G2939AA, Agilent Technologies Inc.). Samples had an average RIN score of 
6.5 ± 0.8. RNA samples were stored at -80 °C until analysis.  
mRNA cDNA Synthesis and qPCR Performance. Genes selected for transcript profiling are 
associated with fatty acid metabolism: fatty acid synthase (FASN), peroxisome proliferator-
activated receptor gamma (PPARG); adipokines: adiponectin (ADIPOQ); and inflammation: 
chemokine (C-C motif) ligand 2 (CCL2), chemokine (C-C motif) ligand 5 (CCL5), haptoglobin 
(HP), interleukin-1β (IL1B), inteleukin-6 (IL6), inteleukin-6 receptor (IL6R), retinoid X receptor 
alpha (RXRA), serum amyloid A3 (SAA3), toll-like receptor 4 (TLR4), toll-like receptor 9 (TLR9) 
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and tumor necrosis factor α (TNF). Complete information about primer sequences and qPCR 
performance are reported in the supplemental file (Suppl. Tab.D. 1 and 3). A portion of the RNA 
was diluted to 100 ng/μL with DNase/RNase-free water for cDNA synthesis through RT-PCR. 
Per each sample, 4 μL of diluted RNA, 5 μL of Random Primers (3 μg/μL; cat#11034731001, 
Roche) and 45 μL of DNase/RNase-free water. The mixture was incubated at 65°C for 5 min and 
kept on ice for 3 min. A total of 36 μL of master mix, composed of 20 μL of 5X First-Strand 
Buffer (cat#EP0441, Thermo Scientific), 5 μL of Oligo dT18 (Custom DNA Oligo Tubes, 
Integrated DNA Technologies), 10 μL of 10mM dNTP mix (cat#18427-088, Invitrogen), 1.25 
μL of Reverse Transcriptase (200 U/μL as final concentration, cat#EP0441, Thermo Scientific), 
0.625 μL of Rnase inhibitor (200 U/μL as final concentration, cat#EO0381, Thermo Scientific), 
and 8.125 μL of  DNase/RNase-free water, was added. The reaction was performed in an 
Eppendorf Mastercycler Gradient following the appropriate temperature program: 25°C for 5 
min, 42°C for 60 min, and 70°C for 5 min. The cDNA was then diluted 1:4 with DNase/RNase-
free water, prior to quantitative PCR analysis. 
Quantitative PCR was performed using 4 μL diluted cDNA combined with 6 μL of a mixture 
composed of 5 μL SYBR Green master mix (cat#95073-05K, Quanta BioSciences), 0.4 μL each 
of 10 μM forward and reverse primers, and 0.2 μL DNase/RNase free water in a MicroAmp™ 
Optical 384-Well Reaction Plate (Applied Biosystems). Each sample was run in triplicate and a 7 
point relative standard curve  plus the non-template control were used. Standard curve was 
created using a pool of RNA from all samples. The pool was then diluted 1:2 to obtain the first 
point of the curve, and then a serial dilution (1:4) was performed to obtain the remaining points. 
The reactions were performed in an ABI Prism 7900 HT SDS instrument using the following 
conditions: 2 min at 50 °C, 10 min at 95 °C, 40 cycles of 15 s at 95 °C (denaturation), and 1 min 
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at 60 °C (annealing + extension). The presence of a single PCR product was verified by the 
dissociation protocol using incremental temperatures to 95 °C for 15 s plus 65 °C for 15 s.  Data 
were calculated with the 7900 HT Sequence Detection Systems Software. The final data were 
normalized using the geometric mean of three internal control genes (ICG): ACTB, GAPDH and 
RPS9 (Khan et al., 2014, Vailati Riboni et al., 2015, Vailati Riboni et al., 2016). Stability of the 
ICG was confirmed by the Genorm algorithm (stability value < 1.5) (Vandesompele et al., 2002). 
microRNA cDNA Synthesis and qPCR Performance. MicroRNA (miRNA) selected for 
expression profiling are associated with immune cell infiltration (miR-26b, miR-126, miR-132, 
miR-155, miR-193b), inflammation and lipolysis (miR-99a, miR-145, miR-221), and positive 
regulation of adipogenesis (miR-103, miR-143, miR-378). Complete information about primer 
sequences and qPCR performance are reported in the supplemental file (Suppl. Tab. 2 and 4). 
miRNA-specific cDNA synthesis was performed starting from 5 μL of 100 ng/ μL diluted RNA, 
using the Quanta qScript microRNA cDNA Synthesis Kit (cat# 95107, Quanta BioSciences, 
Inc.), following the manufacturer’s protocols. The cDNA was diluted 1:4 with DNase/RNase-
free water, and quantitative PCR analysis was performed according to the Quanta qScript kit 
protocol using SybrGreen, the specific primers and a universal primer provided with the kit. 
Each sample was run in triplicate and a 7 point relative standard curve plus the non-template 
control were used. The reactions were performed in an ABI Prism 7900 HT SDS instrument. 
Data were calculated with the 7900 HT Sequence Detection Systems Software. The final data 
were normalized using the geometric mean of, miR-let-7b, miR-16b and miR-181a, which 
served as the internal controls. As for mRNA expression analysis, stability of the ICG was 
confirmed by the Genorm algorithm (stability value < 1.5) (Vandesompele et al., 2002). 
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Suppl. Table D.1.  Accession number, gene symbol, and forward and reverse primer sequences 
of genes analyzed in adipose tissue.  
Accession# Symbol Forward sequence Reverse sequence 
BC140488.1 ADIPOQ GATCCAGGTCTTGTTGGTCCTAA GAGCGGTATACATAGGCACTTTCTC 
NM_174006.2 CCL2 TCAACAGTAAGAAGATCTCCATGCA CAGGACGGTCTTGAAAATCACA 
NM_175827.2 CCL5 CCCTGCTGCTTTGCCTATATCT ATAAAGACAACTGCTGCCATGGA 
NM_001012669.1 FASN ACCTCGTGAAGGCTGTGACTCA TGAGTCGAGGCCAAGGTCTGAA 
NM_001040470.2 HP GGTTCGGAAAACCATCGCTA CACTCGTGTCCCCTCCCTC 
NM_174093.1 IL1B TCCACCTCCTCTCACAGGAAA TACCCAAGGCCACAGGAATCT 
NM_173923 IL6 CCAGAGAAAACCGAAGCTCTCAT CCTTGCTGCTTTCACACTCATC 
NM_001110785.1 IL6R GCTCTTTCTACGTATTGTCCCTGTGT GGGTCGGGCTGTAGGAGTTT 
NM_181024.2 PPARG CCAAATATCGGTGGGAGTCG ACAGCGAAGGGCTCACTCTC 
NM_001304343.1 RXRA ACGTCCTTGCTGTGTTTGAAAA TGAACCAGATTGGTCTACTGAAGGT 
NM_181016.3 SAA3 GGGCATCATTTTCTGCTTCCT TTGGTAAGCTCTCCACATGTCTTTAG 
NM_174198.6 TLR4 GCTGTTTGACCAGTCTGATTGC GGGCTGAAGTAACAACAAGAGGAA 
NM_183081 TLR9 CTGACACCTTCAGTCACCTGAG TGGTGGTCTTGGTGATGTAGTC 
NM_173966.3 TNF CCAGAGGGAAGAGCAGTCCC TCGGCTACAACGTGGGCTAC 
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Suppl. Table D.2. Measured microRNA assay primer sequence information. A PerfeCTa 
Universal PCR Primer (Quanta BioSciences, Inc.) was coupled to the assay primer for 
expression analysis via qPCR. 
miRNAs Sequence 
miR-26b TTCAAGTAATTCAGGATAGGTT 
miR-99a AACCCGTAGATCCGATCTTGT 
miR-103 AGCAGCATTGTACAGGGCTATGA 
miR-126 CGTACCGTGAGTAATAATGCG 
miR-132 TAACAGTCTACAGCCATGGTCG 
miR-143 TGAGATGAAGCACTGTAGCTCG 
miR-145 GTCCAGTTTTCCCAGGAATCCCT 
miR-155 TTAATGCTAATCGTGATAGGGGT 
miR-193b AACTGGCCCACAAAGTCCCGCTTT 
miR-221 AGCTACATTGTCTGCTGGGTTT 
miR-378 ACTGGACTTGGAGTCAGAAGGC 
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Suppl. Table D.3.  qPCR performance of measured genes. 
Gene Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 
ADIPOQ 19.61 0.52 -3.279 0.997 2.018 
CCL2 23.82 4.51 -3.073 0.980 2.116 
CCL5 24.51 5.51 -3.095 0.991 2.104 
FASN 23.95 4.92 -3.369 0.997 1.981 
HP 21.65 2.40 -3.357 0.990 1.986 
IL1B 27.40 8.48 -3.398 0.984 1.969 
IL6 28.70 9.80 -3.011 0.992 2.148 
IL6R 21.93 3.13 -3.204 0.995 2.052 
PPARG 23.71 4.69 -3.238 0.991 2.036 
RXRA 23.61 4.70 -3.249 0.994 2.031 
SAA3 25.46 6.33 -3.318 0.981 2.002 
TLR4 29.43 10.60 -3.101 0.990 2.101 
TLR9 29.71 10.90 -3.803 0.999 1.832 
TNF 27.77 8.81 -3.184 0.991 2.061 
 
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal controls] for 
each time point and each cow. 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
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Suppl. Table D.4.  qPCR performance of measured miRNAs. 
Gene Median Ct1 Median ∆Ct2 Slope3 (R2)4 Efficiency5 
miR-26b 18.57 0.87 -3.43 0.993 1.956 
miR-99a 18.51 0.86 -3.32 0.995 2.003 
miR-103 19.52 2.00 -3.21 0.996 2.050 
miR-126 17.22 -0.64 -3.30 0.996 2.007 
miR-132 23.72 6.24 -3.28 0.992 2.019 
miR-143 20.82 3.24 -3.26 0.993 2.025 
miR-145 17.21 -0.30 -3.50 0.991 1.931 
miR-155 21.95 4.37 -3.29 0.991 2.015 
miR-193b 19.35 1.44 -3.16 0.994 2.074 
miR-221 21.16 3.76 -3.34 0.999 1.991 
miR-378 22.90 5.30 -3.20 0.999 2.051 
 
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal controls] for 
each time point and each cow. 
3 Slope of the standard curve. 
4 R2 stands for the coefficient of determination of the standard curve. 
5 Efficiency is calculated as [10(-1 / Slope)]. 
266 
 
Suppl. Table D.5. Interaction between far-off and close-up feeding management, and time 
(FO*CU*T) on subcutaneous adipose tissue expression (back-transformed LSM and SEM) in 
grazing dairy cows during the transition period 
 
  
 
FO*CU*T 
  
  
 
SlowBCS  FastBCS 
 
p-value 
 Target Wk1 Feed60 Feed90 Feed120  Feed60 Feed90 Feed120 SEM2 FO*CU*T 
Infiltration of immune cells 
CCL2 -1 0.59 0.26 0.92  0.22 0.32 0.66 0.59 0.71 
1 0.52 0.78 1.28  0.31 1.05 1.26 
4 1.39 0.87 1.41  1.30 1.16 0.67 
CCL5 -1 0.83 0.67 0.83  1.24 0.61 0.78 0.50 0.14 
1 1.65 1.20 0.95  0.87 0.74 0.85 
4 0.81 1.44 0.36  0.83 0.82 1.22 
Inflammation and lipolysis 
HP -1 0.08 0.02 0.22  0.08 0.03 0.15 0.46 0.55 
1 0.69 0.10 0.10  0.20 0.18 0.48 
4 0.20 0.10 0.03  0.07 0.08 0.09 
IL1B -1 0.98 0.94 0.56  0.35 0.57 1.01 0.58 0.45 
1 1.34 1.14 0.35  0.44 1.56 0.86 
4 1 1.63 0.16  0.44 0.62 0.53 
IL6 -1 0.71 0.19 0.57  0.05 0.26 0.31 0.46 0.15 
1 0.18 0.57 0.35  0.09 0.68 0.37 
4 0.82 0.52 0.86  0.54 0.40 0.29 
IL6R -1 1.26 0.81 0.86  0.85 0.66 0.74 0.29 0.71 
1 1.22 1.63 0.84  0.91 1.32 0.90 
4 0.93 1.40 0.65  0.93 1.04 1 
SAA3 -1 0.22 0.18 0.20  0.64 0.14 0.19 0.31 0.62 
1 0.50 0.19 0.69  0.65 0.31 0.19 
4 0.17 0.17 0.36  0.21 0.13 0.13 
TLR4 -1 1.29 0.42 0.82  0.63 1.04 0.64 0.52 0.24 
1 0.63 0.64 1.95  1.84 0.72 0.76 
4 0.94 0.77 1.80  0.95 0.78 0.83 
TLR9 -1 0.91 0.47 0.52  0.48 0.35 0.45 0.20 0.77 
1 0.73 1.25 0.55  0.51 1.15 0.52 
4 0.72 0.89 0.46  0.53 0.62 0.54 
TNF -1 1.16 0.74 1.09  0.55 0.75 0.96 0.42 0.05 
1 1.78 1.21 1.08  0.85 1.58 1.39 
4 1.15 1.98 0.37  1.10 1.35 1.06 
Adipogenesis and Lipid metabolism 
ADIPOQ -1 1.20 1.38 0.74  0.74 1.85 0.68 0.62 0.48 
1 0.33 1.04 0.58  0.25 0.47 0.39 
4 0.52 0.73 0.81  0.85 0.47 0.94 
FASN -1 0.22 2.83 0.22  0.14 4.31 0.40 1.94 0.35 
1 0.06 0.08 0.03  0.02 0.07 0.06 
4 0.23 0.09 0.02  0.05 0.09 0.16 
PPARG -1 1.78 1.81 1.09  0.72 2.56 0.78 0.71 0.17 
1 0.46 1.26 0.73  0.34 0.65 0.58 
4 0.80 0.98 0.75  1.06 0.83 1.16 
RXRA -1 1.23 1.58 1.03  1.54 1.73 1.41 0.33 0.88 
1 1.09 1.09 0.68  0.71 0.69 0.89 
4 0.85 0.76 0.64  0.91 0.73 1.04 
1 Wk = week relative to parturition; T = time FO = Far-off feeding management; CU = close-up feeding 
management 
2 SEM = greatest standard error of the mean. 
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Suppl. Table D.6. Interaction between far-off and close-up feeding management, and time 
(FO*CU*T) on subcutaneous adipose tissue microRNA expression (back-transformed LSM and 
SEM) in grazing dairy cows during the transition period 
  
 FO*CU*T 
  
  
SlowBCS  FastBCS 
 
p-value 
Target Wk1 Feed60 Feed90 Feed120  Feed60 Feed90 Feed120 SEM2 FO*CU*T 
Infiltration of immune cells              
miR-26b -1 0.99 0.65 0.91  0.95 1.23 1.03 0.19 0.33 
1 1.16 1.12 0.71  1.08 1.19 0.86 
4 1.09 1.15 0.70  0.79 1.07 0.89 
miR-126 -1 0.58 0.48 0.64  1.61 0.93 0.70 0.38 0.62 
1 0.76 1.30 0.92  0.80 1.49 0.73 
4 0.68 1.03 1.25  0.99 0.66 0.81 
miR-132 -1 1.18 1.31 1.16  0.80 0.90 0.99 0.18 0.26 
1 0.99 1.08 1.10  0.81 0.68 1.10 
4 0.91 0.88 1.34  0.99 0.98 1.08 
miR-155 -1 0.96 1.07 1.60  0.89 0.64 0.87 0.29 0.41 
1 0.98 0.83 2.07  1.34 0.71 1.35 
4 1.13 0.85 1.66  1.44 1.30 1.25 
miR-193 -1 0.98 1.44 0.79  1.51 1.59 1.10 0.41 0.63 
1 1.37 0.80 0.81  0.89 0.55 0.69 
4 0.62 0.49 1.14  0.91 0.44 0.72 
Inflammation and lipolysis            
miR-99a -1 0.59 0.62 0.68  1.73 1.10 0.85 0.35 0.94 
1 0.71 1.03 0.89  1.21 1.22 0.75 
4 0.72 0.66 1.30  0.70 0.63 0.73 
miR-145 -1 1 1.25 1.40  1.56 0.78 0.83 0.52 0.68 
1 1.54 1.15 2.49  1.27 0.89 0.91 
4 0.79 0.90 1.70  1.06 0.83 0.99 
miR-221 -1 0.78 0.86 0.95  0.91 0.62 0.81 0.21 0.6 
1 0.85 0.82 1.24  1.08 0.85 1.08 
4 0.80 0.98 1.35  1.20 0.97 0.90 
Proadipogenic                
miR-103 -1 0.79 0.82 0.90  1.12 0.75 0.97 0.15 0.14 
1 1.38 0.95 1.06  1.07 0.90 1.10 
4 0.93 1.10 1.11  1.12 0.84 0.79 
miR-143 -1 0.77 0.54 0.69  1.61 0.83 0.69 0.49 0.83 
1 1.12 1.68 0.95  0.84 1.86 0.65 
4 0.71 1.22 1.17  0.67 0.85 0.69 
miR-378 -1 0.82 1.10 0.71  1.75 1.67 0.95 0.36 0.42 
1 0.90 0.70 0.71  0.67 0.67 0.71 
4 0.60 0.59 1.15  0.89 0.43 0.75 
1 Wk = week relative to parturition; T = time FO = Far-off feeding management; CU = close-up feeding management 
2 SEM = greatest standard error of the mean. 
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Suppl. Table D.7. Interaction between far-off and close-up feeding management, and time (FO*CU*T) on plasma concentration of 
fatty acids, BHB, and cholesterol grazing dairy cows during the transition period 
.
  
 
 FO*CU*T     
  
 
SlowBCS  FastBCS   p-value 
  Wk1 Feed60 Feed90 Feed120  Feed60 Feed90 Feed120 SEM2 FO*CU*T 
Fatty Acids 
(mmol/L) 
-1 1.011 0.697 0.406  0.776 0.682 0.348 0.090 0.55 
1 1.005 1.073 1.023  0.974 0.964 0.970 
4 0.505 0.543 0.589  0.410 0.524 0.387 
BHB 
(mmol/L) 
-1 0.613 0.480 0.390  0.501 0.437 0.311 0.053 0.41 
1 0.668 0.650 0.678  0.583 0.618 0.676 
4 0.460 0.558 0.525  0.484 0.474 0.594 
Cholesterol 
(mM) 
-1 3425 3036 2515  3146 2627 2412 424 0.60 
1 2241 2095 2180  2462 1521 1737 
4 1734 2180 1994  1630 2800 2231 
1 Wk = week relative to parturition; T = time FO = Far-off feeding management; CU = close-up feeding management 
2 SEM = greatest standard error of the mean. 
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Suppl. Table D.8.  Blast results for the comparison of the analyzed Bos taurus miRNA, and 
some common target mRNA sequences, with the respective Homo sapiens sequences 
Subject # B. taurus # H. sapiens Cover1 E-score2 Identity3 
miRNA 
miR-26b NR_030883.1 NR_029500.1 90% 2.00e-37 99% 
miR-99a NR_030927.1 NR_029514.1 100% 2.00e-41 100% 
miR-103 NR_031387.1 NR_029519.1 100% 1.00e-38 100% 
miR-126 NR_030923.1 NR_029695.1 97% 3.00e-34 99% 
miR-132 NR_031374.1 NR_029674.1 100% 2.00e-50 99% 
miR-143 NR_030868.1 NR_029684.1 100% 1.00e-47 97% 
miR-145 NR_030906.1 NR_029686.1 100% 4.00e-45 100% 
miR-155 NR_031030.1 NR_030784.1 100% 2.00e-26 94% 
miR-193 NR_031097.1 NR_030177.1 100% 1.00e-39 98% 
miR-221 NR_030881.1 NR_029635.1 97% 4.00e-48 95% 
miR-378 NR_030898.1 NR_029870.1 100% 9.00e-32 98% 
mRNA4 
CCL25 NM_174006.2 NM_002982.3 95% 2.00e-141 74% 
FABP NM_174314.2 NM_001442.2 100% 0.00 86% 
PPARG5 NM_181024.2 NM_015869.4 94% 0.00 89% 
1 percent of the B. taurus sequence that overlaps the H. sapiens  sequence 
2 describes the random background noise. The lower the E-value, or the closer it is to zero, the 
more ‘significant’ the match is. 
3 percent similarity between the B. taurus and H. sapiens sequences over the length of the 
coverage area 
4 as miRNA act on the transcribed mRNA, rather than the DNA sequence, the blast was 
conducted on the first  
4 human isoform A was chosen for the blast 
5 human transcription variant 2 was chosen for the blast 
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Suppl. Table D.9.  Blastn (nucleotide) and Blastp (protein) results for the comparison of Bos 
taurus with the respective Homo sapiens mRNA and protein sequences of the players involved in 
CCL2 immune cells infiltration signaling. 
Subject # B. taurus # H. sapiens Cover1 E-score2 Identity3 
mRNA sequence 
CCL2 NM_174006.2 NM_002982.3 95% 2.00e-141 74% 
MMP12 NM_001206640.1 NM_002426.5 79% 0.00 78% 
CCR2, isoform A NM_001194959.1 NM_001123041.2 85% 0.00 85% 
CCR2, isoform B NM_001194959.1 NM_001123396.1 97% 0.00 85% 
CCR4 NM_001100293.2 NM_005508.4 59% 0.00 83% 
Protein sequence 
CCL2 NP_776431.1 NP_002973.1 98% 1.00e-47 72% 
MMP12 NP_001193569.1  NP_002417.2 99% 0.00 68% 
CCR2 isoform A NP_001181888.1 NP_001116513.2 84% 0.00 81% 
CCR2 isoform B NP_001181888.1 NP_001116868.1 97% 0.00 80% 
CCR4 NP_001093763.1  NP_005499.1 100% 0.00 90% 
1 percent of the B. taurus sequence that overlaps the H. sapiens  sequence 
2 describes the random background noise. The lower the E-value, or the closer it is to zero, the 
more ‘significant’ the match is. 
3 percent similarity between the B. taurus and H. sapiens sequences over the length of the 
coverage area 
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Suppl. Figure D.1.  Effect of far-off and close-up feeding management on TNF (tumor necrosis 
factor α) subcutaneous adipose tissue expression (back-transformed LSM and SEM) in grazing 
dairy cows during the transition period 
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APPENDIX E 
 
CHAPTER 7 – SUPPLEMENTARY MATERIAL 
 
 
BHMT activity assay. All liver samples were weighed and homogenized immediately in 4 vol of 
50 mM potassium phosphate buffer (pH 7.4) containing 2 mM EDTA and 1 mM 
mercaptoethanol. The homogenates was centrifuged at 4 °C for 45 min at 18,000 × g. The 
supernatant fraction was used for enzyme assay and protein concentration determination via the 
Bradford assay. DL-homocysteine was prepared fresh daily from homocysteine thiolactone 
hydrochloride (15.4 mg) in 400 µL 2 N sodium hydroxide and 600 µL saturated mono potassium 
phosphate. The standard assay contained 5 mM DL-Hcy, 2 mM betaine (0.05-0.1 µCi), and 50 
mM Tris-HCl (pH = 7.5). The final reaction volume was 0.5 mL. Reaction tubes were capped 
with rubber stoppers and kept in ice water until the assay was started by transferring the tubes 
into a 37 °C water bath. After 1 h incubation, the reaction was terminated by adding 2.5 mL of 
ice-cold water into each tube. The samples were applied to a Dowex 1-X4 (OH-; 200-400 mesh) 
column (0.6 × 3.75 cm), and the unreacted betaine was washed off the column with 15 mL water. 
Dimethylglycine and methionine were eluted into scintillation vials with 3 mL of 1.5 N HCl. 
Seventeen milliliters of scintillation mixture (Ecolume, ICN) were added to each vial and 
counted. Blanks contained all of the reaction components except enzyme, and their values were 
subtracted from the sample values. All samples were assayed in duplicate. 
MTR activity assay. All liver samples were weighed and homogenized immediately in 4 vol of 
50 mM potassium phosphate buffer (pH 7.5) containing 2 mM EDTA. The homogenates was 
centrifuged at 4 °C for 45 min at 18,000 × g. The supernatant fraction was used for enzyme assay 
and protein concentration determination by the Bradford assay. The standard assay contained 1 
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M potassium phosphate buffer (pH 7.2), 0.5 M DTT, 3.8 mM S-adenosylmethionine, 100 mM 
DL-Hcy, 5 mM hydroxocobalamin, and 5 mM methyl-tetrahydrofolate (0.1 µCi). The final 
reaction vol was 0.5 mL. Reaction tubes were capped with rubber stoppers and kept in ice water 
until the assay was started by transferring the tubes into a 37 °C water bath. After 0.5 h 
incubation, the reaction was terminated by adding 0.5 mL of ice-cold water into each tube. The 
samples were applied to an AG 1X8 column, and elute was collected also from additional 2 mL 
of ice-cold water applied to the column. Seventeen milliliters of scintillation mixture (Ecolume, 
ICN) were added to each vial and counted. Blanks contained all of the reaction components 
except enzyme, and their values were subtracted from the sample values. All samples were 
assayed in duplicate. 
CBS activity assay. All liver samples were weighed and homogenized immediately in 4 vol of 50 
mM potassium phosphate buffer (pH 7.4) containing 2 mM EDTA and 1 mM mercaptoethanol. 
The homogenates was centrifuged at 4 °C for 45 min at 18,000 × g. The supernatant fraction was 
used for enzyme assay and protein concentration determination by the Bradford assay. The 
standard assay mixture (400 μL) contained 0.38 mmol·L-1 S-adenosylmethionine, 7.5 mM L-
Hcy, 10 mM 14C-Ser (0.07 μCi), and 50 μL cow liver extract. Reaction tubes were capped with 
rubber stoppers and kept in ice water until the assay was started by transferring the tubes into a 
37 °C water bath. After 1 h incubation, the reaction was terminated by adding 0.4 mL 10% 
trichloroacetic acid and 2.2 mL ice-cold water into each tube. The samples were applied to an 
AG 50 W X8 column, 8 mL of water was applied to the column, and 14C-Ser was eluted by 
applying 24 mL of 0.6M hydrochloric acid to the column. Following an additional wash with 16 
mL water, 14C-cystathionine was eluted by applying 5 mL of 3M ammonium hydroxide to the 
column and collected in scintillation vials. Seventeen milliliters of scintillation mixture 
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(Ecolume, ICN) were added to each vial and counted. Blanks contained all of the reaction 
components except enzyme, and their values were subtracted from the sample values. All 
samples were assayed in duplicate. 
 
